Advanced optical microscopy toolkits for non-invasive imaging in oncology by Osseiran, Sam
Advanced Optical Microscopy Toolkits for
Non-Invasive Imaging in Oncology
by
Sam Osseiran
B.Eng., Polytechnique Montreal (2013)
Submitted to the Harvard-MIT Program in Health Sciences and
Technology
in partial fulfillment of the requirements for the degree of
Doctor of Philosophy in Medical Engineering and Medical Physics
at the
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
September 2018
Massachusetts Institute of Technology 2018. All rights reserved.
Signature redacted
A uthor ................................
Harvard-MIT Program in Health Sciences and Technology
August 24, 2018
Certified by ........................ Signature redacted
Conor vans, PhD
Assistant Professor of Dermatology, Harvar Medical School,
Wellman Center for Photomedicine, Massachusetts General Hospital
"'2 T esis SupervisorSignature redacted S
A ccepted by ....... .................
Emery N. Brown, MD, PhD
Director, Harvard-MT Program in Health Sciences and Technology
Professor of Computational Neuroscience and Health Sciences and
MASSACHUSTS INSTITUTE TechnologyOF TECHNOLOGY Tecnoog
OCT 092018
LIBRARIES
MITLibraries
77 Massachusetts Avenue
Cambridge, MA 02139
http://Iibraries.mit.edu/ask
DISCLAIMER NOTICE
Due to the condition of the original material, there are unavoidable
flaws in this reproduction. We have made every effort possible to
provide you with the best copy available.
Thank you.
The images contained in this document are of the
best quality available.
2
Advanced Optical Microscopy Toolkits for Non-Invasive
Imaging in Oncology
by
Sam Osseiran
Submitted to the Harvard-MIT Program in Health Sciences and Technology
on August 24, 2018, in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy in Medical Engineering and Medical Physics
Abstract
Despite significant advances in the fields of biophotonics and oncology alike, several
challenges persist in the study, assessment, and treatment of cancer, ranging from
the accurate identification and examination of potential risk factors, early diagnosis
of dysplastic lesions, and monitoring of the complex heterogeneity of cellular popula-
tions within tumors. To study such dynamics at the microscale, non-invasive optical
toolkits offer the potential to identify, characterize, and visualize key molecules and
their interactions in their native biological context, ranging from in vitro cell cul-
tures to in vivo studies in both animal models and humans. In the present thesis,
examples of such applications of optical tools will be presented, including: (1) the
assessment of cellular oxidative stress in ex vivo human skin cultures by imaging en-
dogenous and exogenous fluorescent compounds using two-photon excitation fluores-
cence (TPEF) and fluorescence lifetime imaging microscopy (FLIM); (2) visualizing
water and lipid distribution as well as cellular morphology using coherent Raman
scattering (CRS) imaging techniques in the stratum corneum, the most superficial
layer of the epidermis; (3) using photoconvertible labels to optically tag cell subpopu-
lations of interest in situ for long-term monitoring of heterogeneous cell cultures from
in vitro monolayers to in vivo xenograft models; (4) visualizing melanin species in the
context of melanoma with coherent anti-Stokes Raman scattering (CARS) and sum-
frequency absorption (SFA) microscopies. Altogether, development of such advanced
microscopy toolkits will serve to improve both understanding of cancer pathology, as
well as to validate clinical diagnostic and therapeutic strategies.
Thesis Supervisor: Conor L. Evans, PhD
Title: Assistant Professor of Dermatology, Harvard Medical School, Wellman Center
for Photomedicine, Massachusetts General Hospital
3
4
Acknowledgments
None of the work presented in this thesis would have been possible without all the
wonderful people that I have had the pleasure of calling my friends and colleagues
throughout the past 5 years. First and foremost, an enormous thank you to all the
members - past and present - of the Evans team. I have had the incredible privilege
of working closely with a number of talented graduate students (Alex Nichols and
Joachim "Api" Pruessner), postdoctoral fellows (Tracy Wang, Lauren Austin, Zongxi
Li, Manolis Rousakis, Gayatri Joshi, Sinyoung Jeong, Haley Marks, Alex Fast, Amin
Feizpour, John Nguyen, Juanpe Cascales-Sandoval, and others), lab technicians (Nick
Nowell, Jawad Hoballah, Fatima Mubarak, Raymond Lopez, and Michael Murphy), as
well as our quintessential lab admin (Alice Chao). Of course, this fantastic team was
led by Conor Evans, who has taught me virtually all I know about the implementation
and use and optical imaging. From the informal white board chalk talks in his office
to his coaching sessions at my very first international conference (SPIE Photonics
West back in January 2015), Conor has mentored me throughout all critical stages
of graduate school. It is thanks to him - and, of course, the various iterations of
the lab team - that I have become the well-rounded scientist I am today. Of all the
learning and life experiences I will have gained throughout the 5 years spent within
the Evans group however, the daily banter, general camaraderie, and truly awesome
work atmosphere within the team is certainly what I will remember and cherish most
of all.
On the topic of mentorship, I would also like to extend my thanks to Dr. Jagesh
Shah, who has served as my thesis committee chair, as well as Dr. Gabriela Schlau-
Cohen, who agreed to take the role of thesis reader. Their considerable advice and
guidance have helped navigate my scientific curiosity throughout the final years of
graduate school, in addition to helping shape this thesis into the complete body of
work that it is.
Next, I owe many thanks to my roommates over the past few years: Chris Lee,
Benny Maimon, Fernando Martinez, and Gio Sturla. Each one of you have con-
5
tributed in your own ways to making life on Saint Paul Street the adventure that it
was. Additional thanks go out to Taylor Gill and Colin Buss, without whom Thurs-
day nights would not have been the same. Another particular round of thanks go out
to my dearest friends Emily Lindemer and Liam Loscalzo, who have been my family
away from home for my entire time in Boston. From the evenings spent hanging at
the apartment with Zoom to the many trivia nights at Charlie's we've so joyously
lost, my life in Boston would not at all have been the same without you.
I would also like to thank all my friends from back home in Montreal who have
taken the time to come down to visit me in Boston throughout the years. I warmly
extend acknowledgements to Max Lefevre, Phil Cazelais, Marc-Antoine Dumoulin,
and Francis Hamel (RIP); Andreanne Goyette, Steph Andrieux, Ariane Couture,
and Amelie Duval Courchesne; Max Milanovic, Laura Glenn, Simran Dewan, Evan
Weber, and Max Bellefeuille; Vincent Boul6" and Charlotte Girod; Stephanie Bernard
and Sarah Power; and all others who have kindly stopped by to send their regards
while in town. It certainly would have been a long 5 years without the continuous
visits from my dearest friends from my hometown.
Additionally, I would like to express a warm thanks to all the members of my
family who have supported me throughout my graduate school path. Foremost, I
thank my parents Bita Danechi and Amir Osseiran for their unwavering support
every step of the way; my sister Lina Osseiran, as well as my brother-in-law Quentin
Dutilleul and my nephew Felix Dutilleul; my aunt Hana Osseiran; and all other family
members who have been so warm and welcoming during each and every single one of
my return trips home.
Finally, I would like to express my greatest thanks to my fiancee Alexandra Pee-
bles. We had initially met when I was less than halfway through graduate school,
back in December 2015, and endured the vast majority of our relationship apart.
Nevertheless, she has been my source of comfort and peace since the day we started
dating, supporting me through the most stressful aspects of graduate life. Whether
it was anxiety related to meeting deadlines or rehearsing for upcoming presentations,
she would offer rational advice and guidance to help me navigate through my most
6
difficult moments. Alexandra, thank you for your unfaltering love and support, and
simply for making my life what it now is - I cannot wait to see what our future has
in store for us.
7
8
Contents
1 Theory and Principles of Nonlinear Optics for Biomedical Imaging 29
1.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . .
1.2 Two-Photon Excitation Fluorescence (TPEF) . . . . . . .
1.3 Fluorescence Lifetime Imaging Microscopy (FLIM) . . . .
1.3.1 Time-Correlated Single Photon Counting (TCSPC)
1.3.2 Time-Domain Analysis . . . . . . . . . . . . . . . .
1.3.3 Phasor Analysis . . . . . . . . . . . . . . . . . . . .
1.4 Ram an Scattering . . . . . . . . . . . . . . . . . . . . . . .
1.4.1 Spontaneous Raman Scattering . . . . . . . . . . .
1.4.2 Coherent Raman Scattering (CRS) . . . . . . . . .
1.5 Fluorescence Photoconversion . . . . . . . . . . . . . . . .
1.6 Sum-Frequency and Transient Absorption (SFA and TA) .
1.7 Instrumentation and Microscopy Setup . . . . . . . . . . .
2 Raman Scattering Technologies for Cancer Research and
2.1 In Vitro/Ex Vivo Detection and Diagnostics . . . . . . . .
2.1.1 B iofluids . . . . . . . . . . . . . . . . . . . . . . . .
2.1.2 T issue . . . . . . . . . . . . . . . . . . . . . . . . .
2.2 In Vivo Detection and Diagnostics . . . . . . . . . . . . .
2.2.1 Animal Models . . . . . . . . . . . . . . . . . . . .
2.2.2 Human Studies . . . . . . . . . . . . . . . . . . . .
Oncology 47
. . . . . . 47
47
. . . . . . 52
. . . . . . 60
. . . . . . 60
. . . . . . 64
9
. . . . . . 29
. . . . . . 31
. . . . . . 32
. . . . . . 32
. . . . . . 33
. . . . . . 34
. . . . . . 36
. . . . . . 36
. . . . . . 38
. . . . . . 41
. . . . . . 42
. . . . . . 43
3 Quantification of Oxidative Stress in Ex Vivo Human Skin Exposed
to Chemical Sun Filters Using TPEF and FLIM 73
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
3.2 Materials and Methods .......................... 76
3.2.1 Sun Filter Formulation . . . . . . . . . . . . . . . . . . . . . . 76
3.2.2 Tissue Culture and Processing . . . . . . . . . . . . . . . . . . 77
3.2.3 TPEF and FLIM Imaging . . . . . . . . . . . . . . . . . . . . 78
3.2.4 CARS Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . 79
3.2.5 Non-Euclidean Phasor Analysis . . . . . . . . . . . . . . . . . 79
3.2.6 Simulation and Validation . . . . . . . . . . . . . . . . . . . . 82
3.2.7 Quantification of Oxidative Stress . . . . . . . . . . . . . . . . 83
3.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 84
3.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
4 FLIM Data Analysis in Phasor Space: A Si
of Euclidean and Non-Euclidean Distance ME
Fluorescent Species
4.1 Introduction . . . . . . . . . . . . . . . . . . . .
4.2 Materials and Methods . . . . . . . . . . . . . .
4.2.1 Simulation of a Binary Mixture . . . . .
4.2.2 Simulation of a Ternary Mixture . . . . .
4.3 Results and Discussion . . . . . . . . . . . . . .
4.3.1 Binary Mixture with Single Lifetimes . .
4.3.2 Binary Mixture with Multiple Lifetimes.
4.3.3 Ternary Mixture with Single Lifetimes .
4.4 Conclusion . . . . . . . . . . . . . . . . . . . . .
nulated
trics to
Comparison
Distinguish
95
. . . . . . . . 95
. . . . . . . . 100
. . . . . . . . 100
. . . . . . . . 103
. . . . . . . . 106
. . . . . . . . 106
. . . . . . . . 107
. . . . . . . . 111
.. ... 114
5 Characterization of Human Stratum Corneum Structure, Barrier
Function, and Chemical Composition Using CRS
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.2 Results and Discussion . . . . . . . . . . . . . . . . . . . . . .
10
117
. . . . 117
. . . . 120
5.2.1 CRS Imaging Metrics . . . . . .
5.2.2 Stratum Corneum Dehydration
5.2.3 Stratum Corneum Rehydration
5.3 Materials and Methods . . . . . . . . .
5-3.1 Tissue Culture and Processing
5.3.2 Corneometer Measurements .
5.3.3 CRS Microscopy . . . . . . . .
5.3.4 Image Analysis . . . . . . . . .
5.3.5 Skin Explant Dehydration
5.3.6 Skin Explant Rehydration . . .
5.3.7 Statistical Analysis . . . . . . .
. . . . . . . . . . . . . . . . . 120
. . . . . . . . . . . . . . . . . 124
. . . . . . . . . . . . . . . . . 128
. . . . . . . . . . . . . . . . . 137
. . . . . . . . . . . . . . . . . 137
. . . . . . . . . . . . . . . . . 137
. . . . . . . . . . . . . . . . . 138
. . . . . . . . . . . . . . . . . 139
. . . . . . . . . . . . . . . . . 140
. . . . . . . . . . . . . . . . . 140
. . . . . . . . . . . . . . . . . 141
6 Longitudinal Monitoring of Cancer Cell Subpopulations from In
Vitro to In Vivo Using Fluorescence Photoconversion 143
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
6.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 146
6.2.1 Monolayer Cell Culture . . . . . . . . . . . . . . . . . . . . . . 146
6.2.2 3D Spheroid Culture . . . . . . . . . . . . . . . . . . . . . . . 146
6.2.3 Spheroid Disaggregation and Fluorescence-Activated Cell Sort-
ing (FA C S) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
6.2.4 Zebrafish Xenograft Model . . . . . . . . . . . . . . . . . . . . 148
6.2.5 Fluorescence Microscopy . . . . . . . . . . . . . . . . . . . . . 149
6.2.6 Photoconversion . . . . . . . . . . . . . . . . . . . . . . . . . . 149
6.2.7 Image Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . 149
6.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . 151
6.3.1 Photoconversion in Monolayers In Vitro . . . . . . . . . . . . 151
6.3.2 Photoconversion in 3D Spheroids In Vitro and FACS . . . . . 153
6.3.3 Photoconversion in Zebrafish Xenograft Model In Vivo . . . . 157
6.4 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
11
7 In Vivo Imaging of the Melanomagenesis-Associated Pigment Pheome-
lanin Using CARS and SFA 161
7.1 Introduction ....... ................................ 161
7.2 Results and Discussion ...... .......................... 162
7.2.1 Synthetic Pheomelanin ...................... 162
7.2.2 Pheomelanin in FACS-Sorted Mouse Melanocytes . . . . . . . 163
7.2.3 Ex Vivo, In Vivo, and Histological Visualization of Pheome-
lanin in M ouse Skin . . . . . . . . . . . . . . . . . . . . . . . . 164
7.2.4 Pheomelanin Detection in Human Amelanotic Melanoma . . . 169
7.3 M aterials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 175
7.3.1 M ice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
7.3.2 CARS M icroscopy . . . . . . . . . . . . . . . . . . . . . . . . 175
7.3.3 SFA M icroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . 176
7.3.4 Preparation of Synthetic Pheomelanin . . . . . . . . . . . . . 177
7.3.5 CARS Spectral Data Acquisition and Processing . . . . . . . . 177
7.3.6 Melanocyte Extraction . . . . . . . . . . . . . . . . . . . . . . 178
7.3.7 Mouse Ear Imaging . . . . . . . . . . . . . . . . . . . . . . . . 179
8 Outlook and Future Perspectives 181
A MATLAB Scripts and Functions 185
A.1 Simulation of Binary Mixture . . . . . . . . . . . . . . . . . . . . . . 185
A.2 Simulation of Ternary Mixture . . . . . . . . . . . . . . . . . . . . . . 197
A.3 MATLAB Functions for Phasor Analysis . . . . . . . . . . . . . . . . 212
A.3.1 Loading Default Simulated Image Parameters . . . . . . . . . 212
A.3.2 Simulating a Decay Image . . . . . . . . . . . . . . . . . . . . 214
A.3.3 Performing the Phasor Transform . . . . . . . . . . . . . . . . 222
A.3.4 Generating the Phasor Plot . . . . . . . . . . . . . . . . . . . 234
12
'Mmmom"M WRWIPIVIT -1-1 "Rw
List of Figures
1-1 Schematic representation of the fields involved in Raman scattering
processes. (A) Spontaneous Raman scattering, (B) stimulated Ra-
man scattering (SRS), and (C) coherent anti-Stokes Raman scattering
(CARS). The pump, Stokes, and anti-Stokes frequencies are respec-
tively designated by Wp, ws, and WAS, while the dashed and solid lines
respectively refer to virtual and real molecular states. In spontaneous
Raman scattering, a pump photon scatters inelastically, thus generat-
ing a Stokes photon. In SRS, both pump and Stokes fields are incident
on the sample simultaneously; if there is a vibrational band gap that
corresponds to the energy difference between the two beams, the pump
field decreases (stimulated Raman loss, SRL), while the Stokes field is
amplified (stimulated Raman gain, SRG). Finally, in CARS, a new field
is created at the anti-Stokes frequency and can be readily detected via
optical filters, as it is blue-shifted relative to the incident pump and
Stokes fields . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
1-2 Detection scheme for stimulated Raman loss (SRL). Conversely, stim-
ulated Raman gain (SRG) is detected by modulating the pump beam
and detecting the fluctuations of the Stokes beam. . . . . . . . . . . . 40
13
3-1 Fluorescent properties of the sun filter formulation. (a) Trans-illumination
image of the edge of a droplet of sun filter formulation, acquired with
755 nm light. (b) TPEF image of the sun filter formulation acquired
with 755 nm excitation light and fluorescence detection from 445 to
480 nm. (c) Phasor plot of the FLIM data associated with (b), high-
lighting the short fluorescence lifetime of the sun filter formulation. (d)
Temporal decay trace of a typical pixel from (b), illustrating the rapid
decay of the sun filter fluorescence. . . . . . . . . . . . . . . . . . . . 85
3-2 Fluorescence detected from the stratum spinosum layer of the viable
epidermis, acquired at a depth of 50 pm below the skin surface. (a)
TPEF image of human skin treated with vehicle only, showing endoge-
nous NADH fluorescence. (b) Phasor plot of the FLIM data associated
with (a). (c) Temporal decay trace of a pixel from (a), showing the pro-
gressive decay of NADH fluorescence. (d) TPEF image of human skin
treated with sun filter formulation, showing both endogenous NADH
fluorescence across the field of view, as well as exogenous fluorescence
from the sun filters seen in the lower right region of the image. (e)
Phasor plot of the FLIM data associated with (d). (f) Temporal decay
trace of a pixel from (d) with a strong fluorescence contribution from
chem ical sun filters. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
14
3-3 Simulation to validate the proposed non-Euclidean separation algo-
rithm. (a) Phasor plot of simulated endogenous fluorescence reference
sample. (b) Phasor plot of simulated exogenous fluorescence reference
sample. (c) Phasor plot of simulated test image, consisting of both flu-
orophores with concentrations varying in opposite sigmoidal fashion.
(d) Simulated endogenous fluorescence contribution to the test image.
(e) Estimation of endogenous fluorescence contribution computed using
the traditional Euclidean method. (f) Estimation of endogenous fluo-
rescence contribution using the proposed non-Euclidean method based
on the Mahalanobis distance. (g) Column-wise means of the images in
(d-f), illustrating the superior accuracy of the proposed method over
the classical Euclidean approach. . . . . . . . . . . . . . . . . . . . . 87
3-4 Comparison of processing methods to optimally determine endogenous
fluorescence contribution. (a) TPEF intensity image of human skin
treated with chemical sun filters, showing a diffusing pool of formu-
lation in the bottom right portion of the image. (b) Estimate of the
endogenous fluorescence contribution computed using the traditional
Euclidean method. (c) Estimate of the endogenous fluorescence contri-
bution as determined by the proposed non-Euclidean approach based
on the Mahalanobis distance metric. . . . . . . . . . . . . . . . . . . 88
3-5 Diffusion of the lipophilic solvent throughout various layers of human
epidermis (0, 40, and 80 pm below the skin surface), as visualized using
CARS microscopy to probe the CH 2 vibrational mode of Finsolv TN
at 2845 cm 1 at 15-minute intervals over the course of 2 hours. All
images are 318 pum x 318 pm in size. . . . . . . . . . . . . . . . . . . 89
3-6 Fluorescence intensity and computed NORR images of a typical skin
sample. (a) NADH fluorescence intensity. (b) FAD fluorescence inten-
sity. (c) NORR image, obtained by computing FAD/(NADH+FAD)
on a pixel-by-pixel basis. . . . . . . . . . . . . . . . . . . . . . . . . . 90
15
3-7 Normalized optical redox ratio (NORR) of cells in the stratum spinosum
layer of the viable epidermis treated with either vehicle only or sun fil-
ter formulation, and exposed to either 0 or 20 J/cm2 (1 MED) of UVA
irradiation. Bars correspond to mean NORR measurement of cells
from N = 3 fields of view, and error bars represent 1 standard devi-
ation. Statistical significance determined by pair-wise Student's t-test
corrected using Holm's method, annotated with * if p < 0.01 and ** if
p < 0.005. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
4-1 Phasor plot showing the mean coordinates of phasor clusters A, B, and
C, as well as the phasor of a given pixel X. A line is drawn between
phasor X and the mean coordinates of reference cluster A, where its
intersection with the line connecting clusters B and C yields the coor-
dinates of R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
4-2 Phasor plots of the simulated data used to test the accuracy of the
separation algorithms in the context of a binary mixture of single-
lifetime fluorophores. (A) Phasor plot of compound A with a lifetime
of 4.100 + 0.205 ns. (B) Phasor plot of compound B with a lifetime of
0.200 0.010 ns. (C) Phasor plot of the binary mixture of compounds
A and B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
4-3 Estimated concentration maps of either compound in a binary mix-
ture of single-lifetime fluorophores. (A,D) Theoretical concentration
maps of compounds A and B, spatially distributed following squared
sine and cosine functions, respectively. (B,E) Concentration maps of
compounds A and B, respectively, estimated using the Mahalanobis
distance metric. (C,F) Concentration maps of compounds A and B, re-
spectively, estimated using the Euclidean distance metric. (G) Column-
wise means of panels A-C. (H) Column-wise means of panels D-F. . . 108
16
4-4 Phasor plots of the simulated data used to test the accuracy of the
separation algorithms in the context of a binary mixture of fluorophores
with multiple lifetimes. (A) Phasor plot of compound A with a lifetime
of 4.100 0.205 ns. (B) Phasor plot of compound B, characterized by
a combination of 4 distinct lifetimes. (C) Phasor plot of the binary
mixture of compounds A and B. . . . . . . . . . . . . . . . . . . . . . 109
4-5 Estimatcd concentration maps of either compound in a binary mix-
ture of fluorophores with multiple lifetimes. (A,D) Theoretical concen-
tration maps of compounds A and B, spatially distributed following
squared sine and cosine functions, respectively. (B,E) Concentration
maps of compounds A and B, respectively, estimated using the Ma-
halanobis distance metric. (C,F) Concentration maps of compounds
A and B, respectively, estimated using the Euclidean distance metric.
(G) Column-wise means of panels A-C. (H) Column-wise means of
panels D -F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
4-6 Phasor plots of the simulated data used to test the accuracy of the
separation algorithms in the context of a ternary mixture of single-
lifetime fluorophores. (A) Phasor plot of compound A with a lifetime
of 4.100 0.205 ns. (B) Phasor plot of compound B with a lifetime of
1.600 t 0.080 ns. (C) Phasor plot of compound C with a lifetime of
0.600 0.030 ns. (D) Phasor plot of the ternary mixture of compounds
A , B , and C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
17
4-7 Estimated concentration maps of each compound in a ternary mix-
ture of single-lifetime fluorophores. (A,D,G) Theoretical concentration
maps of compounds A, B, and C, respectively, spatially distributed
following cosine functions phase-shifted with respect to one another by
27r/3 radians (B,E,H) Concentration maps of compounds A, B, and C,
respectively, estimated using the Mahalanobis distance metric. (C,F,I)
Concentration maps of compounds A, B, and C, respectively, estimated
using the Euclidean distance metric. (J,K,L) Column-wise means of
panels A-C, D-F, and G-I, respectively. . . . . . . . . . . . . . . . . 113
5-1 CRS images of human stratum corneum acquired from ex vivo skin ex-
plants. (a-c) CARS and (d-f) SRS images of stratum corneum showing
(a,d) lipid-weighted content; (b,e) protein-weighted content; and (c,f)
water-weighted content. The NRB in the CARS data manifests itself
as a homogeneous and unspecific haze distributed across the field of
view . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
5-2 Manual segmentation of SRS lipid content image to distinguish intra-
cellular and extracellular spaces for subsequent analysis. (a) Unlabeled
image. (b) Manually segmented image, showing corneocytes identified
by indices 1 through 22, and extracellular space corresponding to the
surrounding region identified by index number 23. . . . . . . . . . . . 123
5-3 Scatter plot of all intracellular lipid and protein data collected via
SRS, showing a strong correlation (Pearson's R = 0.921) between the
observed metrics and therefore indicative of spectral overlap. . . . . . 124
18
5-4 Corneometer measurements obtained from ex vivo human skin through-
out the dehydration time course on a plastic substrate (i.e. rapid de-
hydration) and a gel substrate (i.e. slow dehydration). Data points
correspond to the mean of the triplicate corneometer measurements
with error bars indicating the standard error of the mean. Statistically
significant deviations from the corresponding initial timepoint are de-
noted by asterisks and determined via Student's t-test (*: p < 0.05/N;
**: p < 0.01/N; ***: p < 0.001/N, adjusted using Bonferroni correc-
tion with N = 4 pairwise comparisons). . . . . . . . . . . . . . . . . . 125
5-5 Corneometry-based assessment of ex vivo human skin hydration dy-
namics during rehydration under various environmental and treatment
conditions. Data points correspond to the rate of change of corneome-
ter measurements per hour, with error bars showing the 95% confidence
interval. For the ambient condition without treatment (control), aster-
isks denote rates of change significantly different from zero; for all other
conditions, they denote rates of change that are significantly different
from the control (*: p < 0.05; **: p < 0.01; ***: p < 0.001, where
p-values are adjusted using Holm-Bonferroni correction with N = 36
m etrics). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
5-6 Chemical content dynamics of ex vivo human skin during rehydration
under various environmental and treatment conditions. Data points
correspond to the rate of change of CRS imaging metrics per hour,
with error bars showing the 95% confidence interval. For the ambient
condition without treatment (control), asterisks denote rates of change
significantly different from zero; for all other conditions, they denote
rates of change that are significantly different from the control (*: p <
0.05; **: p < 0.01; ***: p < 0.001, where p-values are adjusted using
Holm-Bonferroni correction with N = 36 metrics). . . . . . . . . . . . 130
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5-7 Morphological dynamics of ex vivo human corneocytes during rehy-
dration under various environmental and treatment conditions. Data
points correspond to the rate of change of each spatial metric in mi-
crons per hour with error bars showing the 95% confidence interval.
Nearest neighbor distances are computed between corneocyte cell cen-
ters (NNDCenters) as well as between cell walls (NNDwais). For the
ambient condition without treatment (control), asterisks denote rates
of change significantly different from zero; for all other conditions, they
denote rates of change that are significantly different from the control
(*: p < 0.05; **: p < 0.01; ***: p < 0.001, where p-values are adjusted
using Holm-Bonferroni correction with N = 36 metrics). . . . . . . . 131
6-1 In vitro monolayer model of ovarian cancer showcasing the fluores-
cence of DiR before (a) and after (b) photoconversion, with associated
fluorescence spectra summed across the entire field of view (c). . . .. 152
6-2 Longitudinal monitoring of an ovarian cancer cell subpopulation of in-
terest, seen before (a) and after (b) photoconversion on Day 0. The
same field of view was revisited 24 hours (c,d) and 48 hours (e,f) fol-
lowing the photoconversion process to monitor the cellular proliferation
over time. All scale bars correspond to 100 pm. Images in (a,b,d,f)
and (c,e) were acquired at 20x and 10x magnification, respectively. . 153
6-3 3D tumor spheroid of ovarian cancer cells before (a) and after (b)
photoconversion of the topmost peripheral region indicated by the gray
box. Two regions of interest (ROI) have been selected within the image,
where ROI #1 encompassed photoconverted cells while ROI #2 did
not. The corresponding fluorescence spectra are shown in (c), where
solid and dashed lines refer to ROIs #1 and #2, and diamonds and
circles refer to before and after photoconversion, all respectively. . . . 155
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6-4 FACS plot of a cell sample from disaggregated, partially photocon-
verted ovarian cancer spheroids (a), and subsequent seeding of sorted
non-converted (b) and photoconverted (c) cells. The fluorescence spec-
tra from the sorted cells are shown in (d), demonstrating the irre-
versible nature of in situ DiR photoconversion . . . . . . . . . . . . . 156
6-5 In vivo longitudinal monitoring of a photoconverted subpopulation of
melanoma cells indicated by the gray box in a zebrafish xenograft
model following in situ photoconversion. In all images, the eye is lo-
cated at the bottom-left of the field of view and was consistently used
as a fiducial marker throughout the experimental time course to ensure
monitoring of the same area over time. The top row shows a colored
overlay of the two collected fluorescence emission bands, namely 650-
690 nm in green and 760-800 nm in red. The middle row shows a
scatter plot of each pixel, where green and red channel intensities are
plotted against one another in order to generate a representation visu-
ally reminiscent of flow cytometry plots. The red dashed lines in the
scatter plots correspond to the gating criteria to identify pixels con-
taining either photoconverted or standard DiR. These gates are then
used to recolor the images from the top row, where the images in the
bottom row show photoconverted and standard DiR fluorescence in
green and red, respectively . . . . . . . . . . . . . . . . . . . . . . . . 157
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7-1 Synthetic pheomelanin in a 4:1 water:hexane emulsion. (a) CARS
image acquired at WpWs = 2000 cm- 1. Pheomelanin is observed as
small, insoluble aggregates with bright CARS intensity. The surround-
ing water/hexane bubbles show low-level non-resonant CARS back-
ground. (b) Trans-illumination image acquired with the 861 nm pump
beam. (c) CARS spectrum of synthetic pheomelanin referenced to
the wavelength-independent non-resonant signal from a glass cover-
slip, normalized by area under the curve. Three synthetic pheomelanin
samples were measured, with each spectrum shown in gray; the curve
in red corresponds to the mean of the three measurements. . . . . . . 163
7-2 Melanocytes isolated from red-haired C57BL/6 (Mclre/e, Tyr+/+) mice
exhibit strong CARS signal at Wp - ws = 2000 cm- 1. (a) Trans-
illumination image acquired with the pump beam, where the overall
shape of the cells can be well visualized. (b) Confocal fluorescence
image of tdTomato. (c) False color (Green fire blue colormap in Im-
ageJ) CARS image mapping intracellular pheomelanin distribution.
(d) 4x-zoomed view of (c) showing a perinuclear distribution of signal
intensity, consistent with the known biology of protective melanin caps. 165
7-3 Melanocytes isolated from albino-red C57BL/6 (Mclre/e Tyrc/') mice
exhibit negligible CARS signal at Wp - ws = 2000 cm-'. (a) Trans-
illumination image acquired with the 861 nm pump beam. (b) Confocal
fluorescence image of tdTomato. (c) False color CARS image acquired
with pump (Ap = 861 nm) and Stokes beams (As = 1040 nm). (d)
False color image acquired only using the pump beam, showing promi-
nent two-photon fluorescence signals from tdTomato. (e) False color
image acquired only using the Stokes beam, showing weak two-photon
fluorescence signals from tdTomato. (f) False color image illustrating
the true CARS signal obtained by subtracting tdTomato fluorescence
in (d) and (e) from the raw CARS image in (c). . . . . . . . . . . . . 166
22
7-4 Imaging of pheomelanin stores in red-haired mouse ear skin. (a,c,e)
Brightfield trans-illumination image acquired from the microscope eye-
piece. (b,d,f) Maximal projection view of CARS image stack of the
mouse ear, showing bright granules from the pheomelanin stores (red
circles) within melanocytes and at the base of the hair follicle. A CARS
image stack acquired with the pump beam set to 871 nm (wp - Ws =
1866 cm-1) was subtracted from the image stack acquired with the
pump beam set to 861 nm (Wp - Ws = 2000 cm-1) to minimize the
non-resonant signal contribution from structures other than pheome-
lanin. Image stacks are 27 pm thick, with a step size of 1 pm. Note
that an out-of-focus hair (blue arrow) caused a shadow in the trans-
illumination image (a), whereas CARS is highly depth-resolved; there-
fore, the hair was not prominently seen in (b). . . . . . . . . . . . . . 167
7-5 Imaging of pheomelanin stores in a red-haired mouse ear in vivo. (a)
Brightfield trans-illumination image acquired from the microscope eye-
piece. (b) Maximal projection view of CARS image stack of the mouse
ear, showing bright signals from pheomelanin (red circle). A CARS im-
age stack acquired with the pump beam set to 871 nm (Wp -is = 1866
cm-1) was subtracted from the image stack acquired with pump beam
set to 861 nm (wp -ws = 2000 cm-') to minimize the non-resonant sig-
nal contribution from structures other than pheomelanin. The image
stack in (b) is 15 pm thick, with a step size of 1 jm. . . . . . . . . . 168
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7-6 Imaging of pheomelanin stores in a red-haired (C57BL/6 (Mclr'/e,
Tyr+/+) mouse ear section (5 pm thickness). (a) Immunohistochemi-
cal stain of the mouse ear slide using anti-Sox-10 antibody (counter-
stain: haematoxylin), revealing melanocytes in red, some of which are
indicated by black arrows for added clarity. (b) Image of an adjacent
unstained 5 pm thick slide under brightfield illumination, revealing
pheomelanin-rich deposits (shown by black arrows) consistent with the
localization of the melanocytes in the adjacent slide shown in (a). (c)
Trans-illumination image of the unstained slide shown in (b) acquired
with the pump beam set to 861 nm. (d) CARS and (e) SFA images
of the unstained slide shown in (b), revealing bright granular signals
from pheomelanotic stores consistent with positive staining in (a) and
pigmented areas in (b). (f) False-color overlaid image of (d) in green
and (e) in red. A CARS image acquired with the pump beam set to
871 nm (Wp - Ws = 1866 cm- 1 ) was subtracted from the image ac-
quired with the pump beam set to 861 nm (wp - Ws = 2000 cm- 1) to
minimize the non-resonant signal contribution from structures other
than pheom elanin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169
7-7 Imaging of pheomelanin stores in a red-haired mouse ear section (5 pm
thickness). (a) Brightfield trans-illumination image of the haematoxylin-
stained mouse ear slide. (b) Magnified view of the area marked by a
red square in (a). Pheomelanotic stores are seen as slightly pigmented
granules. (c) CARS image of the same field of view as (b), showing
bright granular signals from pheomelanotic stores corresponding to the
pigmented areas in (b). A CARS image acquired with the pump beam
set to 871nm (wp - Ws = 1866 cm- 1 ) was subtracted from the image
acquired with the pump beam set to 861 nm (Wp - Ws = 2000 cm 1 )
to minimize the non-resonant signal contribution from structures other
than pheom elanin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
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7-8 Imaging of human amelanotic melanoma. (a) Clinical photograph of
one amelanotic melanoma lesion. (b) H&E stain of the patient slide
(10 x magnification). (c) Perilesional skin showing normal architecture
of both epidermis and dermis. (d) Brightfield trans-illumination image
acquired from the microscope eyepiece from the perilesional area. (e)
CARS image of the same perilesional area compared to (d) (image ac-
quired with pump beam wavelength at 841 nm (Wp - Ws = 2275cm 1 )
was subtracted from the image acquired with pump beam wavelength
at 855 nm (wp - ws = 2081 cm- 1 ) to minimize the non-resonant back-
ground from structures other than pheomelanin). (f) View of the ame-
lanotic melanoma area showing high density of cells with no obvious
sign of melanin. (g) Brightfield trans-illumination image acquired from
the microscope eyepiece from an unstained slide of the melanoma area,
showing slightly pigmented granular structures (red circle). (h) CARS
image of the same tumor area compared to (g), with the same settings
as for (e). Saturated bright pheomelanin signals were found (red circle)
corresponding to the minimally pigmented region shown in (g). (i,j,k)
Respectively H&E, trans-illumination, and CARS images of the tu-
mor area of slides from a second amelanotic melanoma patient. Strong
pheomelanin signals were again observed (red circles). . . . . . . . . . 172
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Chapter 1
Theory and Principles of Nonlinear
Optics for Biomedical Imaging
1.1 Introduction
Prior to understanding the fundamentals of nonlinear optics, it is a useful exercise to
consider what is meant by linear optics. When a material is exposed to an electric
field 79 (such as light, for example), the material exhibits a polarization j that is
linearly proportional to the field P as shown in Equation 1.1.
9 ~, foxN(1.1)
The proportionality is defined by Eo, a universal constant known as the permittiv-
ity of free space, and x, the material's electric susceptibility. This linear relationship
implies superposition; that is, the polarization response of a material exposed to a
sum of fields simply corresponds to the sum of the polarization responses to each field
considered individually. In addition, this also implies that the incident fields cannot
interact with one another to generate new frequencies at the system's output. This is
a relation commonly introduced in most introductory optics and/or electromagnetic
fields classes in undergraduate science and engineering programs; however, this equa-
tion is but a simple and convenient approximation. In reality, nonlinear polarization
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responses do exist - they simply require an enormous amount of incident power in
order to generate a detectable signal as a result of the vanishingly small nonlinear
electric susceptibility coefficients. In fact, this is because the susceptibility x of a
given material can be represented by a Taylor series expansion, where nonlinear ma-
terial properties emerge with incident fields that are sufficiently strong. This relation
is shown more clearly in Equation 1.2. Considering the large amount of input energy
that is required to elicit this nonlinear optical polarization responses however, an
ensuing question naturally arises: if extremely high irradiation powers are required
to induce nonlinear optical polarizations, how are nonlinear optical signals generated
in biological samples in a non-destructive manner? The answer lies in the use of
ultrafast laser sources.
7P 0 ( (1~)7_j + X(2) J2 + (3 .P3 ) (1.2)
These are laser systems that, instead of emitting a constant beam of coherent
light (unlike continuous wave, or CW, laser sources), emit extremely short - but
extremely powerful - pulses of light. These short pulse durations can range from a
few nanoseconds all the way down to the femtosecond regime. In the case of the
various studies documented in the context of the present thesis, the Spectra-Physics
InSight DeepSee - a commercial femtosecond laser source - is the laser source
of choice. One output can be selectively tuned from 680 up to 1300 nm in single-
nanometer increments, while the other is fixed at 1040 nm. The concurrent use of two
laser beams will become clear in the context of particular nonlinear optical imaging
applications that will be presented in depth in Sections 1.4.2 and 16. The pulse
durations are about 120 fs in duration, and the laser has a repetition rate of 80 MHz.
This also implies an interpulse period of 12.5 ns, which implies that when the laser
is in operation, no light is being emitted 99.999% of the time. However, for the
brief 0.001% of the time where a pulse is emitted, it propagates with a peak power
exceeding 100 kW. The time-averaged power for the laser source nevertheless remains
in the milliwatt range, thereby minimizing photodamage. It is also worth specifying
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that for nonlinear optical imaging, the photon density is crucial factor to consider
from an imaging standpoint. That is, not only does one require kilowatt-range peak
powers, but this energy must also be focused into a small focal volume in order to
generate any appreciable signal. This is conveniently advantageous, because it is this
property that ensures the "intrinsic optical sectioning" that is a hallmark of nonlinear
optical microscopy.
These intrinsic properties of nonlinear optical microscopy eliminate the need for
a confocal pinhole as in the case of single-photon confocal fluorescence microscopy,
for example, used to suppress the out-of-focus light. Given that the signal is strictly
generated at the focus of the microscope objective, full 3D volumetric reconstructions
of biological samples can be achieved by simply scanning the objective focus across
the X, Y, and Z dimensions.
With this introductory framework for nonlinear optics in mind, the following sec-
tions will build on these foundations, ranging from two-photon excitation fluorescence
(TPEF) to coherent Raman scattering (CRS) to sum-frequency and transient absorp-
tion (SFA and TA) imaging techniques.
1.2 Two-Photon Excitation Fluorescence (TPEF)
Two-photon excitation fluorescence (TPEF) is a nonlinear optical interaction whereby
two photons are simultaneously absorbed by a molecule in order to generate a sin-
gle output photon. This nonlinear optical phenomenon was first implemented as a
microscopy technique back in 1990 by Denk and colleagues [9]. It is worth noting,
however, that because TPEF requires the simultaneous absorption of two incident
photons, this nonlinear optical effect is symmetry-forbidden in non-centrosymmetric
molecules. This is because materials and molecules that exhibit inversion symmetry
(i.e. compounds that are centrosymmetric) have even-ordered nonlinear electric sus-
ceptibilities equal to zero. Nevertheless, even-ordered nonlinear optical effects may
still be generated in such media by breaking its symmetry. This can be done by cou-
pling with the molecule's vibrational and/or rotational modes with odd symmetry in
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order to enable excitation.
It is also worth noting that TPEF is not a lossless process. Upon the simultaneous
absorption of two incident photons by a molecule, there is some non-radiative decay,
followed by a transient residency in an excited electronic state for a given period of
time T called the fluorescence lifetime, finally resulting in the emission of a fluorescent
photon as the molecule returns to its ground state. In addition, two-photon excitation
spectra are more complex than simply doubling the wavelength of the single-photon
excitation spectrum. This discrepancy is due to differences in Frank-Condon factors,
which can be better appreciated by taking a look at the 1- and 2-photon spectra of
common fluorophores. Moreover, because TPEF is a X process, the signal intensity
is proportional to the square of the incident power, i.e. 12 (t).
1.3 Fluorescence Lifetime Imaging Microscopy (FLIM)
Fluorescence lifetime imaging microscopy (FLIM) can be viewed as an extension
TPEF when implemented in a two-photon setting, whereby the fluorescence lifetime
T of a given fluorophore can be probed in addition to its intensity [10]. In addition
to probing the optical properties of fluorophores (i.e. excitation and emission param-
eters), FLIM is a tool also capable of probing their temporal dynamics. To this aim,
this imaging technique requires specific hardware (i.e. time-correlated single photon
counting, or TCSPC), and the resulting data can be processed either in the time
domain or in the frequency domain, the latter of which is typically performed using
phasor analysis. FLIM is therefore an extremely useful modality in the context of
molecular imaging, as it provides researchers with an additional dimension of imaging
contrast [11].
1.3.1 Time-Correlated Single Photon Counting (TCSPC)
The implementation of FLIM relies on the operating principles of time-correlated sin-
gle photon counting (TCSPC) [12]. In such a case, the detector (i.e. photomultiplier
tube, or PMT) is connected to pre-amplifier, which is in turn connected to the TC-
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SPC module. For multiple detectors, the each PMT pre-amplifier is first connected to
a routing block before the TCSPC module, whereby the PMTs independently emit an
electronic impulse signal at each photon detection event for multiplexed detection. In
parallel, a synchronization module registers the timing of the laser excitation pulse.
In turn, the time-to-amplitude converter (TAC) measures the time difference between
the arrival of the detected photon and the emission of the following excitation laser
pulse. The difference between this measured time interval and the laser repetition
period (given by the inverse of the pulse repetition frequency, an intrinsic property
of the laser source) corresponds to the fluorescence emission delay for that particular
photon. The hardware network has an overall dead time on the order of 100 ns or
so [12]; for this reason, each incident laser pulse must result in the detection of at
most 1 fluorescence photon per detector in order to limit lifetime biasing towards
shorter values. In other words, this implementation of TCSPC for FLIM does not al-
low for over-counting of photons, which would otherwise result in inaccurate lifetime
measurements.
Once the FLIM data is acquired using the TCSPC techniques described above,
each pixel of the acquired XYT dataset can be analyzed using either time-domain
or frequency-domain analysis - the latter of which is most commonly referred to as
"phasor analysis".
1.3.2 Time-Domain Analysis
Time-domain analysis of FLIM data typically involves curve fitting of fluorescent
decay traces on a pixel-by-pixel basis using a sum of exponential decays. In such a
context, each fluorophore of a given decay trace is characterized by its respective time
constant Ti and relative weight aj, defining its contribution to the overall fluorescence
signal in the pixel in question. The relation between a pixel's temporal decay trace
(t) and the fluorophores therein is summarized in Equation 1.3.
N
I(t) = aie- (1.3)
i=1
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As will be discussed in further detail in Chapter 4, time-domain analysis requires
a fair bit of familiarity with the sample at hand. This encompasses not only the
number of compounds to distinguish, but also an a priori idea of their respective
fluorescent lifetimes [13]. To complicate matters further, there is an added dimen-
sion of complexity when imaging cellular and tissue autofluorescence, including flavin
and nicotinamide adenine dinucleotides (FAD and NADH, respectively). Such com-
pounds naturally exhibit multiple lifetimes, which in turn vary based on their molec-
ular conformation and binding states [14, 15, 16]. Bearing in mind that time-domain
analysis is based on iterative curve fitting, the task of resolving multiple sources of
fluorescence that themselves have multiple lifetimes rapidly becomes computation-
ally demanding. To add to the present challenge, accurate time-domain analysis of
fluorescence lifetimes often requires a prohibitively large number of photon counts
per pixel (typically exceeding 5000 photons), particularly when the fluorescence from
one compound dwarfs the other [13]. This requirement is due to shot noise (also
known as Poisson noise), which is related to the particle nature of light. Consider-
ing that photon emission can be described as a Poisson process, the signal-to-noise
ratio (SNR) is given by SNR = N/v = v , where N is the number of detected
photons. Such elevated photon counts inherently demand longer acquisition times
and/or higher laser excitation power. However, due to the fragile nature of typical
biological samples, these imaging parameters may be incompatible with specimens of
interest - particularly living samples.
1.3.3 Phasor Analysis
As an alternative to time-domain analysis, frequency-domain analysis - more com-
monly referred to as phasor analysis - is much less demanding in terms of prior sam-
ple knowledge [17]. Moreover, this approach yields an intuitive and convenient visual
interpretation of the sample data. Instead of performing curve fitting on a pixel-by-
pixel basis, phasor analysis involves a simple mathematical transform of each pixel's
temporal decay trace. This transformation, related to the Fourier transform, yields
a pair of coordinates (G, S) that describe a so-called phasor, which is characterized
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by its modulus M = 2  S 2 and phase angle # = arctan(S/G). Specifically, the
phasor coordinates (G, S) are obtained by computing the real and imaginary compo-
nents of the Fourier transform of the temporal decay trace evaluated at the angular
laser repetition frequency w, normalized by its area under the curve. These relations
are summarized in Equations 1.4 and 1.5.
100 1(t) cos(wt)dtG = 00 (1.4)fo I (t) dt
- f I(t) sin(wt)dto 
= DO (1.5)
f0 0 I (t) dt
The angular frequency is defined by w = 27rf, where f corresponds to the laser
repetition frequency in the case of pulsed sources (typically on the order of 80 MHz).
On the other hand, single-photon FLIM systems require intensity modulation of a
continuous wave (CW) laser, where f then corresponds to the modulation frequency.
In the special case of a fluorophore characterized by a single well-defined lifetime,
the phasor transform results in a set of phasor coordinates that obey the relation
shown in Equation 1.6, which describes a semicircle with radius 0.5 centered at (0.5, 0)
[17].
(G - 0.5)2 + S2 = 0.25 (1.6)
In the FLIM community, this is referred to as the universal semicircle. In the case
of a decay trace characterized by two fluorescence lifetimes, the transformed phasor
coordinates lie along a line connecting the two individual lifetimes on the universal
semicircle. The specific phasor coordinates along that line in turn depend on the
relative contributions of either fluorescent compound [17, 18]. Given a mixture of
fluorescent compounds, FLIM data analysis in the phasor domain therefore conve-
niently offers the ability to estimate the relative fluorescence contribution of each
compound at every pixel in the image based on the relative distances between each
pixel's corresponding phasor location and the respective reference phasor clusters of
the fluorophores at hand.
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1.4 Raman Scattering
There are a wide variety of coherent Raman scattering (CRS) techniques, but for the
purposes of the present discussion, the fundamentals of spontaneous Raman scattering
will first be discussed, follow by an overview of two of the most commonly used
implementations of CRS, namely coherent anti-Stokes Raman scattering (CARS) and
stimulated Raman scattering (SRS).
1.4.1 Spontaneous Raman Scattering
Raman scattering is a non-parametric process related to the interaction of light with
a molecule and its associated vibrational states. This process was discovered by
Sir Chandrasekhara Venkata Raman in 1928, when he observed the scattering of an
entire spectrum of light upon illumination of a sample with monochromatic light of
frequency Wp. As he expected, the most prominent feature of the spectrum occurred
at the incident light frequency Wp, which is attributed to an elastic interaction known
as Rayleigh scattering. However, weak spectral lines were also observed, which were
later understood to occur as a result of inelastic interactions between incident photons
and the molecular vibrations present in a sample. As energy is transferred during
this process, the spectral lines had shifted frequencies Wp WR, corresponding to
what are now known as Stokes (Wp - wR) and anti-Stokes shifts (Wp + WR). Raman
observed that these shifts and their resulting spectra were highly material specific
a discovery that was awarded the 1930 Nobel Prize in physics. It is worth noting that
in most use cases, the incident field at Wp is within the visible or infrared range of the
electromagnetic spectrum, while the molecular vibrations themselves can be directly
probed at wR that lie in the mid- or long-wavelength infrared ranges.
Fundamentally, Raman scattering is derived from interactions with the time-
varying electromagnetic field of light and the time-varying electric polarizability
caused by molecular vibrations. When a molecule interacts with a photon, it can
experience an instantaneous coupling with the photon's electric field, leading to a
polarization of the molecule. This coupling can result in the creation of a scattered
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photon at frequency Wp - WR if some of the energy from the incident light is con-
verted to drive the molecular vibration; it is scattered at WP + wR if the molecule is
already in an excited vibrational state, whereupon the scattered photon exits with
energy equal to the sum of those of the incident photon and the molecular vibration.
These interactions at Wp - WR and WP + WR correspond to Stokes and anti-Stokes
shifts, respectively. However, this process is far from efficient, as the creation of a
frequency-shifted photon hinges on an infrequent interaction with the vacuum field.
Given that a spontaneous emission process is defined by the creation of a photon in
a previously unoccupied mode, this Raman process is deemed spontaneous [19].
It should be noted that Raman transitions depend on the rate of change of polar-
izability with respect to the molecule's geometry. This implies that Raman scattering
is only possible for certain symmetries of molecular vibrations, which forms the basis
for the so-called selection rules for Raman scattering. While the formalism here pre-
dicts the existence of Stokes and anti-Stokes frequency components, it fails to consider
the strength of individual Raman transitions, which would otherwise require a more
elaborate quantum mechanical formalism that is beyond the scope of the present
discussion. The reader is encouraged to refer to the textbook by Long for a more
rigorous quantum mechanical approach to the principles of Raman scattering [20].
It is also worth noting that there exists a mechanism whereby the Raman scat-
tering response of a molecule can be increased by several order of magnitude, known
as surface-enhanced Raman scattering (SERS), which involved adsorption of the
molecule onto a roughened or nano-sized metallic substrate. Metallic or plasmonic
nanoparticles are known for their unique interaction with light that results in the
excitation of their localized surface plasmon resonance (LSPR). LSPR excitation re-
sults in not only enhanced light absorption and scattering from the nanoparticle, but
also produces an enhanced electromagnetic field around the surface of the nanopar-
ticle that can be readily exploited for Raman enhancement [21, 22, 23, 24]. When
a molecule is adsorbed onto or is within close proximity of the nanoparticle surface,
the EM field felt by the molecule is that of the incident field and the enhanced EM
field at the nanoparticle surface. While the in-depth discussion of SERS is beyond
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the scope of the present thesis work, a more detailed mathematical description of
plasmonic nanoparticle Raman signal enhancement can be found in several excellent
texts by Van Duyne and colleagues [21, 231.
1.4.2 Coherent Raman Scattering (CRS)
Coherent Raman scattering is a term that refers to a class of stimulated interactions
where Raman processes are driven coherently, leading to the generation of strong
scattering signals. This differs from traditional Raman scattering, which is depen-
dent on spontaneous interactions. As was previously mentioned, spontaneous Raman
scattering depends on an infrequent interaction with the vacuum field. In coherent
Raman scattering, two light fields are introduced into a sample that have an energy
difference equal to a molecular vibration of interest. These two fields act to stimulate,
or drive, the Raman process, increasing its efficiency by several orders of magnitude
[19].
Though many types of coherent Raman scattering processes have been discovered
and developed [25, 26], two types of coherent Raman scattering have been specifically
developed towards biomedical applications: stimulated Raman scattering (SRS) and
coherent anti-Stokes Raman scattering (CARS). Both mechanisms of signal genera-
tion are so-called "four-wave mixing" processes, which implies that incident photons
interact with the material's vibrational properties to produce scattering contrast that
can be used for imaging. Important distinctions exist between CARS and SRS how-
ever, resulting in differences in detection schemes and image contrast. Schematically,
the energy diagrams for spontaneous Raman scattering, SRS, and CARS are pre-
sented in Figure 1-1.
Conceptually, SRS and CARS both involve the use of two incident fields at fre-
quencies Wp and ws, respectively referred to as the pump and Stokes beams, where
the difference between these two frequencies is tuned to match a molecular vibration
of interest. In the case of SRS, the introduction of electric fields at both frequen-
cies allows for a transfer of photons at the pump frequency to photons at the Stokes
frequency due to coupling with the sample's endogenous molecular vibrations. This
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Figure 1-1: Schematic representation of the fields involved in Raman scattering pro-
cesses. (A) Spontaneous Raman scattering, (B) stimulated Raman scattering (SRS),
and (C) coherent anti-Stokes Raman scattering (CARS). The pump, Stokes, and anti-
Stokes frequencies are respectively designated by Wp, ws, and WAS, while the dashed
and solid lines respectively refer to virtual and real molecular states. In spontaneous
Raman scattering, a pump photon scatters inelastically, thus generating a Stokes pho-
ton. In SRS, both pump and Stokes fields are incident on the sample simultaneously;
if there is a vibrational band gap that corresponds to the energy difference between
the two beams, the pump field decreases (stimulated Raman loss, SRL), while the
Stokes field is amplified (stimulated Raman gain, SRG). Finally, in CARS, a new field
is created at the anti-Stokes frequency and can be readily detected via optical filters,
as it is blue-shifted relative to the incident pump and Stokes fields.
implies that the pump beam intensity decreases in the presence of a Raman-active
molecule, while that of the Stokes beam increases. In order to pick up this small
energy transfer, SRS microscopy is achieved either by detecting the decrease in pump
intensity (stimulated Raman loss, SRL) or the increase in Stokes intensity (stimulated
Raman gain, SRG).
SRL is achieved through high-frequency modulation (typically on the order of
several MHz to circumvent laser noise and improve both imaging speed and detection
sensitivity [27]) of the Stokes beam via an acousto-optic or electro-optic modulator
(AOM and EOM, respectively). This implies that the SRS signal will manifest itself
as a high-frequency modulation superimposed onto the intensity of the pump beam
(Figure 1-2). Detection thus requires the use of a lock-in amplifier (LIA) or demod-
ulation to isolate the high-frequency component of the pump intensity. Conversely,
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SRG is performed by modulating the pump beam and detecting the high-frequency
fluctuations of the Stokes intensity. Additional information on SRS microscopy is
provided in section 1.7.
p LLIIIi 111] .SRL Signal
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Figure 1-2: Detection scheme for stimulated Raman loss (SRL). Conversely, stimu-
lated Raman gain (SRG) is detected by modulating the pump beam and detecting
the fluctuations of the Stokes beam.
The CARS process, on the other hand, can be conceptually perceived as an initial
induction of a coherent vibrational oscillation of the material, achieved by tuning the
difference ("beat") frequency between the pump and Stokes beams to a given vibra-
tional transition. This results in the creation of a macroscopic, coherently driven
polarization change in the sample at the excited vibrational state of interest. An
interaction of pump photons with this macroscopic polarizability then results in the
strong scattering of photons at the anti-Stokes frequency. In terms of implementation
for microscopy, CARS is.simpler than SRS in that it does not require signal mod-
ulation nor lock-in amplification for detection, since a new wavelength is generated
altogether. As such, detection of the anti-Stokes signal simply requires the use of
proper short-pass and/or band-pass filters that can adequately block out any residual
pump or Stokes light. Additional details on CARS microscopy are described in section
1.7. For further reading, various reviews on the topic are also available [28, 29].
One major difference between CARS and SRS is the existence of the so-called
"non-resonant" background in the CARS signal. This background contribution arises
due to the fact that CARS is a parametric process - that is, the energy state of the
molecule is unchanged after CARS. This differs from SRS and spontaneous Raman,
where molecules gain or lose a quantum of vibrational energy. The parametric nature
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of CARS enables a second, non-resonant, set of interactions that are derived from
purely electronic processes. The end result is that the CARS signal contains both
resonant and non-resonant contributions. This set of additional coherent interactions
has the practical effects of adding a nonspecific, background contribution to CARS
that can also result in shifted and complex vibrational spectra [26].
1.5 Fluorescence Photoconversion
The previous sections of the present chapter focused on microscopy techniques well-
suited for probing the intrinsic properties of endogenous molecular species in a label-
free manner (although they may certainly be used to probe exogenous compounds
as well). In contrast, fluorescent labeling comprises a widely used technique in mi-
croscopy applications in order to allow for the specific visualization of biological fea-
tures of interest [11, 30, 31]. These techniques are highly diverse in their implemen-
tation: standard immunofluorescence (IF) can be used to visualize specific proteins
[32]; genetic engineering allows for the genomic insertion of fluorescent reporter pro-
teins that in turn allow for the monitoring of genetic expression [33, 34, 35, 36, 37];
organelle-specific fluorescent dyes allow for various cytological measurements, both
quantitative and qualitative in their nature [38, 39, 40].
Despite their widespread adoption however, traditional fluorescence-based labeling
techniques are static. That is, they cannot serve to monitor specific cell populations
of interest over time. In fact, there exists a wide variety of applications where the
ability to monitor specific cell subpopulations over time would be of great interest. As
an example, genetic reporters such as green fluorescent protein (GFP) can be useful in
determining whether cells in a cultured population express a particular gene [35, 36].
On the other hand, tracking the fate or lineage of specific cells that express (or do not
express) the gene of interest within the same culture over prolonged periods would
pose a significant challenge [41]. This difficulty is of particular relevance in the study
of treatment resistance in the context of cancer, where resistant subpopulations in
heterogeneous cultures are of particular interest.
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In order to fill this technological niche, so-called "photoconvertible" fluorescent la-
bels have been developed [41, 42, 43, 44]. Much like conventional fluorescent reporters,
these molecules exhibit characteristic excitation and emission profiles. However, they
differ from conventional fluorophores in that their optical properties can be converted
to a new set of excitation and emission spectra. The specific set of optical signa-
tures pre- and post-conversion, as well as the reversibility of the process, are intrinsic
properties of each photoconvertible molecule.
While the excitation and emission properties of biologically relevant fluorescent
reporters can span the entire visible spectrum - ranging from the UV all the way to
the NIR [30] - the red end of the spectrum is typically of greatest value for intravi-
tal imaging. Longer wavelengths such as those in the NIR range have a considerably
lower tendency to be absorbed and scattered by tissues compared to their bluer coun-
terparts, allowing for increased signal generation and collection, in turn maximizing
penetration depth [11, 30, 45]. One such commercially available NIR fluorescent label
is DiR (1,1'-dioctadecyltetramethyl indotricarbocyanine iodide), a cell membrane dye
with excitation and emission peaks at 748 nm and 780 nm, respectively [41]. This
particular reporter has been shown to exhibit irreversible photoconversion following
irradiation with 750 nm femtosecond pulses [41], and is thus particularly well-suited
for the longitudinal monitoring of heterogeneous cancer cell populations (see Chapter
6).
1.6 Sum-Frequency and Transient Absorption (SFA
and TA)
Finally, the same modulation transfer scheme used for acquiring SRS images can
more generally be used to detect any signal where the presence of one beam affects
the intensity of the other beam following an optical interaction with the sample. In
the case of sum-frequency and transient absorption (SFA and TA, respectively), a
signal is generated typically in the case of a strong absorber that can absorb one
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photon from each beam. In the case of SFA, this absorption process is simultaneous;
in the context of TA, the process is step-wise, implying the absorption of one photon
to promote the molecule to a real excited state, followed by a second absorption event
promoting it to an even higher (i.e. more energetic) state. These modalities are thus
ideal for visualizing pigments and chromophores such as hemoglobin and melanin, for
example [46, 47, 48, 49, 50, 51, 52].
1.7 Instrumentation and Microscopy Setup
Nonlinear optical imaging technologies have begun to see a strong push in research
and development that is gaining momentum particularly in the field of cancer research
over the last couple of decades. In the case of coherent Raman scattering for example,
it was not until 1999 that CARS microscopy was developed by Zumbusch et al., where
three-dimensional vibrational imaging of chemical and biological samples was reported
for the first time [53]. Since then, significant strides have been made into applying
these imaging technologies to answer questions in oncology using tools that simply
were not previously available [54].
In order to build a nonlinear optical imaging system, one or more pulsed laser
sources are first required, depending on the imaging modality. The high peak powers
of such pulsed sources are necessary to probe the higher-order optical properties of
samples, while their low average powers avoid damaging the cells and/or tissues at
hand. Early nonlinear optical microscope designs used Ti:sapphire lasers and optical
parametric oscillators (OPO) or amplifiers (OPA) that were tuned to emit near-
infrared (NIR) wavelengths. More recently, commercial laser manufacturers such
as APE, Spectra-Physics, and Coherent have designed automated dual output laser
sources (including an integrated OPO system to allow for wavelength tunability),
which are most useful in the case of imaging techniques requiring more than one beam
(e.g. CARS, SRS, SFA, TA, etc.). For such applications, these sources provide a fixed
NIR output, typically used as the Stokes beam, and another that can be selectively
tuned over a very wide range (generally 680 nm to 1300 nm). The tunable output can
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be readily used for TPEF and FLIM imaging, for example, as they only require one
excitation source. The tunable nature offers the ability to selectively probe a wide
range of fluorophores either sequentially or simultaneously by judiciously selecting
the proper excitation wavelength. The advent of such technology greatly reduces the
complexity of the imaging system, as different molecules can be selectively imaged by
changing the tunable output via the provided laser software in a matter of seconds,
rather than painstakingly adjusting crystal temperatures and cavity length.
In addition to laser wavelength, pulse duration must also be considered when
designing a nonlinear optical platform. In the case of multiphoton processes such
as TPEF, shorter pulses simply imply a greater temporal flux of photons, implying
greater signal generation. In the case of coherent Raman scattering, additional factors
must be considered. Namely, the shorter a pulse is in the temporal domain, the
wider its profile becomes in the spectral domain. Thus, the spectral pulse width of
picosecond laser sources is orders of magnitude narrower than that of femtosecond
pulses. The dependence of pulse duration on spectral resolution thus influences the
performance of a coherent Raman imaging system, which is optimized when the
spectral pulse widths of the laser sources overlap with that of the Raman peak of
interest.
Regarding microscope design, the two external beams are combined using a dichroic
mirror (or, in the case of TPEF and FLIM, the excitation source is simply routed
towards the input port of the microscope). The beams are then raster-scanned across
the sample through a high numerical aperture (NA) objective. Such objectives are
preferred for nonlinear optical imaging - particularly in the case of CRS imaging
- in order to tightly focus the incident light into a small focal volume for optimal
signal generation. Moreover, in the case of CARS, these objectives ensure that the
so-called "phase-matching condition" is met such that anti-Stokes radiation is con-
structively generated [53]. Finally, as with all nonlinear optical techniques, the signal
strictly originates from the focal point of the objective. Therefore, the distribution
of the compound of interest can be mapped in three dimensions by raster scanning
the focus across the sample, and detecting the fluorescence or anti-Stokes light using
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a photomultiplier tube (PMT) downstream of appropriate optical filters.
A branching point in coherent Raman imaging was met in 2008 with the advent of
SRS microscopy [55], following the success of CARS as a label-free microscopy plat-
form. To this end, Freudiger et al. used essentially the same configuration as a CARS
microscope, but modulated the Stokes beam via an electro-optic modulator (EOM)
in order to detect a minuscule variation in the pump beam intensity using a high-end
lock-in amplifier. Such a tool is essential in the context of SRS microscopy, since
the signal originates from small fluctuations of the pump intensity at the modulation
frequency over a significantly larger input power level. As was mentioned earlier, this
configuration is referred to as stimulated Raman loss (SRL), while modulation of the
pump beam and subsequent detection of modulation amplitude in the Stokes beam
is known as stimulated Raman gain (SRG). This same setup is used in SFA and TA
imaging, where the modulation transfer of energy (and therefore, signal amplitude)
is used to detect the presence of strongly absorbing molecules such as hemoglobin or
melanin.
Translation of coherent Raman microscopes from the laboratory to the clinic has
recently begun as well. JenLab now offers the MPTflex CARS, a standalone portable
system with a pivoting handheld scan head capable of both multiphoton fluorescence
and CARS imaging [56]. For a more directed use in intra-operative settings, Invenio
Imaging offers a state of the art portable SRS/CARS imaging system based on fiber
lasers in the form of a compact microscope [57]. The advent of such novel technologies
is promising for the medical community, in that rapid label-free assessments can be
made directly on patients or biopsies in order to improve cancer diagnostic speed and
quality, leading to improved patient well-being.
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Chapter 2
Raman Scattering Technologies for
Cancer Research and Oncology
2.1 In Vitro/Ex Vivo Detection and Diagnostics
2.1.1 Biofluids
The ideal biological specimens for diagnostic tests are biofluids (i.e. blood, urine, or
saliva) as their collection - also known as a "fluid biopsy" - is non-invasive and
they can be repeatedly collected without harm to the patient. Additionally, biofluids
contain a vast amount of important and clinically relevant chemical components, in-
cluding DNA, hormones, proteins, and metabolites. Thus, a considerable amount of
research has been focused on assessing the utility of Raman technologies to analyze
biofluids in cancerous and non-cancerous patients [58, 59, 60]. The following discus-
sion involves prostate, oral and breast cancers; however, a list of additional cancers
diagnosed using biofluid samples and Raman techniques can be found in Table 2.1.
Table 2.2 also provides a compilation of common Raman bands identified in these
studies.
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Table 2.1: Summary of cancers diagnosed
lected representative associated references.
be absolute or all encompassing.
using various Raman techniques and se-
Please note that this list is not meant to
Type of cancer Biofluid Ex vivo tissue In vivo model
Prostate Blood, urine Human
Oral Blood, urine, saliva Human Human
Breast Blood, urine, saliva Human Mouse
Skin Human Human, mouse
Brain Human, pig, mouse Human, mouse
Lung Human Human
Gastrointestinal Blood Human Human, pig, rat
Leukemia Blood
Head and neck Blood Human
Cervical Blood Human Human
Liver Blood Human
Ovarian Human Mouse
Circulating tumor Blood -_
cells
Prostate Cancer
In 2003, Porter and co-workers reported one of the first immunoassays that utilized
SERS for the detection of prostate specific antigen (PSA) in human serum [61]. For
specificity to PSA and signal enhancement, Raman probes were prepared by function-
alizing 30 nm gold nanoparticles (AuNPs) with an anti-human PSA antibody and the
Raman reporter 5,5'-dithiobix(succinimidyl-2-nitrobenzoate) (DSNB). Based upon
their previous studies, the authors found that covalently linking the PSA antibod-
ies to the Raman reporter and in turn the gold nanoparticles increased performance
over physisorption techniques. Solutions of anti-human PSA-gold nanoparticles and
human serum samples containing free PSA were allowed to react, dry onto anti-free
PSA antibody treated gold slides, and interrogated by a fiber-optic Raman system
equipped with a 632 nm HeNe laser. Using the symmetric nitro stretch of DSNB
at 1338 cm- 1 , PSA levels were detected down to 1 pg/mL and were comparable
to commercially available assays. Raman spectroscopy was also coupled with sup-
port vector machine (SVM) analysis to evaluate blood serum from prostate cancer
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Table 2.2: Common Raman band assignments used in cancer diagnostic studies [1,
2, 3, 4, 5, 6, 7, 8]. Please note that Raman vibrations may shift in wavenumber
depending on the sample and that these values should not be regarded as absolute.
shift Vibrational mode Assignment
g vibrations
ng vibrations
Raman
(cm-1)
481
558
600
621
650
678
685
692
798
825
840
903
912
960
1004
1049
1155
1176
1217
1265
1310
1340
1445
1477
1523
1586
1654
1655
1739
2081
2845
2940
v(C-H)
v(C-C6 H5 )
v(C-N), 6(N-H), amide III
t(C-H)
w(CH3-CH2)
6(CH2)
v(C-O)
6(C=C)
v(C=C)
v(C=O), amide I
V(C=O)
v(CH2)
v(CH3)
v(C-C)
v(N-CH3), 6(C=0), fin
t(C-C)
t(C-C)
v(N-CH2), v(C=0), rii
t(C-S)
6(0-C=O)
v(N-H)
as(O-P-0)
6(N-CH 2), ring vibratic
v(C-C-N)
v(C-C)
V(po 43)
v(C-C), ring breathing
v(C-0), v(C-N)
patients and healthy volunteers [1]. While the collected serum samples were investi-
gated using both conventional Raman spectroscopy and SERS, SERS with bare silver
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Glycogen
Uric acid
Creatinine
Phenylalanine
Tryptophan, uric acid
Creatinine
Proteins
Creatinine
Uric acid
DNA backbone
Creatinine
Creatinine
Calcium oxalate dihydrate
Calcium hydroxyapatite
Phenylalanine
Proteins
-carotene
Tyrosine
Tyrosine, phenylalanine
Proteins, a-helix, collagen
Lipids
Collagen, lipids
Collagen, lipids
Calcium oxalate dihydrate
/-carotene
Phenylalanine
Fatty acids
Proteins, a-helix, collagen
Cholesterol esters
Pheomelanin
Lipids
Proteins, lipids
ns
nanoparticles showed the greatest diagnostic capabilities. The acquired SERS spec-
tra from cancerous and normal patients revealed biochemical changes that correlated
to a malignant state. In prostate cancer serum samples, Raman bands at 481 cm-1
(glycogen), 1217 cm- 1 (C-C6 H5 - phenylalanine, tryptophan) and 1445 cm- 1 (CH 2
bending - collagen/lipids) were seen to decrease, while increases were seen at 650
cm- 1 (C-C twist, tryptophan), 685 cm- 1 (C-S twist) and 1586 cm- 1 (C=C bending
phenylalanine). Spectra classified using the Gaussian radial basis function kernel
SVM model resulted in diagnostic metrics of 100% specificity, 96% sensitivity, and
98% accuracy.
Diagnosis of prostate cancer using SERS has also been extended to urine analysis
[62]. In this study, filtered urine samples were mixed with gold nanoparticles and
then spotted onto a CaF2 microscope slide for measurement. Examination of the dif-
ference spectra revealed an increase in Raman bands associated with the metabolite
hypoxanthine in prostate cancer samples. Using PCA-LDA for classification, a sensi-
tivity of 100%, a specificity of 89%, and an accuracy of 95% were achieved. While the
sample size for this study was limited, this work demonstrates the potential feasibility
of urinalysis via SERS and multivariate spectral analysis for cancer diagnoses.
Oral Cancers
Blood sample analysis via Raman spectroscopy has also been carried out for oral
cancers [63, 64, 65]. In 2013, Sahu et al. demonstrated that conventional Raman
spectroscopy could be used to delineate between serum samples from patients that
had been diagnosed with buccal mucosa and tongue cancer, and those from healthy
volunteers [63]. An efficacy of 85% was found when all spectra were independently
analyzed, while 78% efficacy was reported when replicate measurements for inde-
pendent patients were averaged prior to analysis. PCA-LDA was used as the data
analysis model for classification generation. Similar to that seen in prostate can-
cer analysis, changes in Raman bands associated with amino acids and lipids were
most significant. This same group demonstrated that Raman spectroscopy on serum
samples could potentially predict reoccurrence of oral cancer [65].
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Additionally, urine has been investigated for the detection of oral cancer using
Raman spectroscopy [2]. In this study, voided raw urine was collected from 167
patients (73 healthy and 93 cancerous) and evaluated for its chemical components
between 500-1800 cm- 1 using 785 nm excitation. Molecular vibrations associated
with uric acid, specifically C-C stretching at 558 and 649 cm- 1 and N-H stretching at
798 cm- 1 , showed elevated intensities in cancer patients compared to those that were
healthy. Four Raman bands related to creatinine also showed increases, while the
band at 692 cm- 1 (0-C=O deformation) was only present in cancer patients. Other
urinary metabolites - urea, DNA, indoxyl sulfate, pteridine, flavin, tryptophan, and
phenylalanine - showed differences between cancer and healthy patients. PCA-LDA
spectral analysis resulted in a diagnostic sensitivity, specificity, and accuracy of 98.6%,
87.1%, and 93.7%, respectively. Oral cancer detection has been extended to saliva
analysis through coupling Raman spectroscopy and PCA [66].
Breast Cancer
Diagnostic evaluations using blood, urine and saliva for breast cancer have also been
performed. Blood serum analysis using conventional Raman spectroscopy coupled
with PCA-LDA was able to distinguish between normal and cancerous patient sam-
ples with 97% sensitivity and 78% specificity [67]. In order to acquire ample signal,
samples were frozen and solid residues were removed for spectral analysis. Multivari-
ate analysis revealed seven Raman band ratios that led to the discrimination between
cancerous and non-cancerous samples; these discriminatory band ratios involved the
amino acids phenylalanine, tryptophan and tyrosine as well as polysaccharides and 3-
carotene. Bhattacharjee et al. demonstrated the feasibility of using urine as a sample
platform for breast cancer diagnosis [68]. Urine was collected from control and breast
tumor bearing rats, and was then evaluated with Raman spectroscopy in either an
unprocessed or concentrated form. The acquired Raman spectra from unprocessed
urine revealed bands associated with urea (1006 cm- 1 and 1161 cm- 1) and creatinine
(680 cm- 1 and 850 cm- 1). The use of urine concentration led to additional spectral
features being revealed. Still, even with additional features present, the Raman bands
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at 680 cm- 1 and 1006 cm- 1 showed the greatest change between control and tumor
bearing rats. Spectral analysis using PCA-LDA resulted in classification efficiencies of
72% and 91% when using unprocessed and concentrated urine samples, respectively.
Saliva has also been recently evaluated as a biological matrix to diagnosis breast
cancer using SERS [3]. Saliva was collected from 33 healthy patients and 31 cancerous
patients, and then mixed with silver nanoparticles immediately before acquiring the
Raman measurement. Difference spectra revealed saliva acquired from cancerous
patients had protein band decreases at 621 cm- 1 (C-C twist phenylalanine), 1049
cm- 1 (C-O, C-N proteins) and 1176 cm- 1 (C-H tyrosine) and protein band increases
at 1004 cm- 1 (C-C phenylalanine), 1208 cm- 1 (C-C6 H5 phenylalanine) and 1340 cm- 1
(CH 3CH 2 wagging collagen). A partial least square (PLS)-DA algorithm was used
to categorize the data and resulted in diagnostic sensitivities above 72%, specificities
above 81%, and accuracies above 78%.
2.1.2 Tissue
Ex vivo tissue examination through histopathological techniques is regarded as the
gold standard for cancer diagnosis. Histopathology, while reliable, does not allow for
in vivo evaluation, which would be extremely beneficial during surgery; the complete
removal of tumor margins is heavily correlated to increased survival [69, 70, 71]. Thus,
the use of Raman technologies to delineate between cancerous and non-cancerous tis-
sues ex vivo has been readily explored as first step toward the potential intraoperative,
real-time evaluation of tissue during surgery [72, 58, 59]. Although the below discus-
sion focuses on breast, lung, skin and brain cancers, a list of other cancers diagnosed
using ex vivo tissue samples and Raman techniques can be found in Table 2.1. Com-
mon Raman bands identified in these works can be found in Table 2.2.
Breast Cancer
With over 260,000 total cases of breast cancer reported each year [73], it is not sur-
prising that breast tissue has been heavily interrogated using Raman techniques. One
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of the first reports of breast tissue evaluation using Raman spectroscopy was pub-
lished more than 20 years ago [74]. This work focused on the characterization of
molecular components in normal breast tissue as well as the optimization of spectro-
scopic experimental parameters, such as the excitation wavelength, laser power, and
the use of a fiber optic probe for spectral acquisition. A year later, the same group
used these results to assess the potential spectral differences between normal and
cancerous (invasive ductal carcinoma, IDC) breast tissues [75]. Using a NIR excita-
tion source with relatively low power (100-200 mW), the authors reported cancerous
tissue having significant differences, especially in bands correlated to lipid content.
For statistical analysis, the band area ratios of 1654 cm- 1 (C=C stretching in fatty
acids) and 1439 cm- 1 (CH2 scissoring) were chosen due to their sensitivity towards
histopathological variations. Discrimination between normal and diseased tissue was
also possible using a fiber optic probe placed 1 mm into the tumor. It should be noted
that both conventional and fiber optic based Raman systems used in this study were
unable to distinguish between benign (fibrocystic change) and cancerous samples.
Feld and co-workers later published a series of works that reported the discrimina-
tion and molecular characterization of breast tissue from normal, fibrocystic change,
fibroadenoma and infiltrating carcinoma pathologies through the combination of a
Raman microspectroscopic setup and linear combination models [76, 77, 78]. Their
analysis model revealed that bands associated with fat and collagen were important
algorithmic parameters and led to a diagnostic classification sensitivity of 94% and
a specificity of 96%. Much work since these foundational studies has been focused
on investigating the utility of different combinations of Raman spectral features and
multivariate analysis techniques to discriminate between normal, benign and diseased
breast tissue [79, 80, 81, 82, 83].
Raman spectroscopy of calcified species has also been reported as a plausible
method to differentiate between normal and cancerous breast tissue. While calcifi-
cations are regarded as harmless when found in bones, their presence in soft tissue,
especially breast tissue, is often associated with disease. Calcifications are gener-
ally composed of either calcium oxalate dihydrate (COD) or calcium hydroxyapatite
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(HAP), and are extremely difficult to distinguish using traditional pathology tech-
niques [84]. Haka et al. reported that bands located at 912 cm- 1 (C-C stretching) and
1477 cm- 1 (C-O stretching) were indicative of COD calcifications while HAP had a
prominent spectral signature at 960 cm 1 that corresponded to phosphate stretching
[85]. While benign tissues could be distinguished using the COD calcification Raman
bands alone, differentiation between benign and diseased tissues using HAP band
measurements required the use of PCA. PCA resulted in a diagnostic sensitivity of
88% and specificity of 93% when monitoring the increase in bands associated with
calcium carbonate and the decrease in protein bands. Stone and Matousek also ex-
plored the use of transmission Raman spectroscopy for distinguishing between HAP
and COD in breast phantoms at depths translatable to in vivo detection [86]. In a
push towards rapid clinical translation, Barman et al. demonstrated the feasibility
of simultaneously identifying between HAP and COD calcifications and diagnosing
breast cancer lesions in real-time during a stereotactic core needle biopsy [87]. A
combination of Raman spectroscopy and SVM analysis resulted in a 100% positive
predicative value, a 95.6% negative predictive value, a 62.5% sensitivity, and a 100%
specificity for diagnosing breast cancer tissues with or without calcifications. An 82%
overall accuracy for calcification status and breast cancer diagnosis was also reported.
However, the most impressive result from this study was the ability of their SVM al-
gorithm to diagnose ductal carcinoma in situ (DCIS), which was not possible with
their previously developed algorithms for biopsy Raman analysis.
While many studies have focused on utilizing conventional Raman spectroscopy,
Wong and co-workers employed CARS imaging and quantitative data analysis to
distinguish between normal, benign and cancerous breast tissue [88]. In addition,
the team demonstrated the ability of CARS to classify cancer subtypes (DCIS, high
grade and low grade invasive ductal carcinoma (IDC), and lobular carcinoma). CARS
imaging using the CH2 vibration located at 2845 cm- 1 revealed normal breast tis-
sue was dominated by adipose and fibrous structures, while malignant tissues showed
morphological alterations especially within tumor cells that were confined to the base-
ment membrane and duct space. Diagnostic features from the acquired images were
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selected according to pathological standards. Using their developed methodology,
80% of intermediate-grade IDC and 85% high-grade IDC samples were accurately
distinguished.
Lung Cancer
Ex vivo tissue analysis using Raman spectroscopy has also been performed on lung
cancer samples. In 2001, Hamaguchi and co-workers demonstrated the possibility
of distinguishing between normal and malignant lung tissues by using NIR Raman
spectroscopy [89]. By using 1064 nm laser excitation, resolvable biological spectra
could be acquired with only minimal tissue autofluorescence. Cancerous tissues were
found to have strong bands located at 1448 cm- 1 and 1666 cm- 1, which corresponded
to collagen. Huang et al. also utilized NIR Raman spectroscopy, probing between
700-1800 cm- 1 with a 785 nm diode laser, to distinguish between normal and dis-
eased bronchial tissues from 10 patients [4]. Their measurements revealed significant
spectral differences of bands associated with amino acids, collagen, nucleic acids and
phospholipids, with the ratio of Raman band intensities at 1445 cm- 1 and 1655 cm 1
serving as a metric of differentiation. The Wong group used CARS microscopy to
discriminate between normal, benign, and malignant lung tissues [90, 91]. Malignan-
cies were categorized using CARS imaging into different subtypes. Distinguishing
between normal and cancerous tissues required 11 features and resulted in classifica-
tion accuracies of 91% and 92%, respectively. In order to separate adenocarcinoma
from squamous cell carcinoma samples, 25 features were required and led to 76% and
72% classification accuracies. Shifted subtracted Raman spectroscopy has also been
explored as a diagnostic technique for the evaluation of lung tissue samples [92].
Skin Cancer
Skin cancer can be divided into three major subtypes: melanoma, basal cell carci-
noma (BCC) and squamous cell carcinoma (SCC), with melanoma accounting for
less than 2% of all skin cancer cases, but responsible for 75% of skin cancer deaths
[73]. BCC and SCC are often referred to as nonmelanoma skin cancers (NMSCs) and
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their detection has been heavily investigated in the Raman community. One of the
first reported studies to investigate the utility of Raman spectroscopy to identify NM-
SCs was conducted by Gniadecka et al. and compared the spectral features of BCC
to those of normal skin biopsies [93]. Using a NIR Fourier transform (FT) Raman
spectrometer with a 1064 nm Nd:YAG excitation laser, this work revealed alterations
in protein, lipid and polysaccharide bands. BCC spectra showed a decrease at 1270
cm- 1 (amide III - protein) and 1650 cm- 1 (amide I - protein) and were correlated
to disturbances in the a-helix secondary structure of the skin. Additional spectral
alterations were seen at 850, 870, 950, 1420 and 1450 cm 1 and were associated with
changes in protein and lipid structures. The authors employed an artificial neural
network analysis technique to achieve complete separation between BCC and normal
tissues using spectral changes in the regions of 830-900 cm- 1, 900-990 cm- 1 and
1220-1360 cm 1 . Building upon this work, Puppels and co-workers used a logistic
regression model to differentiate BCC from the surrounding normal, healthy epider-
mis. Their analytical approach resulted in 100% sensitivity and 93% specificity for
BCC diagnosis [94]. This same group later reported the ability to distinguish between
BCC and surrounding healthy tissue using high wavenumber (2800-3125 cm-) Ra-
man spectroscopy [95]. They achieved 100% and 99% prediction accuracies for BCC
and healthy tissue, respectively. As high wavenumber analysis eliminates background
signals in the fingerprint region that arise from the use of fused-silica-based optical
fibers, this work demonstrated the potential feasibility of using a fiber optic probe to
diagnose tumor borders in BCC.
Multimodal imaging consisting of CARS, second harmonic generation (SHG), and
two-photon excitation fluorescence (TPEF) has also been explored as a potential tech-
nique to discriminate between BCC and normal tissues. Multimodal imaging allows
for not only structural information (SHG - collagen) but also spatial (TPEF
endogenous fluorophores) and chemical (CARS - lipids) information to be resolved.
Vogler et al. used this multimodal imaging strategy in 2010 and revealed that BCC
tumor cells could be distinguished due to their undetectable collagen structures and
large patches of fat reservoirs [96]. Three years later, this group used the same ap-
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proach to distinguish between BCC and SCC as well as normal tissues [97]. BCC and
SCC both showed a lack of collagen structure, but BCC also demonstrated a weaker
CARS (lipid) signal than that of SCC. Additional morphological features that are tra-
ditionally seen in H&E stains could also be visualized using this strategy and added
to the strength of diagnosis.
Melanoma and NMSCs have also been able to be distinguished from one another.
Wulf and co-workers utilized NIR FT-Raman spectroscopy to delineate melanoma
from pigmented nevi, BCC, seborrheic keratoses and normal tissue [5]. Visual differ-
entiation was based upon band intensity decreases at 1660 cm- 1 (amide I - protein)
as well as increases at 1310 and 1330 cm- 1 (CH twisting and wagging - lipids) for
BCC and SCC, respectively. As proposed in other studies, the decrease in in the
amide I band was attributed to conformational changes in proteins of diseased tissue.
When neural network analysis was employed for tissue discrimination, a melanoma
diagnostic sensitivity of 85% and specificity of 99% was achieved while a sensitivity
of 97% and a specificity of 98% were attained for BCC. These metrics are compara-
ble to those achieved with trained pathologists, demonstrating the potential utility
and translation of this methodology for melanoma and BCC diagnosis. BCC and
melanoma discrimination has also been achieved using PCA for spectral analysis
[98, 99].
Brain Cancer
Brain cancer accounts for over 250,000 diagnosed cancer cases and 189,000 deaths
annually worldwide [100]. Of these reported cases, approximately 50% are identified
as gliomas, which are known for their highly aggressive nature. That said, it is not
surprising that the majority of work in the Raman community has been geared toward
the identification of gliomas. In one of the first reported investigations, Koljenovid
et al. evaluated 20 unfixed cryosections of glioblastoma by Raman spectroscopy and
LDA for separating vital and necrotic tissues [6]. The dominating spectral signatures
from difference spectra (necrotic minus glioblastoma) resembled that of cholesterol
and cholesterol esters, indicating necrotic tissues possess higher concentrations of
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cholesterol. Subtle band changes, corresponding to carotenoids and calcifications,
were also observed. Cluster analysis resulted in 100% diagnostic accuracy when run
on 9 independent tissue samples. This group further explored the utility of Raman
spectroscopy for brain cancer diagnosis using high wavenumber (2400-3800 cm- 1)
Raman spectroscopy [101] and a single-fiber optical probe Raman system [102].
Raman spectroscopy was also compared with IR spectroscopy for the delineation
of glioma, meningioma and schwannoma from normal tissues in a study conducted
by Krafft et al. [103]. In this work, both Raman and IR spectroscopic analysis
resulted in significant differences between diseased and normal tissue samples; how-
ever, Raman spectroscopy was determined to be the better technique due its lack of
"contamination" from water and its ability to spatially resolve a greater number of
chemical components. For meningioma, Raman spectral decreases were seen at 857,
939, 1246 and 1684 cm- 1 when compared to normal tissue. As these bands correspond
to collagen, their observed decreases agree well with the notion that tumors have ir-
regular collagen structures. Glioma tissues were evaluated against tissue that had
been subjected to a hemorrhage, and spectral analysis showed that hemorrhage tis-
sues had increased band intensities at 661, 751, 1003, 1124, 1258, 1346, 1454 and 1603
cm 1 . These bands were correlated to the presence of hemoglobin. When compared
to meningioma, close analysis revealed that glioma tissues had greater band inten-
sities at 719 cm- 1 indicating differentiations could be based on phosphatidylcholine
levels. Schwannomas also showed distinct spectral features at 426 cm- 1 and 508 cm 1
when compared to glioma and meningioma tissues. These bands were attributed to
the presence of tricalciumphosphate within the lesions. Krafft and colleagues later
used Raman microscopic imaging and a spectral unmixing algorithm to investigate
histopathological features such as cell density and nuclei [104]. Raman signatures
in combination with the unmixing algorithm revealed high-grade glioblastomas had
increased nucleic acid levels (782, 1099 and 1576 cm-) over low-grade tissues. Fur-
thermore, this group utilized hyperspectral unmixing of Raman images to correlate
morphological (i.e. number and diameter of cell nuclei) and biochemical (i.e. pro-
teins, lipids and nucleic acids) components with the degree of malignancy in brain
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tissues [105].
Coherent Raman imaging has found applications in the identification and mi-
croscale mapping of gliomas. In 2009, Evans et al. demonstrated the ability of CARS
to delineate fresh astrocytoma samples, a type of glioma, from normal brain tissue
in mouse models of human brain cancer [106]. Images were constructed by using the
lipid CH 2 stretching mode located at 2845 cm- 1 and revealed accurate tumor margins
when compared to traditional H&E stains. Kirsch and co-workers have recently used
CARS to evaluate primary and secondary brain tumors against normal tissue [107].
Primary glioblastoma tumors and brain metastases of breast and melanoma where
shown to exhibit decreased CARS signals and were thus distinguishable from normal
surrounding tissues. Tumor infiltrates were also identified by the gradual disappear-
ance of the 2845 cm- 1 CARS signal into the tumorous region. Additionally, the use
of CARS in a multimodal imaging format similar to that described for skin cancer
(BCC) has also been used to analyze brain tumors [108].
Gliomas have also been identified via another coherent Raman technique, namely
SRS. Building upon their work in 2008 that demonstrated the ability of two-color SRS
imaging to produce high quality brain tissue images [55], Xie and colleagues evaluated
the use of this Raman imaging modality to delineate between diseased and normal
brain tissues as well as differentiate between primary and secondary tumors [7]. Mul-
ticolored SRS images were created using two Raman vibrational modes: 2845 cm-1
(CH 2 stretching - lipids) and 2940 cm- 1 (CH 3 stretching - lipids and proteins).
While the CH2 stretching vibration was used alone to produce images of cytoplasm
and myelin sheaths, images of nuclear morphology resulted from the difference image
of CH2 stretching (2845 cm- 1) subtracted from CH3 stretching (2940 cm- 1). Using
this type of image acquisition, brain tumor tissues showed increased cellularity com-
pared to normal brain tissue and exhibited similar diagnostic features as conventional
H&E tissue analysis. Primary glioma tumors were further distinguishable from brain
metastases from the breast by monitoring the tumor margin. Primary glioma tissue
samples displayed infiltrating glial cells along the white matter tracts of the corpus
callosum, while a defined tumor margin could be seen with tissue samples of brain
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metastases. This group was later able to quantify and correlate acquired SRS signals
at 2845 cm- 1 and 2930 cm- for the differentiation of cellular regions - solid tumor,
cortex and white matter - in human glioblastoma xenografts [109]. The ratio of
Raman signals (2930 cm- 1 /2845 cm- 1 ) revealed solid tumor regions had high levels
of protein compared to both cortex and white matter regions. By monitoring this
Raman signal ratio across the gray matter-tumor interface, tumor infiltration was de-
tectable. Fresh human tumor samples were also analyzed using this multicolor SRS
imaging approach. SRS analysis not only revealed hypercellularity (i.e. increased pro-
tein content), but also cellular and nuclear pleomorphism, pseudopalisading necrosis
and microvascular proliferation. The identified features matched those seen with tra-
ditional H&E analysis further. These impressive studies demonstrate the potential
clinical utility of SRS for intraoperative use in brain tumor cytoreduction surgery
cases as SRS provides ample information to aid in tumor margin identification.
2.2 In Vivo Detection and Diagnostics
2.2.1 Animal Models
Animal models are one of the most invaluable components in translating a diagnostic
or treatment strategy to the clinic. While they do not fully recapitulate the genetic
and epigenetic heterogeneity found in human cancers, animal models allow researchers
to investigate harmful and fatal diseases without risking human lives [110]. Preclin-
ical studies investigating the utility of Raman spectroscopy for the identification of
cancerous lesions have heavily relied on animal models, namely murine models. While
several cancer models have been explored (Table 2.1), the following discussion will fo-
cus on brain and breast cancer detection, as these are the most heavily investigated.
A list of common Raman bands used for in vivo detection and diagnostics can be
found in Table 2.2.
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Brain Cancer
The gold standard for brain tumor detection is histological analysis on biopsied tis-
sues; however this method does not allow surgeons to differentiate infiltrating lesions
from normal tissue in real-time in the operating room. While several groups have
focused on characterizing spectral differences of these tissue populations in ex vivo
tissues, the use of in vivo Raman detection strategies is still in its early stages, with
the majority of work being conducted on experimental animal models. In 2010, Bel-
jebbar et al. demonstrated the potential for in vivo glioblastoma detection using a
microprobe coupled to a portable Raman spectrometer [111]. In this study, rat C6
glioma cells were injected into neonatal Wistar rats and intracerebral tumor devel-
opment was monitored up to 20 days using the Raman microprobe. The microprobe
utilized an 830 nm laser excitation source, a fiber optic probe to deliver incident laser
light and collect the Raman scattered light, and a spectrograph to record Raman spec-
tra. Alterations in bands associated with proteins, lipids and DNA were observed,
and hierarchical cluster analysis of these spectral features showed strong separation
between brain tissue pre-injection (i.e. normal) and tissue from the developed tu-
mor. That same year, Krafft and co-workers reported the in vivo detection of brain
metastases using a Raman spectroscopic imaging system with a 785 nm laser source
[112]. Metastatic brain tumors were induced using murine melanoma cells injected
into the carotid artery of nude mice. Due to the presence of melanin and its associated
Raman signatures (i.e. 587, 976, 1404, and 1595 cm-), the location of melanoma
cells and their developed metastases could be visualized in cortical and subcortical
regions. While the Raman images had lateral resolutions of 250 Pum and required
several minutes to acquire, this work demonstrated the intraoperative potential of
Raman spectroscopic imaging for brain tumor resection.
Recently, SERS has also been recently employed for the in vivo identification of
brain lesions, specifically for fine margin resection. Kircher et al. described the use of
a triple-modality nanoparticle that allowed the combination of MRI, photoacoustic
imaging, and Raman imaging for the intraoperative identification of brain tumor mar-
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gins in live mice [113]. This imaging combination resulted in the location of the whole
brain tumor to be identified (MRI) as well as the tumor's three-dimensional structure
at a high spatial resolution to be visualized (photoacoustic imaging). Raman imaging
further allowed for brain tumor margins to be delineated as confirmed by histological
analysis. To enable the triple imaging strategy, 60 nm spherical gold nanoparticles
were functionalized with Raman reporter and MRI contrasting molecules. Under
this design the nanoparticles served as a photoacoustic contrasting agent, provided
signal enhancement of the Raman tag, and carried contrasting molecules for MRI.
The nanoparticles were injected into the tail vein of orthotopic glioblastoma bearing
mice, and were able to cross the blood-brain barrier and accumulate in tumor cells
via the enhanced permeability and retention (EPR) effect. Tumor site localization
allowed for high signal to noise ratios in all imaging modalities and significantly aided
in the complete resection of glioblastomas. The use of a handheld Raman scanner in
combination with silica coated gold nanoparticles has also been reported [114]. The
handheld scanner allowed for real-time Raman scans of the tumor region and revealed
additional cancer laden regions that were otherwise undetectable by conventional Ra-
man and SERS imaging systems.
The Xie group has demonstrated the use of SRS for rapid and label-free visualiza-
tion of glioblastoma multiforme (GBM) brain tumors [109]. Accurate resections are
of particular importance in the context of brain cancer, given that 85% of recurrent
GBM tumors arise at the resection margin where cancer cells were left behind [115].
Ji et al. used an infiltrative human GBM xenograft mouse model fitted with a cranial
window in order to image the brain tissue non-invasively. Two Raman spectral peaks:
2845 cm- 1 and 2930 cm-1, which correspond to lipids and proteins, respectively, were
chosen to contrast healthy tissue from the brain tumor. These bands were selected
given the marked decrease in lipid content in cancerous tissue, thus offering a source
of endogenous contrast. They showed that while the bright-field image of the tumor
border appears grossly normal, it is readily distinguishable in SRS. While the authors
caution that SRS microscopy still requires rigorous evaluation and validation prior to
clinical translation, their work is among the first to introduce in vivo coherent Raman
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microscopy to the field of cancer research.
Breast Cancer
In an effort to better reconcile rodent models of breast cancer with its human coun-
terpart, Bhattacharjee et al. evaluated the Raman spectra from C57, Swiss albino,
Swiss bare, and agouti mice, as well as Sprague-Dawley rats [116]. They first found
that white-haired rodents provided better signal-to-noise ratio and less background
relative to their colored kin in terms of their Raman spectra. A further investigation
of white-haired and hairless mice across various anatomical sites was then carried out
in order to evaluate the contributions from skin versus those of the mammary tissue.
It was found that the highest quality spectra were obtained from Swiss bare mice,
suggesting they are best suited for future transcutaneous spectroscopic investigations
of breast cancer in animal models.
As for the application of SERS in the context of breast cancer, Qian et al. explored
the applicability of using gold nanorod probes to optically detect breast cancer tumors
in vivo via tagging with polyethylene glycol (PEG) and 3,3-diethylthiatricarbocyanine
iodide (DTTC), a NIR fluorophore and Raman probe [1171. Male nude mice were first
xenografted with human breast cancer cells and maintained until the tumors reached
an approximate size of 5 mm in diameter. The mice were then injected with the
functionalized nanoprobes and imaged at several time points post-injection. Their
work showcased the potential for using SERS and fluorescence simultaneously on a
single platform to map tumors and sentinel lymph nodes in the context of breast
cancer.
A later study by Dinish et al. made use of gold nanoparticles tagged with three
Raman reporters bound to three antibodies for intrinsic breast cancer biomarkers:
Cy5 to TGFLRII, MGITC to CD44, and Rh6G to EGFR [118]. Nude female mice
were inoculated with a human metastatic breast cancer cell line, and nanoprobes were
injected at the center of the tumor once it reached a palpable size. By targeting a
single spectral peak from each Raman reporter, the authors observed the multiplex
SERS spectra in the tumor region up to 48 hours post-administration, followed by
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their clearance after 72 hours. This research suggests the possibility of selectively
targeting and imaging subtypes of breast cancer in vivo for improved diagnosis and
treatment monitoring.
Finally, Jeong et al. recently developed a fluorescence-Raman endomicroscopic
system (FRES) using nanoprobes for simultaneously acquiring fluorescence and SERS
measurements [1191. The nanoprobes consisted of a large silica nanoparticle (200 nm
diameter) covered in smaller Raman-labeled silver nanoparticles (10 nm diameter),
all coated in a silica shell that was conjugated to AF610, a fluorescent dye (10 nm
thickness). To evaluate system performance on a murine breast cancer model, four
mice were xenografted with a human breast cancer cell line expressing high levels of
HER2 and EGFR, both common biomarkers of breast cancer. The authors report
successful molecular detection of the xenografted tumors endoscopically with high
sensitivity via multiplexed active targeting. This technology could thus be translated
to routine endoscopic procedures where diagnosis of particular cancer subtypes in
their early stages is most critical.
2.2.2 Human Studies
Due to the ethical standards surrounding human research, the exploration of Ra-
man spectroscopy techniques for cancer diagnostics has so far been somewhat lim-
ited. However, the works presented here have been conducted on easily accessible
regions that do not require invasive procedures or anatomical regions that can be
accessed through endoscopic probes. Thus the following discussion focuses on skin,
gastrointestinal, cervical and brain cancer detection. Other cancers that have been
investigated using in vivo Raman technologies can be found in Table 2.1. Raman
bands associated with these studies can be found in Table 2.2.
Skin Cancer
Skin cancer is arguably one of the most studied forms of neoplasia in vivo via Raman
spectroscopy, primarily due to the ease of access of suspicious lesions. This avoids
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the need for endoscopy and favors the use of handheld fiber-based Raman probes for
rapid, accurate, and point-of-care diagnosis and classification of suspect skin lesions.
The current clinical standard for skin cancer diagnosis relies on visual inspection
of suspect lesions, often assisted by dermoscopy. This diagnostic methodology leaves
a fair degree of variability in the accuracy of skin cancer diagnosis based on the
experience and training of the dermatologist. This subjectivity thus warrants the
development of tools that are non-invasive, rapid, and portable for a more objective
and rigid framework for evaluating suspicious skin lesions.
To this aim, the Zeng group has been investigating the applicability of Raman
spectroscopy for skin cancer diagnostics. In 2012, the group conducted a clinical
study investigating various types of skin cancer as well as a variety of benign skin
diseases, where the integration time for their studies was set at 1 second or less.
They confirmed the ability to distinguish malignant and pre-malignant lesions from
benign ones, melanomas from nevi (benign pigmented lesions, commonly referred to
as moles), and melanomas from seborrheic keratoses. For highly sensitive detection
(ranging from 95% to 99% sensitivity), a specificity ranging from 15% to 54% was
reported, suggesting the applicability of Raman spectroscopy as a tool for screening
suspicious lesions non-invasively [120]. In a related report, it was also shown that
intentional photobleaching of skin can be a useful technique to reduce the autofluo-
rescence of the sample, effectively increasing the overall signal-to-noise ratio of the
spectroscopic measurements [121]. More recently, the group conducted an indepen-
dent validation of their automatic skin cancer detection methodology, where they used
518 cases from a prior study as a training set and 127 new cases for testing. This
study validated prior work, yielding diagnostic accuracy matching previous findings
[122].
In parallel, the Meinke group conducted an in vivo clinical study using Raman
spectroscopy to discriminate skin cancer from normal tissue via a fiber-coupled probe.
In measuring spectra from 104 cases of various skin cancers, accuracies of 73%, 85%,
and 91% in distinguishing basal cell carcinoma, squamous cell carcinoma, and malig-
nant melanoma from normal skin, respectively, were found [123].
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Related work conducted by the Wulf group further revealed that Raman spec-
troscopy could be used in the context of skin cancer diagnostics in a manner that is
independent of skin pigmentation. Specifically, it was reported that while the degree
of pigmentation does influence the Raman spectra, proper background correction can
negate the contributions from pigments and thus allow for spectral bands of interest
to be interpreted unambiguously [124].
Recent efforts have been made in combining imaging and spectroscopic modalities
to further improve the accuracy of skin cancer diagnostics. One such effort led by
the Tunnell group found that Raman spectroscopy alone was sufficient to distinguish
malignant melanoma from benign pigmented lesions with a diagnostic accuracy of
100%. However, in the case of nonmelanoma skin cancers, the diagnostic accuracy
was improved when reflectance and fluorescence measurements were combined with
the Raman data. In this case, they were able to distinguish actinic keratoses as well
as squamous and basal cell carcinomas from normal skin with a sensitivity and speci-
ficity of 90% and 85%, respectively [125]. Another study conducted by Moryatov
and co-workers found that combining measurements from optical coherence tomog-
raphy (OCT), backscattering, and Raman spectroscopy into a multimodal platform
for diagnosing skin cancer increased sensitivity and specificity by 9% and 8%, re-
spectively, when compared to Raman spectroscopy alone. In particular, they were
able to distinguish melanoma from nonmelanoma tumors with 89% sensitivity and
93% specificity, and basal cell carcinoma (BCC) from non-BCC tumors with 100%
sensitivity and 96% specificity [126]. These two promising trials illustrate that the
advent of multimodal imaging and spectroscopic platforms can be used to improve
skin cancer diagnostics over the use of Raman spectroscopy alone.
Gastrointestinal Cancers
Cancers of the gastrointestinal tract can occur anywhere between the oral cavity and
the anus, and represent a particularly difficult diagnostic challenge. Raman spec-
troscopy has been used in several studies investigating mouth or oral cancer, properly
known as oral squamous cell carcinoma (OSCC). Considerable progress in this field
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has been made by the Krishna group, where a study in 2012 on 10 normal and 10
cancerous ex vivo tissues, as well as 10 in vivo measurements, revealed differences
in the spectra of normal versus cancerous samples. Moreover, they showed that the
spectra from the normal in vivo and ex vivo tissues were similar enough to warrant
further in vivo study in the use of Raman spectroscopy as a diagnostic tool for OSCC
[127]. Indeed, the group later published an investigation of premalignant lesions of
the mouth in vivo, finding that premalignant lesions can effectively be distinguished
from normal and cancerous sites in patients with and without smoking habits [128].
The group further studied the applicability of Raman spectroscopy for OSCC diag-
nostics by investigating whether early changes associated with cancer - including
malignancy-associated changes (MAC) and cancer field effects (CFE) - can be iden-
tified spectroscopically. In acquiring 722 spectra from a total of 84 subjects, it was
found that early neoplastic transformation can indeed be detected via Raman spec-
troscopy [129].
Esophageal and gastric cancers have been another focus of diagnostic research in
the field of Raman spectroscopy, with particular emphasis on the precancerous cellular
transformation from squamous to gastric cells in the lower esophagus - a condition
known as Barrett's esophagus (BE). To this aim, the Huang and Yeoh groups have
put forth a number of reports investigating the applicability of Raman spectroscopy
for esophageal and stomach cancer diagnoses, beginning with an in vivo assessment of
gastric dysplasia. Using narrow-band image-guided Raman spectroscopy, 30 patients
were included in a study where 54 spectra were acquired from normal tissues and 18
from dysplastic gastric tissues, yielding 94.4% sensitivity and 96.3% specificity [130].
In a related study, the same team examined 67 gastric patients and identified gastric
cancer with a diagnostic accuracy of 93.7% (94.0% sensitivity and 93.4% specificity)
[131]. The ability of Raman spectroscopy to distinguish between benign and malig-
nant stomach ulcers was then tested, and sensitivities of 90.8%, 84.7%, and 82.1%
as well as specificities of 93.8%, 94.5%, and 95.3% for classification of normal tis-
sue, benign ulcers, and malignant ulcers, respectively, were found [132]. Using more
elaborate data processing algorithms to improve overall accuracy, an in vivo gastric
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cancer diagnostic accuracy of 94.6% was subsequently achieved [133].
The Stone group has also significantly contributed to the translation of Raman
technologies from the laboratory to the clinic. In 2011, Kendall et al. evaluated a
custom Raman probe designed for esophageal diagnostics on excised biopsy samples.
They studied normal, low risk (Barrett's esophagus), and high risk (dysplasia and
cancer) samples, where 1304 Raman spectra were acquired from a total of 123 sam-
ples. In classifying test spectra against a training set, their methodology resulted
in sensitivity and specificity of 66-84% and 81-96%, respectively [134]. Subsequent
work by Almond et al. in 2014 reported the development of a novel custom Raman
probe, where a confocal design was implemented to specifically interrogate superficial
tissues ( 150 pm) in an attempt to better detect surface lesions that may be cured via
endoscopic therapy. While their study was limited to validation on ex vivo resected
samples, their endoscopic Raman spectroscopy setup detected Barrett's esophagus-
associated high-grade dysplasia (HGD) and esophageal adenocarcinoma with 86%
sensitivity and 88% specificity [135]. While this technology has yet to be fully tested
in vivo, this group is currently focusing on building various probes and adjusting tol-
erances to maximize performance in a clinical trial evaluating their implementation
of endoscopic Raman spectroscopy in patients with Barrett's esophagus.
Extending the use of Raman spectroscopy further into the gastrointestinal tract,
Bergholt et al. investigated Raman spectra from tissues of the esophagus and stom-
ach, both ex vivo and in vivo. This study found that there is significant variability
between the spectra from the esophagus as compared to those of the stomach, but
the spectra from different anatomical sites within a given tissue were fairly similar.
Moreover, cancerous tissues from the esophagus and stomach were found to be dis-
tinguishable with accuracies of 94.7% and 89.3%, respectively [136]. A subsequent
study showcased the relevance of combining Raman spectroscopy with autofluores-
cence measurements in vivo, yielding a diagnostic accuracy for gastric cancer of 92.2%,
greater than either of the two approaches evaluated independently (89.7% for Raman
spectroscopy alone, and 86.3% for autofluorescence alone) [137]. A later study by
Bergholt et al. showed that esophageal cancer could be diagnosed with an accuracy
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of 96.0% when the Raman spectroscopic assessment is guided by a wide-field imaging
modality such as white light reflectance, narrow-band imaging, or autofluorescence
imaging in the context of a clinical endoscopic examination [138]. A fully automated
online Raman spectroscopy platform with multimodal image-guided sampling for gas-
tric cancer diagnosis was then developed, where 305 patients were examined yielding
a diagnostic accuracy of 85.6% [139]. Later work demonstrated that the technology
can be further exploited to target biopsy sites more specifically, as well as providing
a platform for distinguishing between dysplastic and neoplastic lesions more consis-
tently [140].
Subsequently, using a fiber optic confocal Raman endoscope, Bergholt et al. evalu-
ated the potential for in vivo detection of high-grade dysplasia in Barrett's esophagus
and identified diagnostic sensitivity and specificity of 87.0% and 84.7%, respectively
[141]. Different endoscope configurations have also been investigated, where it was
found that a beveled probe tip coupled to a ball lens outperformed the standard vol-
ume Raman probe via selective interrogation of the superficial tissue and suppression
of autofluorescence contributions [142]. Even more recently, Wang et al. investigated
spectral bands in the fingerprint and high-wavenumber regions of Raman spectra from
the esophagus, and distinguished esophageal squamous cell carcinoma (ESCC) from
normal tissue with a diagnostic accuracy of 97.3% [143].
Finally, Raman spectroscopy has also been investigated for the diagnosis colorectal
tissue for cancer by the Huang group. They developed a novel fiber optic probe
capable of acquiring fingerprint and high-wavenumber bands simultaneously from the
subsurface of the colorectal tissue and identified a diagnostic accuracy of 88.8% in
detecting colorectal cancer, with 93.3% sensitivity and 88.3% specificity [144].
Cervical Cancer
The diagnostic potential of Raman spectroscopy has also been studied in the con-
text of cervical cancer, where it was found that spectral variations within normal
tissue were an obstacle in properly identifying cervical cancer lesions. To this aim,
the Mahadevan-Jansen group identified various classes of cervical tissue that can be
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considered normal: truly normal, previously diseased normal, and adjacent-to-disease
normal. The inclusion of these subcategories increased classification accuracy to 97%
[145].
In parallel, the Huang group studied 105 spectra from 29 patients (65 normal and
40 precancerous spectra) using genetic algorithm-partial least squares-discriminant
analysis (GA-PLS-DA), yielding 82.9% diagnostic accuracy (72.5% sensitivity and
89.2% specificity) [146]. As was done in the context of esophageal and gastric cancer
described above, they furthered their research by examining the fingerprint and high-
wavenumber spectral bands of the cervical Raman spectra. Combining the data from
both spectral domains into their analysis, a diagnostic accuracy of 82.6% was identi-
fied for the 476 spectra (356 normal and 120 precancerous) collected from 44 patients
[147]. Duraipandian et al. then evaluated the use of confocal Raman spectroscopy
against near-infrared autofluorescence (NIR AF) spectroscopy alone as well as com-
posite NIR AF/Raman spectroscopy. They found confocal Raman spectroscopy to
have a diagnostic accuracy of 84.1%, an increase over the composite approach (82.3%),
as well as NIR AF spectroscopy alone (59.6%) [148].
Finally, the Krishna group identified a particular challenge in the diagnosis of
cervical cancer in the Indian subcontinent: most cervical cancers in such parts of
the world are already advanced upon detection, leaving few intact cervical regions for
assessment of normal tissue. In order to find normal baseline tissue, they explored the
possibility of using vaginal tissue as an internal control for spectroscopic assessment
of the cervical tissue. Indeed, the spectral features of normal vaginal and cervical
tissues were found to be closely similar, such that cervical cancer diagnoses based on
Raman spectroscopy could be facilitated in conditions where normal cervical tissue
is otherwise unavailable [149].
Brain Cancer
In the context of brain cancer, proper surgical resection of the tumorous mass is
critical to minimize the odds of recurrence. To address this need, the Leblond group
developed a handheld Raman spectroscopy probe for the classification of brain tissue
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intraoperatively [150]. They conducted a study on 17 patients with gliomas ranging
from grade 2 to 4, where a total of 161 spectral measurements were collected. Their
study revealed a diagnostic accuracy of 92%, with 93% sensitivity and 91% specificity
[69]. These results were contrasted with the surgeon's visual inspection of the affected
brain tissue using bright-field microscopy and magnetic resonance (MR) guidance,
which yielded an accuracy of 73%, a sensitivity of 67%, and a specificity of 86%. This
study thus illustrates the utility of Raman spectroscopy in detecting brain tumors
intraoperatively, and sets a robust foundation for pursuing clinical trials to further
contrast the effectiveness of Raman spectroscopy against the current standard of care
for guiding brain cancer resections.
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Chapter 3
Quantification of Oxidative Stress
in Ex Vivo Human Skin Exposed
to Chemical Sun Filters Using
TPEF and FLIM
3.1 Introduction
Despite the growing use of sunscreen products, skin cancer incidence steadily remains
on the rise, with one in five Americans expected to develop some form of skin can-
cer throughout their life [151, 152]. Furthermore, while some evidence of sunscreen
protection against melanoma has been obtained [153], this was rather modest and
challenging to demonstrate, in comparison to other cutaneous tumors [154]. One po-
tential explanation for this discrepancy involves the chemical sun filters in sunscreens,
which are responsible for absorbing ultraviolet radiation to minimize DNA damage to
underlying skin cells. Prior studies have shown that some commercial chemical sun
filters are capable of generating reactive oxygen species (ROS) when exposed to ul-
traviolet (UV) radiation under in vitro experimental conditions [155]. Consequently,
it has been proposed that these compounds may generate ROS in vivo at the site of
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application, thereby inducing oxidative stress in skin [155, 156]. Over a prolonged
period of time, chronic oxidative stress may in turn contribute to skin aging, actinic
keratosis, DNA damage, as well as the onset and pathogenesis of squamous and basal
cell carcinomas [157, 158, 159, 160].
The study of oxidative stress in biological samples can be carried out using a
wide variety of techniques. Traditional tissue processing methods can be used to
extract, isolate, and quantify the amount of flavin and nicotinamide adenine dinu-
cleotides (FAD and NADH, respectively), two key coenzymes in redox metabolism,
using western blotting, quantitative polymerase chain reaction (qPCR), immunohisto-
chemistry (IHC), or liquid chromatography/tandem mass spectrometry (LC/MS-MS)
[161, 162]. However, the processing necessary for these techniques is either inherently
destructive or does not provide spatial information, and as such, bars the ability to
assess heterogeneous cellular-level responses within the tissue. On the other hand,
exogenous labels such as fluorogenic probes can be used to preserve spatial integrity,
and have had great success mapping spatial patterns of ROS generation in vitro [155].
These dyes, however, can be challenging when used in skin, whether ex vivo or in vivo,
as many probes experience uneven uptake within skin [163]. This irregular diffusion
leads to regional differences in probe signal intensity that may arise primarily due to
uneven distribution rather than true contrast in oxidative stress.
Given these challenges, label-free optical imaging techniques have been found to
be well suited for probing oxidative stress within tissues [164]. These tools capture
fluorescence signals that arise from metabolic coenzymes of interest, enabling the
mapping of oxidative stress on the sub-cellular level with submicron spatial resolution
throughout intact tissue. Label-free imaging also removes any artifacts that can
result from processing and permeabilizing tissue, as the imaging contrast arises from
endogenous fluorescence rather than exogenous reporters of ROS.
To study oxidative stress within skin without such exogenous labels, one advan-
tageous approach is two-photon excitation fluorescence (TPEF) microscopy, which
directly assesses the fluorescence intensities of FAD and NADH [162, 165, 166, 167].
The intrinsic fluorescence of these metabolic coenzymes is advantageous for study-
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ing cellular metabolic perturbations, as FAD only fluoresces in its oxidized form,
while NADH is strictly fluorescent in its reduced form; their counterparts, FADH 2
and NAD+, are not fluorescent. Together, these coenzymes act as electron carri-
ers during the catabolic processes that result in ATP production, and the relative
oxidized-to-reduced coenzyme ratio, commonly referred to as the redox ratio, can be
used to make inferences about a cell's metabolic state. By imaging these intrinsic
fluorophores within a given biological sample, one can then compare the signals ob-
tained from both molecules in order to quantitatively assess oxidative stress using the
ratio of FAD fluorescence intensity to that of NADH, i.e. FAD/NADH [164]. The
normalized optical redox ratio (NORR), defined as FAD/(NADH+FAD), is also a
commonly used imaging metric of oxidative stress, as it is strictly bound between 0
and 1 and more closely follows a normal distribution [162, 1681.
This study sought to devise a method to non-invasively and non-destructively
examine the impact of chemical sun filter exposure on the redox metabolism of epi-
dermal skin cells, and determine whether these compounds can cause an oxidative
shift in skin tissue. Viable, cultured ex vivo models of human skin were imaged us-
ing TPEF microscopy to quantify the change in optical redox ratio on a cell-to-cell
level throughout the epidermis of skin based on the endogenous fluorescence of FAD
and NADH [164]. A minimalist model formulation of sunscreen was designed for
the present study containing five commonly used chemical sun filters in proportions
that emulate a sun protection factor (SPF) of roughly 45. This minimalist approach
was preferred in order to avoid any potential interference from inactive sunscreen
ingredients, while adhering to FDA guidelines on maximum concentrations for each
individual sun filter [169].
Due to the competing fluorescence contribution of sun filter compounds, however,
a new analysis method based on FLIM and phasor analysis had to be developed to
extract the optical redox ratio and map oxidative stress changes within skin. Indeed,
the fluorescence from sunscreen formulations is not only fairly weak, but also varies
depending on the combination and relative concentrations of chemical sun filters
therein [170]. In turn, this variability limits the use of hyperspectral fluorescence
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imaging to provide accurate and reliable contrast between endogenous and exogenous
sources of fluorescence. In contrast, the photophysical dynamics of these sun filters
are consistently short-lived [160, 171], warranting a highly sensitive time-correlated
approach such as FLIM to accurately decouple the endogenous tissue fluorescence
from that of the exogenous compounds based on differences in fluorescence lifetime.
This method successfully enabled the quantification of oxidative stress caused by
both ultraviolet light exposure and sun filters, and additionally allowed for the direct
imaging of sun filters as they diffused through skin tissue.
It is worth noting that TPEF imaging is not exclusive to NADH and FAD, as some
other endogenous compounds in skin exhibit fluorescent properties as well, including
melanin, elastin, collagen, and keratin. Conveniently, the optimal excitation and
emission parameters for probing melanin autofluorescence are distinct from those of
NADH and FAD; moreover, the signal from these coenzymes dominates the autoflu-
orescence from the stratum spinosum layer of the epidermis [172]. As for fluorescent
extracellular proteins, elastin and collagen are primarily found within the dermis,
while keratin forms within the more superficial layers of the epidermis. As such,
the imaging parameters described in the present study are based on commonly used
methods to maximize signals from NADH and FAD within the stratum spinosum
roughly 50 pm below the skin surface [161, 162, 168, 173].
3.2 Materials and Methods
3.2.1 Sun Filter Formulation
The minimalist model formulation of sunscreen was composed of five commonly used
chemical sun filters (avobenzone, octocrylene, homosalate, octisalate, and oxyben-
zone) dissolved in a lipophilic solvent typically included in sunscreen formulations
(C12-15 alkyl benzoate, also known as Finsolv TN) in proportions that emulate a
SPF of roughly 45 (see Table 3.1). The fluorescence of the formulation is primarily
attributed to the presence of avobenzone, one of the most commonly used chemical
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sun filters in sunscreens [160, 174].
Table 3.1: Composition of sun filter formulation
Compound Concentration (% m/m)
Avobenzone 3
Octocrylene 4
Homosalate 8
Octisalate 5
Oxybenzone 4
Finsolv TN 76
3.2.2 Tissue Culture and Processing
In order to study oxidative stress in human skin in response to chemical sun filters,
discarded skin tissues were obtained from elective patient surgeries in compliance
with the institutional review board of Massachusetts General Hospital (MGH IRB
protocol #2014P00135). The skin was then processed on arrival, where it was cut
into square pieces roughly 1-2 cm 2 in size, placed on an RPMI-agarose nutritive
gel bed, and maintained in an incubator at 37'C with 5% atmospheric CO2. EX
vivo human skin explants were imaged using FLIM under 4 different experimental
conditions: treatment with a 30 pL topical dose of either the sun filter formulation
described in Table 3.1 or Finsolv TN alone as a vehicle-only control, and subsequently
immediately exposed to either 0 or 20 J/cm 2 of UVA irradiation. This corresponds
to 1 minimal erythemal dose (MED) for a fair-skinned individual of Fitzpatrick skin
type I, i.e. the minimum amount of UVA irradiation necessary to elicit a reddening
response in skin [175, 1761. Three distinct areas were then imaged for each skin
sample, where each field of view consisted of a representative slice of the stratum
spinosum within the viable epidermis, roughly 50 pm below the skin surface.
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3.2.3 TPEF and FLIM Imaging
In using a fluorescence-based approach to study the effects of exogenous compounds
like chemical sun filters, a common challenge often arises: many of these compounds
are natively fluorescent [170], and may therefore interfere with the fluorescent signals
from NADH and/or FAD. In the case of this study, it was found that the mixture
of chemical sun filters was itself fluorescent, with excitation and emission properties
similar to those of NADH. The formulation was not found to be emissive in the FAD
spectral range. Because of this fluorescence, optical redox ratio measurements cannot
be obtained on tissue exposed to the formulation, since there is no way to distinguish
the fluorescence signal of the sun filters from that of NADH using TPEF microscopy
alone. To circumvent this obstacle, the sun filter formulation was imaged using two-
photon FLIM to determine if its fluorescence can be distinguished from that of NADH
based on lifetime.
The laser source used to perform TPEF imaging is a dual-output femtosecond
pulsed laser system (Spectra-Physics Insight DeepSee), where one output can be
tuned to any integer wavelength ranging from 680 to 1300 nm. The beam was di-
rected into the input port of a commercial inverted microscope (Olympus FV1000)
for imaging with a 60 x water immersion objective (Olympus UPLSAPO 60XW, 1.20
NA), and the total laser power at the output of the objective was below 35 mW for
all imaging experiments. The fluorescence signals were detected using two distinct
photomultiplier tubes (Hamamatsu H7422P-40 for NADH and H7422P-50 for FAD).
The FLIM data was collected using time-correlated single photon counting (TCSPC)
hardware (Becker & Hickl SPC-150), with each image containing 256 x 256 pixels
in area and 256 time bins for each pixel's associated fluorescence decay trace. The
imaging acquisition parameters resulted in photon count rates ranging from 2 x 104
to 2 x 105 photons per second, with a total acquisition period of 90 seconds. Cali-
bration of the FLIM system was ensured using a solution of fluorescein (pH 9.0) with
a known lifetime of 4.05 ns. Each area was first imaged with 755 nm laser light for
multiphoton excitation of NADH with detection of fluorescence from 445 to 480 nm,
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followed by 860 nm excitation for FAD with emission detection from 500 to 550 nm.
3.2.4 CARS Imaging
The Finsolv TN molecule can be readily visualized using coherent anti-Stokes Raman
scattering (CARS) microscopy by probing the symmetric CH2 stretching vibration at
2845 cm- 1 of its long C12-15 hydrocarbon tail. As such, the tunable output of the
laser source was set to 803 nm as the pump beam and the fixed 1040 nm output was
used as the Stokes beam to generate a strong anti-Stokes signal at 654 nm, allowing
for the monitoring of solvent penetration dynamics in skin. To this aim, an ex vivo
skin sample was given a single topical treatment of Finsolv TN, and subsequently
monitored at 15-minute intervals over the course of 2 hours, examining depths 0, 40,
and 80 pm below the skin surface.
3.2.5 Non-Euclidean Phasor Analysis
The separation of fluorescent species based on their lifetime is best achieved using
the phasor approach [168, 17, 177, 18]. This method is derived from Fourier anal-
ysis, where rather than fitting a linear combination of decaying exponentials onto a
decay trace Iij(t) in the temporal domain, the data is transformed into a phasor with
coordinates (Gij, Sij) defined as
fo0 hij (t) cos(wt)dt
Gij ij (t) dt(31
and
S?,j foI j (t) sin(wt)dtSig= 00 (3.2)so- Ij (t) dt
where the subscripts ij denote the coordinates of a given pixel, W is the angular
frequency related to the laser pulse repetition rate defined as W = 27f, and f here
corresponds to 80 MHz. For a pixel characterized by a single exponential decay, the
phasor transform results in a set of coordinates that lies on the so-called universal
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semicircle described as
(G - 0.5)2 + S 2 = 0.25. (3.3)
For a fluorescence decay trace that contains two lifetimes, the phasor transform
results in a coordinate pair that lies within the semicircle rather than on its bound-
ary. The phasor coordinates here are determined by a linear combination of the two
phasors corresponding to the two fluorescent species contributing to the signal. In
order to compute the fluorescent lifetimes of a two-compound mixture, the eigenvec-
tor associated with the largest eigenvalue of the phasor cluster covariance matrix is
commonly used to determine the orientation of the cluster's major axis. By extend-
ing this axis across the phasor plot, the short and long fluorescent lifetimes can be
determined by the two intersections of the major axis with the universal semicircle
[17, 178].
When there are three lifetimes, as expected in samples exposed to the sun filter
formulation (sun filters: 120 ps; free NADH: 300-800 ps; bound NADH: 1.0-6.5
ns), the phasor coordinates are enclosed within a triangle whose vertices are located
on the universal semicircle and correspond to the individual lifetimes of the three
components [17]. In the context of this study, the goal is to use phasor analysis to
distinguish the NADH fluorescence (a compound with two lifetimes) from that of
the chemical sun filters (a mixture with a third, distinct lifetime). To this aim, one
method would be to compare the phasor coordinates of a given pixel to that of phasor
clusters generated from (1) NADH alone and (2) sun filter formulation alone. This
comparison could be quantified by computing the Euclidean distance between said
pixel's phasor coordinates and those of the NADH and sun filter phasor cluster means.
However, by strictly and only considering the mean coordinates of the NADH and sun
filter phasors, all information relating to their distributions is essentially discarded.
Classically, NADH fluorescence lifetimes are typically thought of as either short
or long, depending on whether the coenzyme is free or protein-bound, respectively.
However, recent work suggests that these protein-bound complexes can result in an
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entire subset of long lifetimes that are dependent on the nature of the protein to which
NADH is bound [179, 180]. As a result, the phasor cluster corresponding to NADH
fluorescence is fairly broad due to its multi-lifetime nature, warranting a separation
technique that considers the statistical distributions of reference clusters for improved
separation accuracy.
To this aim, the use of the Mahalanobis distance is proposed, where this metric
describes the distance between a given observation and an entire distribution, rather
than simply the distribution's mean [181]. Mathematically, given an observation
X~ =[Gij , S2g]T from a pixel with spatial coordinates ij, and a reference set with mean
pref [Gp , SI]T and covariance matrix Cref, the Mahalanobis distance is defined as
Dzj,ref V'~-7;) nJ( i~.(3.4)
For a given pixel with spatial coordinates ij, the proportion kij of photons that
strictly arose from NADH as opposed to chemical sun filters is given by the ratio of
its Mahalanobis distance to the sun filter mixture, Dij,SF, divided by the Mahalanobis
distance from the NADH reference sample mean to the sun filter mixture, DNADH,SF-
If kij is computed to be < 0.5 (i.e. if more than half of the pixel's fluorescence
can be attributed to the exogenous compound), then the perspective is flipped: the
Mahalanobis distance from the phasor to the NADH reference cluster, Dij,NADH, is
now divided by the Mahalanobis distance from the sun filter reference sample mean
to the NADH reference cluster, DSFNADH. This ratio is then subtracted from 1 in
order to provide the fraction of signal that arose from NADH as opposed to the sun
filters. Mathematically, these relations can be expressed as
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Dij,sF
DNADH,SF
if
1
kj < -, (3.5)
2'
then
kj = 1 - Dij,NADH
DSF,NADH
By inspection, it is readily apparent that if a given phasor is very far from the
sun filter phasor cluster, the computed proportion of photons generated from NADH
approaches 1; conversely, as said phasor approaches the sun filter phasor cluster, the
value of kij approaches 0. With this in mind, FLIM images containing fluorescence
signals from both NADH and sun filters can be processed on a pixel-by-pixel basis
to produce entire k-arrays whose elements are bound between 0 and 1. The element-
wise product of these arrays with the original TPEF intensity images can then be
computed in order to isolate the fluorescence signal arising strictly from NADH. In
turn, these processed images can be used in conjunction with FAD intensity images
to compute optical redox ratios on a pixel-by-pixel basis to allow for quantification
of oxidative stress in skin cells.
3.2.6 Simulation and Validation
In order to validate the improved accuracy of the proposed non-Euclidean approach
over traditional Euclidean-based separation, simulated image data was generated and
processed in MATLAB. First, endogenous and exogenous compounds were simulated
to generate multivariate normally-distributed random phasors with mean Pendo
[0.42, 0 .3 5 ]T and covariance matrix Cend = 10-4 x [9, -2; -2, 2.25] for the en-
dogenous compound, and mean p- = [0.96 , 0 .0 5 ]T and covariance matrix Cexo =
10-5 x [6.4, -1; -1,1.6] for the exogenous compound. The simulation then gener-
ates a set of three synthetic images 256 x 256 pixels in size: an endogenous reference
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image, an exogenous reference image, and a simulated test image.
For the test image, the concentration of endogenous compound is set to 1 on
the far left pixel column and 0 on the far right, with a sigmoidal decay horizontally
across the image. Conversely, the concentration of exogenous compound is 0 on the
far left and 1 on the far right, with the sigmoidal decay in the opposite direction,
such that the total compound content at any given pixel is 1. The sigmoid describing
the middle 254 columns is described by Equation 3.6, where the column subscripts j
strictly range from 2 to 255, inclusively.
k(j) = 1 (3.6)
1 + exp (j 28)
The test image is then processed by the algorithm described in Section 3.2.5
using the simulated endogenous and exogenous images as NADH and chemical sun
filter references, respectively. In addition, the test image is also processed using
the classical Euclidean approach, where the endogenous fluorescence contribution is
computed by dividing the Euclidean distance between the phasor and the exogenous
reference by the sum of the Euclidean distances between the phasor and each reference
image phasor cluster [18]. The two analysis approaches are then compared by taking
column-wise means in order to generate line plots, which intuitively illustrate the
differences between the two methods from the expected simulated results.
3.2.7 Quantification of Oxidative Stress
In order to accurately calculate the fraction of fluorescence contributed by NADH
as opposed to the chemical sun filters, the NADH images were first spatially binned
using a mask 5 x 5 pixels in size. Only pixels with a minimum photon count of 1000
were considered for subsequent processing, where a custom script written in MAT-
LAB served to transform the data using the phasor approach and separate out the
NADH fluorescence signal versus that of the chemical sun filters based on the non-
Euclidean distance metric described in Section 3.2.5. Using the isolated fluorescence
signal from NADH, NORR values for each field of view were then generated by com-
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puting FAD/(NADH+FAD) on a pixel-by-pixel basis. Given that both NADH and
FAD are predominantly found within the cytoplasm and mitochondria with weaker
fluorescence signals coming from nuclear regions, this correlated spatial distribution
results in fairly consistent pixel-wise NORR values across the cell. As such, these
pixel values can be averaged to obtain a single NORR value for each cell within a
field of view [161, 162, 168]. Individual cells were manually segmented from each
resulting image using FIJI image analysis software. From there, mean NORR values
were computed for each individual cell, from which an average NORR value could
be computed for each individual field of view, representative of the cells present
therein. The triplicate NORR values from all three imaged fields of view for each
experimental condition were then used to compute a mean and a standard deviation.
These triplicate measurements were then used for statistical comparison using the R
software package for all statistical calculations. A one-way ANOVA was first calcu-
lated between all conditions, with the null hypothesis rejected. Pairwise Student's
t-test corrected using Holm's method were then carried out between groups to test
for significance using R defaults. Results were considered statistically significant if
p < 0.01.
3.3 Results and Discussion
Beginning with the sun filter formulation alone, it is found to be transparent with
no visible aggregates under trans-illumination at 755 nm, as can be seen in Figure 3-
1(a); in Figure 3-1(b), however, the formulation's fluorescence intensity in the NADH
channel is readily notable. The corresponding phasor plot (Figure 3-1(c)) shows the
vast majority of the pixels forming a tightly bound cluster near the bottom right of
the plot, highlighting its short lifetime. The formulation's fluorescence lifetime is on
the order of 120 ps, as computed by fitting an exponential decay to the fluorescence
decay trace of the sun filter mixture using SPCImage software (Figure 3-1(d)).
An ex vivo examination of NADH fluorescence in the stratum spinosum of human
epidermis at a depth of 50 pm below the skin surface revealed bright signals from the
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Figure 3-1: Fluorescent properties of the sun filter formulation. (a) Trans-illumination
image of the edge of a droplet of sun filter formulation, acquired with 755 nm light.
(b) TPEF image of the sun filter formulation acquired with 755 nm excitation light
and fluorescence detection from 445 to 480 nm. (c) Phasor plot of the FLIM data
associated with (b), highlighting the short fluorescence lifetime of the sun filter for-
mulation. (d) Temporal decay trace of a typical pixel from (b), illustrating the rapid
decay of the sun filter fluorescence.
cytoplasm, as NADH is located primarily in the mitochondria and cytosol (Figure
3-2(a)). The corresponding phasor plot is shown in Figure 3-2(b), where the NADH
phasors cluster around the central upper region within the universal semicircle; the
associated fluorescence decay of NADH is shown in Figure 3-2(c). In the case of
skin topically treated with the sun filter formulation, a coalesced pool of sun filter
formulation can be appreciated in the bottom right portion of Figure 3-2(d). In this
scenario, the associated phasors are distributed between the original NADH cluster
and the pure sun filter formulation cluster, as is made apparent by the elongated tail
of the phasor plot in Figure 3-2(e). Finally, Figure 3-2(f) illustrates the decay trace
of a pixel with a strong fluorescence contribution from the chemical sun filters.
The use of FLIM throughout the course of this study thus adds a temporal di-
mension over TPEF imaging alone, enabling the distinction of photons emitted by
sun filters from those emitted by NADH using the algorithm described in Section
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Figure 3-2: Fluorescence detected from the stratum spinosum layer of the viable
epidermis, acquired at a depth of 50 pm below the skin surface. (a) TPEF image
of human skin treated with vehicle only, showing endogenous NADH fluorescence.
(b) Phasor plot of the FLIM data associated with (a). (c) Temporal decay trace of
a pixel from (a), showing the progressive decay of NADH fluorescence. (d) TPEF
image of human skin treated with sun filter formulation, showing both endogenous
NADH fluorescence across the field of view, as well as exogenous fluorescence from
the sun filters seen in the lower right region of the image. (e) Phasor plot of the FLIM
data associated with (d). (f) Temporal decay trace of a pixel from (d) with a strong
fluorescence contribution from chemical sun filters.
3.2.5 based on the Mahalanobis distance. In order to validate the accuracy of the
developed method, simulated images of endogenous and exogenous references (i.e.
NADH and chemical sun filters, respectively) as well as a test image were generated
as described in Section 3.2.6. The phasor plots generated for the simulated endoge-
nous reference, exogenous reference, and test sample are shown in Figure 3-3(a-c).
The actual fluorescence contribution of the endogenous sample in the test image is
shown in Figure 3-3(d). Next, the traditional Euclidean method (Figure 3-3(e)) and
the proposed non-Euclidean approach based on the Mahalanobis distance (Figure 3-
3(f)) are both used to estimate the endogenous fluorescence contribution. Finally,
Figure 3-3(g) shows the column-wise means of the endogenous fluorescence contri-
bution images from Figure 3-3(d-f). While both methods accurately distinguish the
two simulated fluorophores when their relative contributions are comparable, the tra-
ditional Euclidean method fails particularly in scenarios where one fluorophore with
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a broad phasor distribution dominates over another. This can be appreciated in the
leftmost region of the curve in Figure 3-3(g), where the Euclidean estimates plateau
around 0.95 as the endogenous fluorescence begins to dominate, while the proposed
Mahalanobis-based approach consistently follows the simulated data curve.
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Figure 3-3: Simulation to validate the proposed non-Euclidean separation algorithm.
(a) Phasor plot of simulated endogenous fluorescence reference sample. (b) Pha-
sor plot of simulated exogenous fluorescence reference sample. (c) Phasor plot of
simulated test image, consisting of both fluorophores with concentrations varying in
opposite sigmoidal fashion. (d) Simulated endogenous fluorescence contribution to
the test image. (e) Estimation of endogenous fluorescence contribution computed
using the traditional Euclidean method. (f) Estimation of endogenous fluorescence
contribution using the proposed non-Euclidean method based on the Mahalanobis
distance. (g) Column-wise means of the images in (d-f), illustrating the superior
accuracy of the proposed method over the classical Euclidean approach.
Having validated the proposed approach on simulated data, the algorithm was
applied to all NADH image sets in order to decouple the endogenous fluorescence from
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that of the chemical sun filters. The performance of the algorithm is demonstrated
in Figure 3-4, showing the TPEF intensity image (Figure 3-4(a)), the Euclidean
estimate of the endogenous fluorescence contribution (Figure 3-4(b)), and the same
estimate computed using the proposed non-Euclidean method (Figure 3-4(c)). Taken
together, the results shown in Figures 3-3 and 3-4 support the applicability of the
described non-Euclidean separation algorithm for distinguishing endogenous NADH
fluorescence from topically applied exogenous compounds with a similar fluorescence
signature but a distinct lifetime.
04
Figure 3-4: Comparison of processing methods to optimally determine endogenous
fluorescence contribution. (a) TPEF intensity image of human skin treated with
chemical sun filters, showing a diffusing pool of formulation in the bottom right por-
tion of the image. (b) Estimate of the endogenous fluorescence contribution computed
using the traditional Euclidean method. (c) Estimate of the endogenous fluorescence
contribution as determined by the proposed non-Euclidean approach based on the
Mahalanobis distance metric.
While commercial sunscreens are typically formulated to remain in the uppermost
layers of skin with minimal transdermal penetration, the FLIM data counterintuitively
suggested that the chemical sun filters in the model formulation diffused throughout
the viable epidermis. This diffusion into the skin is important to understand, as the
pharmacokinetics of the sun filters will influence its oxidative effects.
The optimal design of topical formulations is challenging, as solvents/carriers and
solutes may propagate throughout the tissue at different rates based on their charge,
polarity, and structure [163]. While the imaging approach based on FLIM and phasor
analysis developed here indeed demonstrates the ability to distinguish endogenous
from exogenous fluorescence, coherent Raman imaging is a label-free modality that
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can be used to longitudinally visualize the diffusion of a solvent throughout the tissue
by directly probing its molecular vibrational properties [55].
Sunscreen formulations tend to be complex mixtures of diverse ingredients, while
the model formulation studied here simply consisted of five chemical sun filters dis-
solved in Finsolv TN, a lipophilic solvent commonly used in sunscreen. Considering
its molecular properties and the lipophilic nature of the sun filters, it was hypothesized
that the solvent was acting as a carrier, thereby dragging the formulation contents
into the deeper layers of the epidermis. To verify whether this was indeed the case, a
5 pL droplet of Finsolv TN was topically applied to ex vivo human skin and visualized
using CARS microscopy. CARS is a parametric four-wave mixing process where a
known molecular vibrational resonance can be probed by interacting with two inci-
dent pulsed laser beams, known as the pump and Stokes beams, in order to generate
a unique and spectrally distinct anti-Stokes signal that can be readily detected using
an appropriate set of optical filters [28]. In the case of Finsolv TN, the molecule has
an alkyl tail 12 to 15 carbons in length; by probing the symmetric CH 2 stretching
vibrational mode at 2845 cm- 1 , the solvent can be readily visualized as it diffuses
throughout the tissue.
15 min 30 min 45 min 60 min 75 min 90 min 106 min 120 min
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Figure 3-5: Diffusion of the lipophilic solvent throughout various layers of human
epidermis (0, 40, and 80 pm below the skin surface), as visualized using CARS mi-
croscopy to probe the CH2 vibrational mode of Finsolv TN at 2845 cm-- at 15-minute
intervals over the course of 2 hours. All images are 318 pm x 318 pm in size.
As can be seen in Figure 3-5, the solvent droplet shows bright CARS signals at
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the topmost layer of skin that progressively fades over time as the solvent diffuses
and penetrates into the underlying strata. At 40 and 80 pm below the surface, the
intensity is seen to progressively rise, peak around 60 minutes following application,
and fall thereafter as the Finsolv TN continues to diffuse radially throughout the
epidermis. The use of CARS microscopy thereby confirmed the penetration of the
formulation solvent into the deeper layers of the epidermis, consistent with the prior
observation of sun filter fluorescence in the stratum spinosum using FLIM. More
generally, this application of CARS imaging showcases the use of a distinct nonlinear
optical modality for visualizing the formulation's solvent itself, which can prove useful
in the optimization and validation of topical formulations, among other applications.
Having validated the penetration of and diffusion of both the sun filters and their
solvent, we next studied whether these agents induce oxidative stress onto the cells of
the viable epidermis. To this aim, NADH and FAD fluorescence intensities are used to
compute NORR values, defined as FAD/(NADH+FAD), with a representative image
set shown in Figure 3-6.
Figure 3-6: Fluorescence intensity and computed NORR images of a typical skin
sample. (a) NADH fluorescence intensity. (b) FAD fluorescence intensity. (c) NORR
image, obtained by computing FAD/(NADH+FAD) on a pixel-by-pixel basis.
This study's key finding is shown in Figure 3-7, which shows the magnitude of re-
dox perturbations in skin caused by both UVA and sun filter exposure. The greatest
redox perturbation is a large oxidative shift triggered by exposure to UVA irradiation.
This transition to an oxidative stress state is known to arise from the generation of
ROS via UVA photochemistry and matches well what has been observed previously
[158, 159, 167, 182, 183, 184]. Interestingly, we do indeed observe a small shift in
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redox state towards oxidative stress in skin tissues exposed only to the minimalist
sun filter formulation (p = 0.08971), which would warrant further investigation with
larger sample sizes. It is also worth noting that had the vehicle- and formulation-
treated samples been solely considered, the calculated p-value would have been below
the 0.05 threshold for statistical significance. However, in order to account for the
family-wise error rate stemming from multiple pair-wise comparisons when consider-
ing all treatment conditions, the Holm-Bonferroni correction was used and resulted
in a corrected p-value exceeding 0.05. Nevertheless, the observed oxidative shift is
likely caused by the ROS generation mechanism previously described in in vitro stud-
ies, where the long triplet state lifetime of the chemical sun filters enables them to
react with ground state triplet molecular oxygen, thereby promoting it to an excited
singlet state [155, 171, 185, 186, 187]. Importantly, however, when sun filter-treated
skin was exposed to UVA irradiation, there is a clear benefit, with the chemical sun
filters limiting the oxidative stress induced by UV light exposure. This protection was
observed even though a substantial concentration of the study's sun filter formulation
was found to penetrate into the viable epidermis, indicating that these chemical ab-
sorbers still serve an important function even if they are not confined to the epidermal
surface.
3.4 Conclusions
These results have important implications in the context of commercial sunscreen for-
mulations, and motivate the need for future studies investigating these effects. First,
commercial sunscreens are purposely designed to limit the majority of skin penetra-
tion to the topmost layers of the epidermis; given that the formulation studied here
primarily consisted of Finsolv TN, it is expected that the penetration of chemical sun
filters observed in this context is not entirely representative of commercial sunscreen
behavior [163]. Second, sunscreens contain a wide variety of additional ingredients
ranging from moisturizers to antioxidants, which could limit redox state perturba-
tions, though the exact effects of these additives are not well characterized in vivo
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Figure 3-7: Normalized optical redox ratio (NORR) of cells in the stratum spinosum
layer of the viable epidermis treated with either vehicle only or sun filter formulation,
and exposed to either 0 or 20 J/cm2 (1 MED) of UVA irradiation. Bars correspond to
mean NOR.R measurement of cells from N = 3 fields of view, and error bars represent
1 standard deviation. Statistical significance determined by pair-wise Student's t-
test corrected using Holm's method, annotated with * if p < 0.01 and ** if p < 0.005.
[155, 158, 184]. Still, the small redox changes observed due to the sun filter formula-
tion begs the question as to what occurs following exposure to commercial products,
and could be helpful in understanding how to best design topical sunscreens and
sunscreen-containing cosmetics in the future.
It should be noted that while small oxidative shifts caused by the sun filters in this
study were observed, the patient sample sizes in this preliminary work are small, and
are therefore not intended to support general claims regarding oxidative stress in vivo.
Instead, this study describes a methodology that can now be expanded to investigate
the effects of topical agents applied to skin in a non-invasive manner, in spite of the
intrinsic fluorescence of the applied compounds. Specifically, it was found that the
fluorescent nature of the studied chemical sun filters and, perhaps more importantly,
their intrinsically short fluorescent lifetime, allow for spatiotemporal mapping of these
compounds within skin. By exploiting the brevity of their fluorescence lifetime, the
treated skin samples' time-correlated fluorescent emission from 445 to 480 nm can be
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transformed using the phasor approach to distinguish photons emitted from NADH
versus chemical sun filters. This separation allows for analysis of redox state per-
turbations by processing the isolated NADH signals together with those of FAD to
characterize the response of viable epidermal cells to chemical sun filter and/or UVA
exposure. In addition, this method enables the tracking of exogenous fluorescent
compounds as they penetrate and permeate throughout the epidermis, as was shown
in the present study with chemical sun filters, and further validated using CARS
microscopy to monitor the solvent itself. As such, the proposed methodology can be
applied to study a wide range of topical agents, provided the fluorescence lifetimes of
the exogenous compounds are distinct from those of endogenous fluorophores.
This method is now ready for translation to clinical settings, where large-scale
investigations into the kinetics and physiological dynamics of sun filters can be stud-
ied on human patients. Mobile two-photon FLIM systems are already commercially
available, and would be suitable for capturing the sun filters' diffusion and redox
perturbations in skin [172, 188]. Importantly, future studies can focus on the use of
more realistic commercial sun filter formulations to better inform the dermatology
community, commercial sunscreen manufacturers, and consumers alike.
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Chapter 4
FLIM Data Analysis in Phasor
Space: A Simulated Comparison of
Euclidean and Non-Euclidean
Distance Metrics to Distinguish
Fluorescent Species
4.1 Introduction
Fluorescence lifetime imaging microscopy (FLIM) is an extremely useful tool in the
context of molecular imaging, as it provides microscopists with an additional dimen-
sion of imaging contrast [10]. In addition to probing the excitation and emission
properties of fluorophores, FLIM is a tool also capable of probing the temporal dy-
namics of these molecules. When a fluorophore absorbs electromagnetic energy -
whether in the form of a single photon or multiple photons simultaneously - it is
promoted to an excited state. Following some degree of rapid non-radiative decay,
the molecule then relaxes back down to its ground state, thereby emitting a photon in
the process. This decay back to the ground state is a stochastic process that follows
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a Poisson distribution, characterized by a time constant known as the fluorescence
lifetime, denoted by r [11].
The fluorescence lifetime of a molecule is a characteristic property, much like its
optical excitation and emission properties. However, this does not imply that the
lifetime is invariant; to the contrary, it can be influenced by the molecule's local
environment. For example, naturally fluorescent coenzymes such as flavin and nicoti-
namide adenine dinucleotides (FAD and NADH, respectively) can exhibit a strong
shift in fluorescence lifetime depending on whether they are free in solution or protein-
bound [165, 164, 14, 15]. Other microenvironmental factors such as temperature, pH,
viscosity, solvent polarity, molecular conformation, and metal ion chelation among
others can also have an impact on fluorescence lifetime [16]. In a typical biological
context however, the factors most likely to have an observable and measurable effect
within a given field of view are enzymatic binding, ion chelation, or molecular quench-
ing, as in the case of F6rster resonance energy transfer (FRET) [189, 190, 17, 191].
With this in mind, the fluorescence lifetime of each fluorophore within an imaging
field can therefore be viewed as an intrinsic characteristic property; FLIM can thus
readily serve to distinguish a mixture of multiple fluorescent species at hand.
This complementary source of imaging contrast in the specific context of NADH
and FAD imaging has already yielded considerable insight into the metabolic states
of cells and tissues [165, 192, 191, 193, 164, 162, 167, 177, 180, 15]. These far-reaching
applications in cancer research range from validation of therapeutics in the laboratory
space to characterization of dysplastic and cancerous lesions in situ in the context of
clinical research. Other applications include the ability to discern cellular and tissue
autofluorescence from exogenous compounds in order to study the pharmacokinetics
and pharmacodynamics of exogenous compounds as they are administered to a given
biological system [14, 16].
Despite its noteworthy benefits, one persistent challenge that often arises in the in-
terpretation of FLIM data lies in the accurate distinction of fluorophores within a mix-
ture, particularly in the case of a large discrepancy in their respective concentrations
[14, 16]. FLIM data analysis can broadly be categorized into two major approaches:
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time-domain and frequency-domain (more commonly referred to as phasor analysis)
[17, 18]. Traditional time-domain analysis of FLIM data entails multi-exponential
curve fitting of the fluorescent decay traces on a pixel-by-pixel basis, where each of
the N fluorophores within a given pixel's decay trace are distinguished based on their
time constants T2 and relative weights ac, as in Equation 4.1.
N
1(t)e (4.1)
i=1
This approach requires considerable a priori knowledge of the sample at hand,
both in terms of the number of compounds N to distinguish, as well as a general
idea of their respective fluorescent lifetimes [13]. An additional layer of complexity
arises in distinguishing exogenous compounds from cellular and tissue autofluores-
cence, which may arise from compounds such as NADH and FAD - compounds that
naturally have multiple lifetimes already, based on their molecular conformation and
binding state [14, 15, 16]. Given that time-domain analysis is fundamentally based
on iterative curve fitting, the distinction of exogenous sources of fluorescence from
endogenous sources that themselves have multiple lifetimes quickly becomes compu-
tationally demanding. Moreover, this approach often requires a prohibitively large
number of photon counts per pixel (typically in excess of 5000 photons) in order to
ensure accurate lifetime estimates, particularly when the concentration of one fluo-
rophore is significantly larger than the other [13]. Such photon counts require longer
sample exposure times and/or higher excitation power, which may be incompatible
with the biological sample at hand. It is worth noting that known fluorescent lifetimes
may be specifically defined as part of the model function used to fit the experimental
data to save on computation time and to favor convergence around biologically rep-
resentative values. The trade-off, however, is that fitting such a model would assume
that there is no variance in lifetime-discrete states - an assumption that is not al-
ways valid in biology, particularly in the context of endogenous coenzymes such as
FAD and NADH.
For the purposes of limiting sample photodamage as well as facilitating data anal-
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ysis and interpretation, phasor analysis is quickly becoming the preferred approach
for processing FLIM data. This alternative methodology requires substantially less
prior knowledge about the sample and conveniently offers an intuitive visual repre-
sentation of the data at hand. Rather than curve fitting, phasor analysis involves a
transformation of each pixel's temporal decay trace into a pair of coordinates (G, S)
that describe a phasor, characterized by its coordinates in two-dimensional space [17].
The transformations correspond to the real and imaginary components of the Fourier
transform of the temporal decay trace normalized by its area under the curve, eval-
uated at the angular laser repetition frequency w, as shown in Equations 4.2 and
4.3.
f 0 I(t) cos(wt)dtG = 0 (4.2)fec I (t) dt
rf I(t) sin(wt)dtS_ =0 (4.3)fo" I (t) dt
Note that the angular frequency w is related to the laser pulse repetition rate f
by w = 27rf. In the case of pulsed laser sources, f is typically on the order of 80
MHz; with single-photon FLIM systems, a continuous wave (CW) laser is intensity-
modulated, where f then corresponds to the modulation frequency. In the case of a
single fluorophore characterized by a unique lifetime, the phasor transform results in
a set of phasor coordinates that obey the relation shown in Equation 4.4, describing
a semicircle with radius 0.5 centered at (0.5, 0) [17].
(G - 0.5)2 + S2 =0.52 (4.4)
In the context of phasor analysis of FLIM data, this is referred to as the uni-
versal semicircle. For a decay trace characterized by two fluorescence lifetimes, its
transformed phasor coordinates would lie along a line connecting the two individual
lifetimes on the universal semicircle. The exact phasor coordinates along that line
would naturally depend on the relative concentrations of the two fluorescent species
[17, 18]. It follows that for a heterogeneous binary mixture of fluorescent species,
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the transformed FLIM image would result in an elongated cluster stretching one
set of reference phasor coordinates to the other. Given such a mixture, FLIM data
analysis offers the ability to estimate the relative fluorescence contribution of each
compound at every pixel in the image based on the relative distances between each
pixel's corresponding phasor location and the respective reference phasor clusters of
the fluorophores at hand.
A challenge arises however in discerning the two fluorescent species when the
reference phasor clusters are inherently broad. This can result from a number of
contributing factors, including low photon counts and intrinsic variability of the fluo-
rescence lifetime of one or both compounds, as is typically the case with endogenous
fluorophores such as NADH. In such cases, estimating the contribution of either com-
pound using traditional Euclidean distances in phasor space becomes problematic,
resulting in decreased accuracy when pixels from the binary mixture image are dom-
inated by one compound over the other. This is because the pixel's corresponding
phasor falls within the variance of the reference phasor cluster, thereby complicating
accurate distinction. To reduce this inaccuracy, we have previously proposed the use
of the Mahalanobis distance, a non-Euclidean metric, for phasor analysis in the con-
text of signal separation and compound distinction in a binary mixture [14]. Instead
of simply considering the mean phasor cluster coordinates of the reference sample,
this distance metric additionally considers the cluster's covariance, thereby taking
into account the spread of the cluster for separation purposes. The Mahalanobis
distance is given by Equation 4.5 [181].
D(M =- )T C () - p e) (4.5)
In this context, Dij,ref is the Mahalanobis distance between the phasor of a given
pixel ij and a reference cluster; xis a vector composed of the (G, S) phasor coordi-
nates of the pixel ij; t > is a vector composed of the mean (G, S) phasor coordinates
of the reference phasor cluster; and C-1 is the 2 x 2 covariance matrix of the reference
phasor cluster. Note that the Euclidean distance can be obtained by replacing the
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covariance matrix in Equation 4.5 with the identity matrix, yielding Equation 4.6.
D E ( - p~ )T (7 - Tf) (4.6)
In the present analysis, the Euclidean and Mahalanobis (i.e. non-Euclidean) dis-
tance metrics are compared and contrasted in terms of their ability to estimate the rel-
ative contributions of each fluorescent compound in a heterogeneous mixture. Three
particular contexts are considered here: a binary mixture of compounds with well-
defined single fluorescence lifetimes; a binary mixture of fluorophores with multiple
lifetimes; and a ternary mixture of single-lifetime fluorescent species.
4.2 Materials and Methods
All simulations presented herein were performed in the MATLAB R2017b environ-
ment (MathWorks, Natick, MA). The various functions and scripts are provided in
Appendix A.
4.2.1 Simulation of a Binary Mixture
The main script for simulating a binary mixture of fluorescent compounds and es-
timating their respective concentrations is provided in simulationMainBinary.m.
Throughout the first few lines of code, the user must specify the dimensions of the
imaging field of view in terms of the numbers of pixels along the Y and X dimen-
sions (numPixelsY and numPixelsX, respectively). Next, the lifetimes of the two
compounds (tauTheoreticalA and tauTheoreticalB) must be specified, as well
as the relative uncertainty on these values (tau-error). In the case of a compound
with multiple lifetimes, the relative weights of each lifetime (alphalB, alpha2_B,
and so forth) as well as the uncertainty of these weighting coefficients (alpha-error)
must also be specified. Finally, the number of photons per pixel must also be de-
fined (totalNumPhotonsSignal), in addition to the number of spurious noise pho-
tons for each set of images (totalnumPhotonsNoise-A, totalnumPhotonsNoiseB,
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and totalnumPhotonsNoise_Mix).
Next, a row vector is defined such that the squared sine and cosine functions
describing the concentration of either compound in the mixture image are evaluated
over the course of one full amplitude cycle. Stated mathematically, x is a row vector
with numPixelsX elements spanning 0 to 7r, and the concentration of compound A
(concA) is defined as sin2 x while that of compound B (concB) is given by cos 2 x.
These row vectors are then replicated vertically numPixelsY times in order to generate
the mixture image.
The phasor transform and plotting parameters are then specified by the user.
These include: the harmonic number used for the phasor transform itself (harnomicNumer,
default: 1); the 2D histogram step size in phasor space (steps, default: 0.0025); the
laser repetition frequency in Hz (freqO, default: 80 x 106); the minimum threshold in
order to display a histogram bin count value in the phasor plot relative to the largest
bin value (histogramThreshold, default: 0.001, i.e. bins with at least 0.1% of the
counts in the largest bin will be displayed in the phasor plot); the preferred colormap
for the phasor plot (cmap, default: ' jet'); flags determining whether or not the 95%
confidence ellipse is to be drawn around each generated phasor plot (drawEllipseA,
drawEllipseB, and drawEllipse-Mix; defaults: all 0); flags determining whether
or not the intercepts between the major axis of the 95% confidence ellipse and
the universal semicircle are to be indicated on the phasor plot (drawIntercepts-A,
drawInterceptsB, and drawInterceptsMix; defaults: all 0); and finally, the num-
ber of fluorescent compounds present in each reference image (numSpeciesA and
numSpeciesB; defaults: all 1) and the mixture image (numSpeciesMix, default: 2).
Additional imaging parameters are then set by default, although they can readily
be changed by the user to evaluate different simulation conditions. These include: the
number of time bins for the histogram decay traces (numTimeBins, default: 256) as
well as a pre-defined instrument response function (IRF) used to compute the phasor
transform.
Using all the above input parameters, the simulated images are finally generated,
where each image pixel has its associated fluorescence decay trace defined in terms of
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photon counts in the temporal domain over numTimeBins bins. For each decay trace, a
time constant T is defined by the theoretical lifetime tauTheoretical provided by the
user adjusted by some random variable normally distributed around 0 with a standard
deviation of tauSigma given by tau-error x tauTheoretical. The resulting time
constant is then used to generate an exponential probability density function. This
function is convolved with the instrument response function (IRF), yielding Equation
4.7.
itf(t) -e -r * IRF(t) (4.7)
T
This is the probability density function from which photon arrival times are drawn
using the MATLAB function datasample. If spurious noise photons are also included
in the simulated decay trace, they are simply drawn from a uniform temporal distri-
bution across the laser pulse period. It is worth noting that the photon arrival times
are drawn from a continuous basis; in order to simulate a decay trace, they are binned
into numTimeBins bins in order to generate the decay trace histogram.
Next in the simulation comes the phasor transform of each individual decay trace
in order to generate all (G, S) coordinates as well as the phasor plots. The phasor
transform function computes the results of Equations 4.2 and 4.3 by trapezoidal
numerical integration. The phasor plots are then generated by binning the (G, S)
coordinates in a 2D histogram and displaying the resulting cluster in a plot along
with the universal semicircle.
In the case of the traditional Euclidean approach for estimating the contribution
of a pair of fluorophores in a binary mixture, the contribution k(E) of compound A
for a given phasor can be estimated by computing the ratio of the Euclidean distance
between the phasor and the mean coordinates of cluster B, to the sum of the Euclidean
distances between the phasor and the mean coordinates of clusters A and B together.
This relation is best summarized by Equation 4.8, where the values D and D(E)jan baijB
can be computed using Equation 4.6 [18, 177].
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D(E)
k(E) ij,B (4.8)
A D) +D(
ijA j,B
It is readily apparent that a phasor located at the mean coordinates of cluster
A will result in a k(E) value of 1, signifying a pixel whose fluorescence is completely
dominated by compound A. Conversely, a phasor at the center of cluster B will yield
a value of 0, implying the absence of compound A.
In using the Mahalanobis distance however, the mathematics are somewhat more
nuanced. Given that the computed distances are non-Euclidean, they operate in a
space governed by the covariance of each respective reference phasor cluster. For this
reason, Mahalanobis distances calculated using different references cannot be summed
together as is the case of the denominator in Equation 4.8. Instead, the contribution
k(m) of compound A for a given phasor estimated using the Mahalanobis distance is
given Equation 4.9.
D(M) Dij,B I A
D(M) + D(M
k( ) DA ''A (4.9)2
In this context, D( corresponds to the Mahalanobis distance between the phasor
of pixel ij and the mean coordinates of reference phasor cluster B; D(M) is the- Ma-A,B
halanobis distance between the mean coordinates of phasor cluster A from reference
cluster B. The converse relations are true for D(M) and D(. In this case, it can stillij,A B,A
be observed that a phasor located at the center of cluster A would yield k(m) = 1
since this would imply D(M) D(M) and D(M) D(M) 0. Consistently, a phasorij,B -A,B ij, A -A, A-
located at the mean coordinates of cluster B would result in k(M) = 0, considering
D( = D(M) and D(M) = D(M) = 0.
ij,A -B,A ij,B -B,B
4.2.2 Simulation of a Ternary Mixture
The simulation of a ternary mixture is essentially similar in implementation to that
of the binary mixture, but with a few key differences. The resulting script is available
in simulationMain-Ternary.m.
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In this case, there are three compounds to be simulated, where all parameters re-
lated to the third fluorophore are denoted tauTheoretical-C, totalNumPhotonsNoise_C,
and so forth. In order to generate a ternary mixture with uniform pixel intensity, the
adopted approach is to simulate three distinct sinusoidal concentration patterns, each
phase-shifted relative to one another by 27r/3 radians. Mathematically, this implies
defining a row vector x spanning 0 to 2w, where the concentrations of compounds A, B,
and C are defined by (1+cos (x))/2; (1+cos (x + 27/3))/2; and (1+cos (x - 27r/3))/2.
The functions used to simulate the decay traces and associated images are otherwise
the same as those used in Section 4.2.1.
It is worth recalling that a fluorescence decay trace characterized by three distinct
lifetimes results in a set of phasor coordinates located somewhere within a triangle
whose vertices are located along the circumference of the universal semicircle. The
vertex coordinates in turn are determined by the individual lifetimes of the three
compounds at hand. The exact position of the decay trace's corresponding phasor
depends on the relative weights of each fluorescent compound: if one compound
dominates strongly over the other two, the phasor will be located nearest to that
corresponding triangle vertex.
With this foundation in mind, one may consider a triplet of fluorescent compounds
A, B, and C, each resulting in phasor clusters A, B, and C, corresponding to the ver-
tices of the triangle containing all phasors of the ternary mixture. In order to estimate
the contribution of compound A to a pixel from the mixture image corresponding to
a phasor denoted X, the Euclidean approach now involves calculating the areas of two
triangles in phasor space: triangles ABC and XBC [194]. The sides of these triangles
are computed using the Euclidean distances between triangle vertices. This relation
can be expressed by Equation 4.10.
k(E3) _ AAXBC
kA AAABC
By inspection, it is clear that if phasor X is located at the mean coordinates of
phasor cluster A, then AAXBC = AAABc and therefore k (E3) 1 implying that the
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decay trace is strictly the result of compound A fluorescence. If phasor X is located
anywhere along the line connecting vertices B and C, then AAXBC - 0, resulting
in a null value of kAE3). In such a case, the areas of triangles XAC and XAB can
be computed in order to estimate the relative contributions of compounds B and C,
respectively, by dividing them by the area of triangle ABC as per Equation 4.10.
In the case of ternary separation using the Mahalanobis distance, triangular areas
in phasor space cannot be computed in a straightforward manner. This is because the
Mahalanobis distance is a normalized distance metric that considers the covariance of
a reference distribution. Therefore, computing arithmetic operations such as the area
of a triangle using Mahalanobis distances obtained from different reference samples is
analogous to calculating the area of a geometric shape whose sides are each expressed
in different spatial units. This approach is mathematically incorrect, and results in
wildly inaccurate concentration estimates.
B
C
G
Figure 4-1: Phasor plot showing the mean coordinates of phasor clusters A, B, and
C, as well as the phasor of a given pixel X. A line is drawn between phasor X and the
mean coordinates of reference cluster A, where its intersection with the line connecting
clusters B and C yields the coordinates of R.
To overcome this challenge, an alternative approach can be implemented. Rather
than computing the ratio between the areas of a pair of triangles, one may first
compute the Mahalanobis distance between the coordinates of a given phasor X and
a reference sample A. Next, a line can be drawn between the mean coordinates of
phasor cluster A and phasor X, where the intersection of this line with the line
connecting phasor clusters B and C is denoted R (Figure 4-1). The Mahalanobis
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distance between coordinates R and phasor cluster A is then computed, whereby the
Mahalanobis contribution of compound A to the total fluorescence signal of the decay
trace associated with phasor X is obtained via Equation 4.11.
M3 D(M)k _ X,A (4.11)
D(M)R,A
If phasor X is located along the line connecting phasors clusters B and C, then
k(M3) - 0. On the other hand, if it is located at the center of phasor cluster A, then
k(M3) - 1. These mathematical relationships are consistent with those described in
the binary separation case.
4.3 Results and Discussion
4.3.1 Binary Mixture with Single Lifetimes
The first accuracy comparison is that of a mixture of two fluorescent compounds
A and B, heterogeneously distributed across a simulated field of view 512 x 512
pixels in size. In order to ensure a uniform fluorescence intensity across the field
of view, the concentration of compound A is distributed horizontally following a
squared sine function over one full cycle; that of compound B is similarly distributed,
but following a squared cosine function over one cycle. Their fluorescence lifetimes
are set to 4.100 0.205 ns for compound A and 0.200 0.010 ns for compound B,
where the uncertainties correspond to 5% of the corresponding lifetime value. In
order to test the limits of performance of the separation algorithms, the photon count
per pixel is set to 100 for all simulated FLIM images here. The resulting phasor plots
are shown in Figure 4-2.
With larger and larger photon counts, both methods eventually converge to the
correct solution. However, in the present context, low photon counts are simulated in
order to evaluate the separation accuracy of the two methods under strenuous imaging
conditions. As a result, the generated phasor clusters are abnormally broad, posing a
challenge in accurately estimating the contributions of either fluorophore. In applying
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Figure 4-2: Phasor plots of thie simulated data used to test the accuracy of the sep-
aration algorithms in the context of a binary mixture of single-lifetime fluorophores.
(A) Phasor plot of compound A with a lifetime of 4.100 0.205 ns. (B) Phasor plot
of compound B with a lifetime of 0.200 t 0.010 ns. (C) Phasor plot of the binary
mixture of compounds A and B.
Equations 4.8 and 4.9 to the heterogeneous mixture image simulated using squared
sine and cosine distributions of compounds A and B, Euclidean and Mahalanobis
concentration maps of each compound can be generated as seen in Figure 4-3.
In the case of a pair of fluorescent compounds with well-defined single lifetimes that
are on opposite sides of the universal semicircle in phasor space, both the Euclidean
and Mahalanobis approaches for estimating fluorescence contributions perform sim-
ilarly overall. However, it is worth noting the increased accuracy in the case of the
Mahalanobis method, specifically when one compound with a broad phasor cluster
dominates the other in terms of concentration. This observation is particularly ev-
ident in Figure 4-3(G,H), where the Mahalanobis-based approach more accurately
identifies the dominant contribution of compound A and the corresponding absence
of compound B. While both estimates still deviate slightly from the simulated values
in the case of pixels dominated by compound A fluorescence due to the low SNR, the
Mahalanobis algorithm is found to be of equal or superior accuracy relative to the
Euclidean approach in all cases.
4.3.2 Binary Mixture with Multiple Lifetimes
In the second set of simulations, a fluorophore with a single lifetime of 2.500 t 0.125
ns is compared to another with 4 distinct lifetimes, intended to represent the various
possible lifetimes of the endogenous fluorophore NADH [15]. The lifetimes are set to
Ti= 0.770 t 0.0385 ns, T2 = 1.210 0.0605 us, T3 = 3.710 0.1855 ns, and T4 =
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Figure 4-3: Estimated concentration maps of either compound in a binary mixture of
single-lifetime fluorophores. (A,D) Theoretical concentration maps of compounds A
and B, spatially distributed following squared sine and cosine functions, respectively.
(B,E) Concentration maps of compounds A and B, respectively, estimated using the
Mahalanobis distance metric. (C,F) Concentration maps of compounds A and B,
respectively, estimated using the Euclidean distance metric. (G) Column-wise means
of panels A-C. (H) Column-wise means of panels D-F.
0.770 0.239 ns. The weights of each respective lifetime are set to ai = 15 2.25%,
a2 = 25 3.75%, OZ = 35 5.25%, and a 4 = 25 3.75%. These weighted lifetimes
are consistent with what is experimentally observed of NADH fluorescence in cells
and tissues in terms of its phasor cluster size, position, and orientation [15].
In running the same set of simulations as in Section 4.3.1 for this second pair of
fluorophores, the phasor plots shown in Figure 4-4 are generated. It is worth noting
that in this case, a higher number of photons are required to properly resolve the two
clusters given their close proximity in phasor space. The photon count per pixel is
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therefore set to N = 1000. As expected, the phasor cluster of compound A is located
along the universal semicircle since it is defined by a single lifetime (Figure 4-4(A)).
On the other hand, that of compound B (i.e. a simulated rendition of NADH) is
located within the semicircle, roughly at the center of a quadrilateral whose vertices
lie on the semicircle coordinates given by each of its four defining lifetimes (Figure
4-4(B)) [15]. The phasor plot of the mixture image, composed of compounds A and B
distributed horizontally across the simulated field of view following squared sine and
cosine distributions, shows a bimodal phasor cluster as expected (Figure 4-4(C)).
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Figure 4-4: Phasor plots of the simulated data used to test the accuracy of the
separation algorithms in the context of a binary mixture of fluorophores with multiple
lifetimes. (A) Phasor plot of compound A with a lifetime of 4.100 0.205 ns. (B)
Phasor plot of compound B, characterized by a combination of 4 distinct lifetimes.
(C) Phasor plot of the binary mixture of compounds A and B.
In examining these phasor plots, one can reasonably expect the traditional Eu-
clidean approach to result in a fairly inaccurate estimate of each compound's respec-
tive contribution to the fluorescence signals simulated in the binary mixture image.
As was discussed prior, this is because the Euclidean approach strictly considers the
mean coordinates of the reference phasor clusters. Given their overlapping distribu-
tions, a methodology using a metric that factors in their relative spreads in phasor
space - such as the Mahalanobis distance - would be expected to outperform the
Euclidean method.
To test this hypothesis, the Euclidean and Mahalanobis algorithms are both eval-
uated in terms of their ability to estimate the relative concentrations of either com-
pound in the binary mixture image, similarly to the procedure in Section 4.3.1. The
resulting estimated concentration maps are shown in Figure 4-5.
In the case of two fluorophores whose phasor clusters significantly overlap in pha-
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Figure 4-5: Estimated concentration maps of either compound in a binary mixture
of fluorophores with multiple lifetimes. (A,D) Theoretical concentration maps of
compounds A and B, spatially distributed following squared sine and cosine func-
tions, respectively. (B,E) Concentration maps of compounds A and B, respectively,
estimated using the Mahalanobis distance metric. (C,F) Concentration maps of com-
pounds A and B, respectively, estimated using the Euclidean distance metric. (G)
Column-wise means of panels A-C. (H) Column-wise means of panels D-F.
sor space, the algorithmic approach based on the Mahalanobis distance indeed vastly
outperforms the traditional Euclidean method, as made evident by the column-wise
means of the estimated concentration maps (Figure 4-5(G,H)). In this particular sce-
nario, the Euclidean approach results in concentration estimates that plateau around
80% and 20% when they should be 100% and 0%, respectively; the Mahalanobis
methodology, on the other hand, results in more accurate estimates around 90% and
10%, respectively. As in the previous simulation, these deviations from simulated
values (particularly in the context of one fluorophore dominating over the other) are
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partially related to low SNR. The accuracies of both algorithms increase with larger
photon counts and decreased uncertainty of fluorescence lifetime values, with the
Mahalanobis approach converging at a significantly faster rate.
The simulated performances of both algorithmic approaches assessed in Section
4.3.1 showed generally comparable separation accuracies. This is because the two
compounds at hand were on opposite sides of the universal semicircle, and thus natu-
rally offered a high degree of contrast. In such a scenario, opting for one method over
the other is unlikely to result in any significant discrepancy in data interpretation. In
the present set of simulations however, the differences are indeed significant, where
the Mahalanobis approach is seen to roughly halve the overall separation error. Given
a binary mixture of one compound with a lifetime of 2.5 ns (such as Coumarin 6, for
example) and another that is representative of NADH autofluorescence, this set of
simulations shows the great value in using the proposed non-Euclidean approach for
distinguishing exogenous from endogenous fluorescence.
4.3.3 Ternary Mixture with Single Lifetimes
These separation techniques can also be generalized from a binary mixture to a ternary
mixture and beyond. For the purposes of the present work, the simulations are limited
to a three-compound mixture, where the performances of both the Euclidean and
Mahalanobis techniques are contrasted.
In order to simulate a ternary mixture with constant fluorescence intensity across
the field of view, the concentrations of each respective compound are spread horizon-
tally according to cosine functions, each phase-shifted with respect to one another by
27r/3 radians. The reference phasor clusters of compounds A, B, and C, each defined
by fluorescence lifetimes of 4.100 0.205 ns, 1.600 0.080 ns, and 0.600 + 0.030 ns,
as well as the phasor plot of the ternary mixture are all shown in Figure 4-6.
The three-phase cosine distributions of compounds A, B, and C result in an el-
liptical phasor pattern as seen in Figure 4-6(D). It is worth noting that this ellipse
is contained within the triangle whose vertices lie at the centers of phasor clusters
A, B, and C. The application of the Euclidean and Mahalanobis separation algo-
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Figure 4-6: Phasor plots of the simulated data used to test the accuracy of the sepa-
ration algorithms in the context of a ternary mixture of single-lifetime fluorophores.
(A) Phasor plot of compound A with a lifetime of 4.100 0.205 ns. (B) Phasor plot of
compound B with a lifetime of 1.600 0.080 ns. (C) Phasor plot of compound C with
a lifetime of 0.600 0.030 ns. (D) Phasor plot of the ternary mixture of compounds
A, B, and C.
rithms for ternary mixtures as previously described in Equations 4.8 and 4.9 yield
the concentration estimates shown in Figure 4-7.
In the case of the Euclidean separation method based on computed areas of trian-
gles, it is clear that this standard approach is extremely accurate, failing only in the
absence of a compound it is tasked to detect. Even in such circumstances however,
the Euclidean algorithm yields an estimated concentration of the absent compound
below 5%.
In contrast, the Mahalanobis distance is not found to be as effective in the con-
text of a ternary mixture as it was in the previous simulations of binary mixtures.
Here, the reference phasor clusters tend to be elongated, with orientations more or
less parallel to the line connecting the opposite two phasor clusters. With a smaller
covariance along the axis connecting the phasors of the mixture image to the reference
phasor cluster, small spatial deviations along said axis result in large differences in
concentration estimates. Moreover, because the covariance of the reference cluster is
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Figure 4-7: Estimated concentration maps of each compound in a ternary mixture of
single-lifetime fluorophores. (A,D,G) Theoretical concentration maps of compounds
A, B, and C, respectively, spatially distributed following cosine functions phase-shifted
with respect to one another by 2-r/3 radians (B,E,H) Concentration maps of com-
pounds A, B, and C, respectively, estimated using the Mahalanobis distance metric.
(C,F,I) Concentration maps of compounds A, B, and C, respectively, estimated using
the Euclidean distance metric. (J,K,L) Column-wise means of panels A-C, D-F, and
G-I, respectively.
considered in computing the Mahalanobis distance, the angular differences between
phasors in the mixture image and a particular reference cluster result in asymmetri-
cal concentration estimates. This observation is most apparent in the Mahalanobis
estimates of compound C, where the peak of the red dashed curve in Figure 4-7(L)
is both spatially offset and slanted relative to the simulated theoretical data.
Given a ternary mixture, the Euclidean approach involving the computation of
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ratios of triangle areas is therefore objectively superior to the Mahalanobis method
in terms of estimation accuracy. This is also true of mixtures involving N > 3 com-
pounds, where areas of N-sided polygons can be computed using Euclidean distances
to estimate the contributions of each respective fluorescent compound in the sample
mixture.
4.4 Conclusion
In the present work, two separation algorithms were compared and contrasted in the
context of distinguishing mixtures of fluorescent compounds using simulated fluores-
cence lifetime imaging data. Specifically, these approaches were based on Euclidean
and Mahalanobis distance metrics, where it was found that the Mahalanobis approach
outperformed the Euclidean method in a binary mixture in all tested conditions.
This superior accuracy is the result of additional considerations that are taken into
account in computing the relative concentration of the simulated fluorescence com-
pounds. Namely, the Mahalanobis distance considers the covariance matrix of the
reference phasor clusters at hand, dramatically improving the estimation accuracy -
particularly in the case of spatially broad phasor clusters.
Interestingly, it was found that this conclusion only held true in the case of bi-
nary mixtures of fluorescent species. In ternary mixtures, the Euclidean approach
involving the calculation of triangle areas in phasor space resulted in a vastly su-
perior separation accuracy, while the Mahalanobis approach resulted in consistently
faulty concentration estimates. In the case of a ternary mixture, the shape and rela-
tive orientation of reference phasor clusters worked against the separation algorithm,
resulting in displaced and asymmetric concentration peaks.
Of course, it is impossible to simulate each and every conceivable mixture of
fluorescent compounds, each with their own respective lifetimes. It is for this reason
that the various scripts and functions are provided to the reader in Appendix A. Using
the attached software tools, it is possible to simulate any fluorescent compound by
adjusting parameters such as the fluorescence lifetime (and its associated uncertainty),
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the number of photons per pixel, the number of temporal bins in the decay trace
histogram, the image size, the fluorescence intensity pattern, and so on. In providing
these tools to the FLIM community, it is hoped that researchers will be empowered
to bridge the gap between theory and application by validating their experimental
observations with simulations in order to ultimately strengthen the foundations of
their imaging experiments.
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Chapter 5
Characterization of Human
Stratum Corneum Structure,
Barrier Function, and Chemical
Composition Using CRS
5.1 Introduction
The particular functions of skin beyond its role as an interface are diverse and in-
clude thermal insulation and regulation [195], defense against foreign pathogens [196],
touch-based sensation [197], vitamin D production [198], and prevention of water loss
[199, 200]. These roles are dependent on the skin's unique structure and composition,
of which the epidermis serves as the outermost selectively permeable barrier that
interfaces with the environment.
The epidermis is itself a multilayered structure. The deepest cell layer consists of
the stratum basale which underlies the stratum spinosum, followed by the stratum
granulosum, and finally followed by the stratum corneum at the skin's surface. De-
pending on anatomical site, the stratum corneum typically ranges in thickness from
10 to 30 layers of enucleated cells known as corneocytes and is the primary source
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of the skin's barrier function [201]. This is accomplished through the structural or-
ganization of these cells, which are stacked like protein-rich bricks glued together by
a lipid-rich ceramide mortar [202]. The biochemical compositions of both the intra-
cellular and extracellular spaces of the stratum corneum thus play important roles in
the skin's barrier function and maintaining hydration.
The stratum corneum can be compromised by a wide variety of factors, both
internal and external. Internal perturbations include abnormal enzyme activity, a
decrease in natural moisturizing factors, and reductions in stratum corneum water
content. These chemical changes can all contribute to a decrease in corneodesmoly-
sis, where the rivet-like proteinaceous complexes that bind neighboring corneocytes
together ultimately remain intact rather than undergoing enzyme-driven breakdown,
resulting in the formation of powdery flakes at the skin surface. In contrast, external
factors such as a dry environment can lead to the gradual dehydration of epidermal
layers starting with the stratum corneum. As the deeper layers of the epidermis
dehydrate, various inflammatory mediators are progressively released which induce
keratinocyte proliferation and disruption of epidermal differentiation. This cascade
can ultimately lead to a haphazard synthesis of inadequately structured extracellular
matrix elements and hampers the natural barrier function of healthy stratum corneum
[203, 200, 204].
The management of dry skin is most commonly achieved using topical agents
such as cosmetic moisturizers due to their humectant properties [205, 206]. These
compounds, including glycerin and hyaluronic acid, tend to draw and retain water due
to their abundant hydroxyl groups and can also influence the phase of the extracellular
lipid matrix under dry environmental conditions [207]. Glycerin, for example, favors
an appropriately fluid lamellar arrangement of extracellular lipids rather than the
solid crystalline phase that tends to form under dry conditions [208, 204].
In order to quantitatively monitor skin hydration, conventional methods based
on the measurement of skin electrical properties have been developed and validated.
One such industry standard involves the use of a corneometer, a device equipped with
a pen-sized handheld probe that is gently pressed onto the skin surface to measure
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hydration based on the capacitance of the skin itself [2091. Given the high dielec-
tric constant of water under standard ambient conditions, its capacitive properties
can be probed for non-invasive inferences of skin hydration. Despite its status as
a commercial standard, recent studies have identified sources of small but signifi-
cant experimental variation in corneometry measurements. One study in particular
reported a measurement dependence on the contact pressure applied between the
probe and the skin, with increasing pressure resulting in overestimated hydration
values [210]. The same group later found intra-sample variability in cases where hy-
dration levels approached saturation, suggesting a decrease in probe sensitivity at
the upper limits of hydration [211]. Despite these rather modest sources of vari-
ability, corneometry has been widely used in the validation and efficacy testing of
cosmetic products and topical drug formulations as well as in occupational health
studies [212, 213, 209, 214, 215, 216].
While corneometry is a simple, rapid, and effective method for the indirect as-
sessment of skin hydration via capacitance measurements, it is inherently limited to
point-based acquisitions over a bulk surface area of approximately 1 cm 2. Because
of this, corneometry lacks the sub-cellular spatial resolution needed to identify differ-
ences between intracellular versus extracellular hydration and it cannot be used to
distinguish the hydration of the various layers and sublayers that constitute human
skin [2111. Such information would be useful in assessing and validating treatment
strategies by offering spatial information at the cellular scale in a depth-resolved man-
ner. With such specificity, it would be possible to identify the problematic anatomical
component requiring treatment (e.g. decreased water retention within corneocyte cell
bodies, altered lipid composition of the extracellular matrix), in addition to moni-
toring the effects of the treatment strategy over time. Dermatological investigations
that would otherwise require such levels of contextual detail are technologically lim-
ited to destructive sampling techniques such as histology or cryo-scanning electron
microscopy [217].
As of now, a critical niche remains unaddressed for assessing skin hydration, struc-
ture, and composition in a non-invasive and non-destructive manner with subcellular
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3D resolution on living tissues. A potential solution to this problem lies within the
non-linear optical imaging modalities that have seen increasing use over the past
few decades along with the significant advances in endogenous molecular imaging
[218, 28, 164, 158, 172, 219, 220]. In particular, coherent Raman scattering (CRS)
imaging techniques have become a valuable tool in biomedical research by enabling the
visualization of specific chemical groups via contrast based on molecular vibrational
signatures [54, 29, 27]. Of these techniques, coherent anti-Stokes Raman scattering
(CARS) and stimulated Raman scattering (SRS) are two complementary CRS tech-
niques that can be readily used to visualize and quantify both the structure and the
chemical composition of skin. Moreover, these optical processes occur simultaneously;
it follows that an appropriate microscopy setup allows for simultaneous CARS and
SRS imaging.
In this chapter, the parallel use of both CRS microscopy and corneometry are re-
ported to characterize the structure, barrier function, and chemical content of human
ex vivo skin samples undergoing dehydration and humectant-induced rehydration.
In addition to the bulk hydration assessment offered by corneometry, CRS image
stacks of the stratum corneum in ex vivo skin explants were acquired to examine
the distribution of lipid, protein, and water content by probing their molecular vi-
brational signatures in two separate experimental contexts designed to determine the
morphological and chemical imaging metrics that best explain skin hydration.
5.2 Results and Discussion
5.2.1 CRS Imaging Metrics
The focus of this study was to build an imaging and analysis method for the chemical
and morphological characterization of the stratum corneum under changing hydration
conditions. An ex vivo skin model was imaged with CRS microscopy techniques
without a priori biases such that the data could be assessed post-acquisition using
mathematical and statistical methods. As an exploratory characterization study, the
120
number of subjects was initially set at N = 3 per experiment, noting that hundreds
of individual cells and their associated parameters were measured to characterize
changes in skin.
For non-invasive investigations of human skin in a laboratory setting, ex vivo
human skin samples acquired from discarded tissues as a result of elective patient
surgeries are typically used as a model to recapitulate the active physiology of a living
individual's skin [221, 14]. In the context of this study, such human skin explants were
imaged via CRS microscopy to visualize the architecture and biochemical content of
the stratum corneum. Hydration-relevant parameters such as lipid content can be
measured by probing the symmetric CH2 stretching vibrational mode at 2845 cm-1
[28] while the CH3 molecular vibration at 2950 cm- 1 can be used to detect proteins by
their hydrophobic amino acids with methyl groups [222]. Water molecules themselves
can be readily detected by probing the strong OH stretching vibrational mode at 3220
cm- 1 [223].
Representative CARS and SRS images of the stratum corneum acquired simul-
taneously by probing each of the three vibrational bands of interest are shown in
Figure 5-1, illustrating the particularly strong contrast observed between the intra-
cellular and extracellular spaces. Corneocytes appear as polygonal cells surrounded
by a bright extracellular matrix rich in lipids (Figure 5-1(a,d)) and proteins (Figure
5-1(b,e)). Water content (Figure 5-1(c,f)), on the other hand, is mostly confined
within the corneocyte cell bodies, with a much lower abundance in the extracellular
space.
While both imaging modalities generate similar contrast, CARS images uniquely
contain an inherent background anti-Stokes signal that is generated independently of
Raman-active molecules, known as the non-resonant background (NRB). While the
anatomical features in CARS images of the stratum corneum can be readily appre-
ciated, the interpretation of individual pixel values becomes challenging due to the
unspecific contribution from the NRB, which manifests as a broad and homogenous
distribution of background signal centered within the field of view. Importantly, the
generation of NRB is exclusive to CARS; the SRS signals in Figure 5-1(df) strictly
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Figure 5-1: CRS images of human stratum corneum acquired from ex vivo skin ex-
plants. (a-c) CARS and (d-f) SRS images of stratum corneum showing (a,d) lipid-
weighted content; (b,e) protein-weighted content; and (c,f) water-weighted content.
The NRB in the CARS data manifests itself as a homogeneous and unspecific haze
distributed across the field of view.
arise from the targeted Raman-active molecules. Conveniently, since these processes
occur simultaneously, the acquisition of CARS data in addition to SRS comes at no
additional cost.
The CRS microscopy platform used to image human stratum corneum in the
context of this study was capable of generated a total of 35 imaging metrics, although
not all metrics were found to be of value, as will be discussed later. First, the system is
equipped with two simultaneous imaging modalities (i.e. CARS and SRS) to probe the
distribution of three chemical species of interest, namely lipids, proteins, and water,
thereby generating 6 metrics. The relative ratios between these chemical species
(i.e. lipid-to-protein, lipid-to-water, and protein-to-water) can also be assessed by
computing image intensity ratios on a pixel-by-pixel basis, thus bringing the metric
count to 12. With manual segmentation of corneocytes and generation of regions of
interest (ROIs) as shown in Figure 5-2, each of the 12 previously defined metrics can be
redefined with respect to anatomical component (i.e. intracellular vs. extracellular).
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This then doubles the metric count once more for a total of 24 metrics regarding
skin hydration. By further considering intracellular-to-extracellular ratios of chemical
content for both modalities, 6 more metrics are added to the count. Finally, using
the manually generated ROIs for each corneocyte, 5 morphological parameters can be
defined based on cellular geometry: cell diameter, perimeter, and circularity, as well
as the nearest neighbor distances (NND) between adjacent corneocyte cell centers
(NNDCenters) and cell walls (NNDwaiis). Together with corneometer measurements
acquired in parallel with CRS imaging, this investigative toolkit is therefore capable of
characterizing 36 observable morphological and chemical metrics for each skin sample
at a given timepoint under a particular set of experimental conditions. However,
imaging metrics generated using CARS microscopy were ultimately discarded due to
the generation of strong NRB resulting in poorly interpretable longitudinal data.
Figure 5-2: Manual segmentation of SRS lipid content image to distinguish intra-
cellular and extracellular spaces for subsequent analysis. (a) Unlabeled image. (b)
Manually segmented image, showing corneocytes identified by indices 1 through 22,
and extracellular space corresponding to the surrounding region identified by index
number 23.
Initial assessment of the acquired CRS imaging data found a strikingly similar
contrast in the protein and lipid channels across all experimental conditions (Figure
5-1(d,e), for example). This is not surprising, as femtosecond laser sources such as
the one used in this study have an inherently broad frequency spectrum. As such,
such laser sources can generate strong CRS signals at the cost of decreased spectral
specificity [28]. Following acquisition of the imaging data, it was unclear whether
the observed similarities truly illustrated correlations in the distribution of lipids and
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proteins, or whether the femtosecond laser sources used were too spectrally broad
to resolve the two vibrational peaks of interest (2845 and 2950 cm- 1 for lipids and
proteins, respectively). To verify whether this was indeed the case, the SRS lipid and
protein chemical content image sets were statistically analyzed to determine whether
the observed SRS lipid intensity in each cell could be explained by its corresponding
SRS protein intensity. As seen in Figure 5-3, a strong correlation was indeed observed
between the SRS lipid and protein signals (Pearson's R = 0.921). This lipid-protein
correlation was less strong in the case of CARS, but nevertheless significant (Pearson's
R = 0.812). Therefore, protein-associated imaging metrics were not considered for the
statistical analysis of the dehydration and rehydration results that follow. It is worth
noting, however, that methods to increase the spectral specificity in femtosecond CRS
microscopy - collectively referred to as "spectral focusing" - have been previously
reported [222, 224, 225], and can be implemented to include the ability to reliably
probe protein content within cells and tissues.
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Figure 5-3: Scatter plot of all intracellular lipid and protein data collected via SRS,
showing a strong correlation (Pearson's R =0.921) between the observed metrics and
therefore indicative of spectral overlap.
5.2.2 Stratum Corneum Dehydration
For the dehydration investigation, ex vivo skin explants were first imaged with CRS
microscopy and probed with the corneometer immediately upon retrieval from the
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incubator. Following the first set of data acquisition, one set of skin samples was
allowed to dry on a plastic substrate while the other was maintained in parallel on
its nutritive gel under ambient conditions bed to limit dehydration. Imaging was
then performed at two additional timepoints alongside corneometer measurements
performed in triplicates for each experimental timepoint and each treatment condi-
tion. The corneometer data is shown over time for both the dehydrated and moist
conditions in Figure 5-4, and illustrates a net overall decrease in skin hydration as
the skin samples are left to dry. As expected, the skin samples that were maintained
on the moist gel bed retained their hydration more efficiently.
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Figure 5-4: Corneometer measurements obtained from ex vivo human skin throughout
the dehydration time course on a plastic substrate (i.e. rapid dehydration) and a
gel substrate (i.e. slow dehydration). Data points correspond to the mean of the
triplicate corneometer measurements with error bars indicating the standard error of
the mean. Statistically significant deviations from the corresponding initial timepoint
are denoted by asterisks and determined via Student's t-test (*: p < 0.05/N; **:
p < 0.01/N; ***: p < 0.001/N, adjusted using Bonferroni correction with N = 4
pairwise comparisons).
Linear regression analysis was performed for each CRS imaging metric and cor-
neometer measurement in order to find statistically significant trends over time and
to investigate the environmental influence on these dynamics. A linear mixed effect
model for each metric was designed to explore the possibility of modeling each ob-
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served metric as a linear function of time (a fixed factor). Each patient was considered
as a random factor and each field of view per patient as a nested random factor within
each patient, given that each skin sample for each patient was imaged at 3 different
areas per treatment condition. Note that the given area imaged at each timepoint
was different. As opposed to a marginal model which would indiscriminately con-
sider the means from all subjects together, this conditional model approach allows
for subject-specific statistical analysis. Given that patient number and patient sample
area were exchangeable (since all samples were completely anonymized), they could
readily be assigned as random factors. The linear mixed model was adopted while
holding the treatment condition constant by first modeling the data collected under
the rapid drying condition before modeling the kinetics of slowed dehydration over a
moist nutritive gel substrate.
CARS imaging data was closely explored during this step of the analysis. As men-
tioned above, CARS microscopy images contain both a chemically specific response
as well as a nonspecific response (i.e. NRB). This latter nonspecific response arises
as a function of the density of a given material and its electronic polarizability; these
two factors mix to give rise to a coherent signal that adds to the chemically specific
signal. In analyzing the CARS imaging data, it became clear that the CARS data
contained at least two responses to dehydration: not only were there changes in the
chemical content of the skin, but there were changes in cellular morphology as well.
These morphological changes, which included changes in tissue thickness, cell size,
and intercellular distance, could lead to variations in the proportion of the CARS
signal that arises from non-resonant contributions. As this nonspecific factor leads to
chemically independent changes in the total CARS signal intensity [28], chemically-
weighted CARS imaging data was not included in the statistical analysis. CARS
imaging is therefore used to inform manual image segmentation and morphological
assessment, i.e. metrics independent of chemical signatures.
The hourly rates of change for each metric under both dehydration conditions are
listed in Table 5.1 along with the 95% confidence intervals and p-values. The most
significant changes observed under both conditions were primarily morphological,
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with parameters such as cell diameter and perimeter seen to decrease, while the
NND between cell walls was observed to increase. These observations suggest that
corneocytes undergo a generalized decrease in size as they dehydrate in addition to
progressively retracting away from one another, consistent with previous findings
using cryo-scanning electron microscopy [217].
As seen in Table 5.1, relative water content as determined by SRS water intensity
was found to decrease at an average rate of approximately 7% per hour for both
intracellular and extracellular spaces under the dry environmental condition. This
rapid dehydration rate was diminished by the wet gel substrate where the time-
dependent variation of tissue water content was no longer significant. Interestingly,
these changes are also reflected in the corneometry measurements where a dramatic
dehydration rate of -15.3 units per hour was recorded on the plastic substrate while
the corresponding rate on the gel substrate was found to be roughly 35% slower (i.e.
-9.92 units per hour). The lipid-to-water ratio in both intracellular and extracellular
spaces was consistently seen to increase only under the dry condition and more so in
the case of the extracellular space. While the intracellular lipid content also decreased
slightly over time under both conditions, this decrease was more rapid over the plastic
substrate which further contributed to the contrast in lipid-to-water ratios between
the two experimental conditions.
Despite the small number of patient samples, this imaging based approach was able
to measure and visualize a large number of cells needed to generate a significant body
of data. Overall, marked differences in hydration dynamics were observed between ex
vivo patient samples depending on the type of substrate, most strikingly in the case
of intracellular water content assessed via SRS microscopy. Given these newfound
nuances, the proposed methodology supports the applicability of using CRS imaging
to complement corneometry in order to non-invasively and non-destructively measure
cellular morphology and probe hydration-relevant metrics with subcellular resolution.
Whereas corneometry relies on making bulk 1 cm2 point measurements that extends
down to the dermal layer, CRS imaging in the context of this study was able to detect
subtle chemical changes in a micron-thin slice of the stratum corneum on a pixel-by-
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Table 5.1: Stratum corneum metric dynamics measured over the time course of ex
vivo human skin dehydration on two different substrates. For the plastic substrate,
asterisks denote rates of change significantly different from zero; for the gel substrate,
they denote rates of change that are significantly different from the plastic substrate
(*: p < 0.05; **: p < 0.01; ***: p < 0.001, where p-values are adjusted using Holm-
Bonferroni correction with N = 36 metrics. IER: intracellular-to-extracellular ratio;
NND: nearest neighbor distance; CI: confidence interval.)
PLASTIC SUBSTRATE GEL SUBSTRATE
METRIC Hourly rate 95% C1 p-value Hourly rate of 95% CI p-valueof change change
Corneometry
Corneometer -15.3 [-22.1, -8.57] 3.13 x 10-3 -9.92 [-21.6, 1.79] 1.00
Water content
Intracellular -6.66 % * [-8.35, -4.97] % 1.38 x 10-' -2.46 % *** [-4.33, -0.60] % 2.90 x 10-22
Extracellular -6.95 % *** [-9.08, -4.82] % 1.26 x 10-5 -1.98 % [-5.67, 1.71] % 6.84 x 10-2
IER 0.17% [-0.18, 0.53] % 1.00 -0.42 % [-1.03, 0.19] % 0.543
Lipid content
Intracellular -4.42% [-6.62, -2.21] % 7.55 x 10-2 -2.56 % *** [-4.86, -0.27] % 1.43 x 10-
Extracellular -3.20% [-5.96, -0.44] % 1.00 -2.74% [-6.41, 0.92]% 1.00
IER -1.23% [-2.57,0.11]% 0.821 0.14% [-2.02,2.29] % 1.00
Lipid-to-water ratio
Intracellular 2.26% [0.61, 3.91] % 0.256 -0.02 % *** [-1.85, 1.81] % 5.74 x 10-
Extraceliular 3.73 % * [1.88, 5.57] % 1.48 x 10-2 -0.49 % * [-3.14, 2.17] % 1.44 x 10-2
Morphology
Cell diameter -7.06 pm * [-14.6, 0.51] pm 4.94 x 10-2 -3.97 pm [-13.0, 5.09] pm 0.545
Cell perimeter -4.92 pm [-8.70, -1.13] pm 0.756 -3.61 pm [-9.58, 2.36] pm 1.00
NNDcentm -0.28 pm [-0.96,0.41] pm 1.00 0.45 pm [-0.54, 1.45] pm 0.912
NNDw.j, 2.01 pm [0.79,3.231 pm 0.0265 1.11 pm [-0.75, 2.97] pm 1.00
pixel basis. With a field of view of 212 x 212 pm2 , objects such as single corneocytes
and entire extracellular spaces surrounding collections of corneocytes can be analyzed
at high resolution with chemical specificity. Thus, while total probed volume for CRS
measurements is several orders of magnitude smaller than that of the corneometer, it
can still serve as a useful complementary tool between in hydration studies.
5.2.3 Stratum Corneum Rehydration
The second portion of this study was focused on the rehydration dynamics of skin
following topical application of two humectant agents: glycerin and hyaluronic acid.
To simulate dehydrated skin tissue, ex vivo skin explants were removed from the
incubator and allowed to dry under ambient conditions prior to humectant treatment.
As confirmed by a plateau in the corneometer hydration measurements, samples in
this model approach were considered dehydrated at the initial timepoint of the CRS
rehydration study. Experiments were carried out in subject batches, where each batch
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encompassed a single day of experiments of all conditions on all tissue samples from
a single subject.
Linear mixed effect model regression analysis was performed for each CRS imaging
metric along for each corneometer measurements in order to find statistically signif-
icant trends in treatment response over time and to investigate the environmental
influence on these dynamics.
* Ambient, No Treatment
_ Ambient, Glycerin
E * Ambient, Hyaluronic Acid
0 n Humid, No Treatment
E * Humid, Glycerin
U *** w Humid, Hyaluronic Acid
-25 -15 -5 5 15 25 35 45 55 65Rate of Change [1/hour]
Figure 5-5: Corneometry-based assessment of ex vivo human skin hydration dynamics
during rehydration under various environmental and treatment conditions. Data
points correspond to the rate of change of corneometer measurements per hour, with
error bars showing the 95% confidence interval. For the ambient condition without
treatment (control), asterisks denote rates of change significantly different from zero;
for all other conditions, they denote rates of change that are significantly different
from the control (*: p < 0.05; **: p < 0.01; ***: p < 0.001, where p-values are
adjusted using Holm-Bonferroni correction with N = 36 metrics).
Corneometer measurements performed throughout the various rehydration con-
dition time courses are shown in Figure 5-5. From the results, it can be seen that
the sample left under ambient conditions without topical treatment continued to de-
hydrate slightly, albeit without statistical significance. Interestingly, all treatment
conditions significantly improved the rehydration rate and successfully restored skin
hydration as verified by corneometry.
Interestingly, the most significant metric impacted by both time course and topical
treatment was the intracellular water and lipid contents of corneocytes as measured
by SRS microscopy (Figure 5-6(a,b)). Under both dry and hydrated conditions, the
intracellular water and lipid contents were found to decrease over time, except in the
event of glycerin application under ambient conditions - the only condition where
intracellular chemical content increased at a positive rate. This was also the con-
dition under which the intracellular lipid-to-water ratio decreased most significantly
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Figure 5-6: Chemical content dynamics of ex vivo human skin during rehydration
under various environmental and treatment conditions. Data points correspond to
the rate of change of CRS imaging metrics per hour, with error bars showing the 95%
confidence interval. For the ambient condition without treatment (control), asterisks
denote rates of change significantly different from zero; for all other conditions, they
denote rates of change that are significantly different from the control (*: p < 0.05;
**: p < 0.01; ***: p < 0.001, where p-values are adjusted using Holm-Bonferroni
correction with N = 36 metrics).
throughout the rehydration process (Figure 5-6(c)). In contrast to these CRS re-
sults, corneometry indicated an increase in skin hydration following both glycerin
and hyaluronic acid treatment, although the hydration increase following the latter
treatment was less pronounced under ambient environmental conditions. These find-
ings suggest the possibility that, in this ex vivo model system, the water retained by
the tissue following humectant application is taken up but not necessarily retained
in corneocyte cell bodies. This disagreement is not necessarily problematic: while
corneometry is considered most sensitive to the topmost 15 to 45 pm of the interro-
gated sample, its bulk probing volume actually extends several tens of microns deeper
into the skin albeit with decreasing sensitivity [211, 226]. This lack of spatial speci-
ficity may result in a significant portion of the viable epidermis and dermis being
interrogated as well, which could explain the apparent discrepancy in the changes in
corneocyte water content as measured by SRS imaging.
Of note, the diameter of cells treated with glycerin was also observed to gradually
increase over the time course of the experiment under all conditions with the exception
of glycerin treatment in the humid incubator environment. This observation may be
interpreted as a transient swelling of the cells over time, however, without statistically
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significant retention of hydration (Figure 5-7). This correlation between corneocyte
size and hydration is generally consistent with previous findings assessed via cryo-
scanning electron microscopy [217].
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Figure 5-7: Morphological dynamics of ex vivo human corneocytes during rehydration
under various environmental and treatment conditions. Data points correspond to
the rate of change of each spatial metric in microns per hour with error bars show-
ing the 95% confidence interval. Nearest neighbor distances are computed between
corneocyte cell centers (NNDCenters) as well as between cell walls (NNDwa,,nsr). For the
ambient condition without treatment (control), asterisks denote rates of change sig-
nificantly different from zero; for all other conditions, they denote rates of change that
are significantly different from the control (*: p < 0.05; **: p < 0.01; ***: p < 0.001,
where p-values are adjusted using Holm-Bonferroni correction with N = 36 metrics).
Skin explants treated with hyaluronic acid and left to rehydrate under ambient
conditions showed an overall decrease in terms of intracellular water content, although
these changes differed in magnitude from their untreated counterparts in a statistically
significant manner. Indeed, under ambient conditions, the intracellular water loss
was slowed, while the humid and warm environment of the incubator was found to
exacerbate the water loss rate. This overall trend is consistent with that observed
in samples treated with glycerin. Interestingly, the intracellular lipid content in the
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hyaluronic acid treated explants under ambient conditions was now found to decrease
at a significantly accelerated rate relative to the untreated samples. It is also worth
noting that some aspects of cellular morphology were also impacted by hyaluronic
acid treatment under ambient conditions. In particular, the hyaluronic acid treatment
under the humid and warm conditions of the tissue incubator resulted in increased
distances between corneocyte cell centers and their walls, suggestive of tissue swelling
as a result of increased hydration.
It is also worth examining the overall similarities and differences in the samples
kept at room temperature relative to those maintained in the tissue incubator at 37'C,
5% atmospheric C0 2, and 95% relative humidity between measurements. The warm
and humid environment of the incubator was found to significantly affect the water
and lipid loss rates, with intracellular loss rates increasing 2- and 3-fold, respectively,
relative to the untreated sample under ambient conditions. The extracellular water
and lipid contents were also found to decrease significantly, which was otherwise only
observed in the case of hyaluronic acid treatment under ambient conditions. Despite
this radical shift in water content throughout the stratum corneum, the corneometer
nevertheless measured a dramatic rise in skin hydration, similar in magnitude to a
topical application of glycerin under ambient conditions. This discrepancy highlights
the difference in probing volumes between corneometry and water content assessment
via SRS microscopy.
When skin samples were treated with either glycerin or hyaluronic acid and main-
tained in the incubator between measurements, the observed trends generally resem-
bled those of untreated incubated skin: the intracellular and extracellular water and
lipid loss rates increased significantly, despite corneometry showing a marked increase
in terms of skin hydration. Corneocyte morphology, however, was generally found to
remain unaffected, other than in the particular case of hyaluronic acid treatment
under humid and warm conditions as noted above.
A summary of all observable metrics that show variability over time is presented
in Table 5.2. As demonstrated by corneometry, skin samples required the warm
and humid environment of the incubator and/or a topical application of glycerin or
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Table 5.2: Summary of observed changes over the time course of skin explant rehy-
dration. (N/C: no change; +++, ++, +: strong, moderate, and modest increase,
respectively; - , -, -: strong, moderate, and modest decrease, respectively.)
AMBIENT ENVIRONMENT HUMID ENVIRONMENT
METRIC No treatment Glycerin Hyaluronic No treatment Glycerin Hyaluronic
____________acid acid
Corneometry
Comeometer -+++ + +++ +++ +++
Water content
Intracellular -- + ---- ---
Extracellular N/C N/C N/C --- --- ---
IER N/C N/C N/C N/C N/C N/C
Lipid content
Intracellular N/C N/C ---- ---
Extracellular N/C N/C ---- --- ---
IER N/C N/C N/C N/C N/C N/C
Lipid-to-water ratio
Intracellular +-- N/C N/C - N/C
Extracellular N/C N/C N/C N/C N/C N/C
Morphology
Cell diameter N/C N/C N/C N/C N/C N/C
Cell perimeter N/C N/C N/C N/C N/C N/C
NNDten. N/C N/C N/C N/C N/C +
NNDwan. N/C N/C N/C N/C + ++
hyaluronic acid in order to rehydrate. The SRS imaging results point to an interest-
ing suggestion that the stratum corneum itself may not retain or increase its water
content within corneocytes during glycerin and hyaluronic acid induced rehydration.
In fact, in this ex vivo model system, the SRS imaging results indicate that the rate
of intracellular water loss from the stratum corneum accelerated for all conditions un-
der the warm and humid incubator conditions. It should be noted that calculations
carried out on the CARS images (data not shown) show the opposite overall trend, an
effect that is hypothesized to arise from two factors. First, as noted above, structural
changes to the skin are likely to cause changes to the non-resonant signal contribution
that contaminates the CARS signal. Second, an additional non-resonant contribution
in the CARS images arises from the glycerin and hyaluronic acid treatments them-
selves, creating a false increase in apparent water content. The SRS imaging data,
which instead scales linearly with molecular concentration and does not contain non-
resonant signal contributions, clearly points to a net dehydration effect in all tested
model samples.
Interestingly, this finding does not exactly agree with conventional understand-
ing of stratum corneum behavior, warranting further discussion. First, it should be
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kept in mind that while the data is generated from many dozens of cells over many
tissue samples, all samples were derived from a small set of subjects who underwent
surgery. Discarded ex vivo tissue samples from these procedures were transported
under cold, wet conditions prior to processing and placement into the tissue explant
culture system for one to three days. It is therefore important to note that this ex
vivo skin explant model may not be entirely representative of normal, healthy skin.
Despite this fact, skin explant models are used widely in biological, cosmetic, and
drug studies [163, 221, 14], highlighting the importance of understanding how they
respond to various challenges and conditions on the cellular level.
Second, the dehydration approach used in this study approximated, but did not
match, normal skin drying in humans. Dry skin in vivo involves changes and al-
terations in skin cellular biology that can occur over the course of days and weeks.
The drying method used here created a bulk dehydration of thinned skin samples in
mere hours, and may have driven the skin to states not normally experienced in vivo.
While this caveat may not apply to skin undergoing the initial stages of dehydration,
it may indeed affect rehydration. As this dehydration/rehydration approach is used in
research [227, 163], it is important to understand the implications of findings derived
from such models.
It is furthermore worth recalling that CRS imaging modalities are non-destructive
techniques that assesses chemical content directly based on the intrinsic molecular vi-
brations of the chemical groups of interest. Other techniques have previously been
used to study stratum corneum hydration including high pressure freezing before
freeze substitution [228] and cryo-scanning electron microscopy [217], although in us-
ing such investigational approaches, it cannot be excluded that the harsh tissue pro-
cessing protocols affect the integrity of the corneocytes themselves. CRS microscopy
methods therefore offer the advantage of requiring little-to-no sample preparation,
and have already been used to pursue dermatological investigations in human sub-
jects [229]. Having an established framework for processing CRS image data using
linear mixed effect models, investigations can further be performed on human vol-
unteers in order to ascertain stratum corneum hydration dynamics in the most ideal
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biological context in vivo.
The discrepancy in hydration between corneometry and CRS imaging in the
present model system is thought to arise from both the volumes of tissue interro-
gates and the nature of the measurement itself. Nonlinear optical imaging techniques
such as SRS are able to probe focal volumes on the scale of the cubic micron with
three-dimensional spatial resolution. In contrast, the current industry standard for
hydration measurements, corneometry, is known to integrate signals over several tens
of microns and can encompass all layers of the epidermis beyond the stratum corneum
as well as a portion of the dermis within human skin. Whereas CRS imaging directly
measures the concentration of given molecular species such as water, corneometry
indirectly measures tissue water content via quantification of capacitance. This dif-
ference highlights the need for complementary chemically sensitive CRS microscopy
techniques with corneometry. The CRS imaging method developed for this study
does indeed suggest something unexpected occurring to the stratum corneum, a find-
ing that is not anticipated by the corneometry measurements alone. The ex vivo
models in this study experienced major, opposite changes in water content between
bulk tissue and the stratum corneum under conditions that were expected to lead to
tissue rehydration.
These results strongly suggest the need for future studies that make use of im-
proved model systems, increased subject numbers, and perhaps a pivot to in vivo
experiments. For the reasons discussed above, improved tissue sources and model
systems should be explored. Optimized and traceable skin explant cultures can now
be purchased from commercial vendors such as Genoskin Inc., providing improved
tissue cultures that remain viable for substantially longer time courses than mod-
els such as those used in the present study. Genoskin and similar vendors can also
provide tissues from a wider range of donors, which can increase subject numbers
to ensure that results arise from respective populations. Ultimately, however, these
experiments should transition away from model systems to in vivo studies. Skin cul-
ture models are only a way to prolong the eventual decay of ex vivo skin tissue, and
dehydration/rehydration models can never fully match real dry skin.
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To meet these clinical research needs, we are developing new, portable CARS and
SRS microscopy systems with the goal of carrying out in vivo CRS imaging of skin
in the near future. A portable clinic-ready imaging system will be key to visualize
dry or compromised skin and capture the full biological dynamics of treatment re-
sponse. Such an instrument can also incorporate additional detection methods and
imaging modalities, including two-photon excited fluorescence (TPEF), which can
be used to probe coenzymes such as flavin and nicotinamide adenine dinucleotides
(FAD and NADH, respectively) to probe metabolic perturbations [164, 14]; tran-
sient and sum-frequency absorption (TA and SFA, respectively) to probe the strong
absorptive properties of pigments and chromophores such as melanin species and
hemoglobin [52, 51, 8]; as well as second-harmonic generation (SHG), which relies on
the birefringent nature of collagen fibers to generate a strong signal that maps ori-
ented extracellular matrix proteins without the use of exogenous labels [230]. These
imaging techniques can be judiciously combined with one another to best comple-
ment standard measurement techniques to tease out the detailed biological response
to dehydration and rehydration.
In the present study, investigations were limited to the stratum corneum, where
each imaging field of view typically contained a few tens of corneocytes that, together
with the extracellular space, translated to tens of observations. In exploring other
layers of skin with additional nonlinear imaging techniques such as those described
above, this methodological approach to assessing imaging metrics therefore allows
one to easily record many hundreds or even thousands of observables, each defined by
a handful of categorical descriptors such as patient number or treatment condition.
Programming languages such as Matlab and Python lend themselves particularly
well to processing such datasets, as the computations involve iterative processing of
multichannel image data with binary masks generated via manual segmentation. The
image analysis then returns a data table where each row corresponds to an individual
observation, and each vector corresponds to either a descriptor (e.g. patient number,
treatment condition, timepoint, etc.) or an observed metric (e.g. water content,
lipid content, cell diameter, etc.). Such data formats are ideal for statistical software
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packages such as R, where linear mixed effect models can serve to identify longitudinal
trends and differences between treatment conditions.
Further work in assessing chemical content across the various strata of human skin
using CRS microscopy (and other complementary nonlinear optical imaging methods)
may also further inform the development of new topical formulations; combining these
imaging toolkits with corneometry will further shed light on both the microscopic and
macroscopic effects of topical treatment strategies.
5.3 Materials and Methods
5.3.1 Tissue Culture. and Processing
Human skin samples were obtained from discarded tissues resulting from elective pa-
tient surgeries in compliance with the institutional review board of Massachusetts
General Hospital (MGH IRB protocol #2015P001267). Upon receiving the skin sam-
ples, they were immediately trimmed to remove the subcutaneous fat, and subse-
quently cut into square pieces approximately 1 to 2 cm2 in size. The skin samples
were then placed on a nutritive gel bed consisting of complete cell medium supple-
mented with 2% agarose and placed in an incubator at 37'C with 5% atmospheric
CO 2 and 95% relative humidity.
5.3.2 Corneometer Measurements
Skin hydration state was measured on ex vivo human skin explants using a corneome-
ter (Corneometer CM 825, Courage+Khazaka Electronic GmbH, Cologne, Germany)
according to the manufacturer's instructions. For each measurement, the probe was
applied to the skin which then outputs a readout in arbitrary units ranging from 0 to
120. Prior work has served to classify the corneometer readouts obtained from 349
volunteers, where values below 30 indicate very dry skin; measurements ranging from
30 to 40 correspond to dry skin; and values above 40 are considered normal [209]. It
is worth noting, however, that these classifications were determined based on data
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acquired from intact patient skin; the cutoffs between very dry, dry, and normal skin
for ex vivo human skin explants that have been maintained in an incubator at 37'C
with high humidity are likely to differ.
5.3.3 CRS Microscopy
CRS imaging was performed using a dual-output femtosecond pulsed laser source
(Insight DeepSee, Spectra-Physics, Santa Clara, CA). One output is widely tunable
from 680 to 1300 nm and is used as the pump beam in all CRS experiments, while the
other output, fixed at 1040 nm, is used as the Stokes beam. Imaging lipids requires
tuning the pump beam to 803 nm in order to probe the symmetric CH2 stretching
vibrational mode at 2845 cm- 1 , which generates an anti-Stokes signal at 654 nm. Pro-
teins can be probed at a slightly higher energy using a pump wavelength of 796 nm to
collect the 645 nm anti-Stokes light, where the CH3 stretching vibration at 2950 cm-1
has been associated with protein signatures. Finally, the OH vibrational stretching
mode at 3220 cm 1 can be probed by tuning the pump beam to 779 nm, generating
anti-Stokes light at 623 nm. The laser beams were combined using a dichroic mirror
and routed to the input port of a commercial inverted microscope (FV1000, Olympus,
Tokyo, Japan), where imaging was performed using a 1.20 NA objective (UPLSAPO
60XW, Olympus, Tokyo, Japan). Laser powers were maintained below 40 mW at the
output of the microscope objective for all skin imaging experiments. CARS detec-
tion was achieved using a photomultiplier tube (H7422PA-50, Hamamatsu Photonics,
Hamamatsu City, Japan) with appropriate optical filters for detecting each respective
anti-Stokes signal in an epi-configuration. For SRS, the Stokes beam intensity was
modulated using an electro-optic modulator (EO-AM-R-20-C2, Thorlabs, Newton,
NJ) driven at 20 MHz. The detector consisted of a commercial system comprised of
a photodiode coupled to a lock-in amplifier (Lock-In Amplifier, APE GmbH, Berlin,
Germany) placed downstream of the sample in a trans-configuration.
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5.3.4 Image Analysis
Three-dimensional CRS image stacks of the stratum corneum under both hydrated
and dehydrated conditions were acquired from the skin surface down to a depth
of 15 pm at 1-[m intervals along the depth axis. The vibrational bands of lipids,
proteins, and water were probed using both CARS and SRS imaging modalities,
resulting in a total of 6 image stacks per imaging area, per timepoint, per treatment
condition. Each image stack was then inspected visually and the most superficial
slice containing clearly delineated corneocytes - i.e. the topmost slice underlying the
keratin layer - was used for all subsequent image analysis. Each corneocyte image set
was then processed using FIJI image processing software in order to manually segment
corneocytes from the lipid SRS image and generate one region of interest (ROI) per
corneocyte within a given field of view. The lipid channel was selected for manual
segmentation due to the high contrast between the extracellular and intracellular
chemical composition. Once all cells in the field of view were identified, the region
of the image encompassing all the identified cells was also selected as an ROI itself.
The cell ROIs were then subtracted from this region, resulting in a single ROI that
can be used to analyze the extracellular space within the stratum corneum.
The ROIs are then all imported into Matlab (Mathworks, Natick, MA), where a
custom image analysis routine applies the segmented masks to the imaging data from
all 6 channels, allowing for average measurements of water, lipid, and protein con-
tent to be computed for each individual cell within a field of view, in addition to the
extracellular space. The algorithm uses the ROI data to perform morphological anal-
ysis, where metrics such as cell diameter, perimeter, circularity, and nearest neighbor
distances are computed. Applying the ROIs to the imaging data results in a variety
of metrics that can be extracted beyond water, lipid, and protein content. Ratios
can be computed to compare signals from intracellular and extracellular spaces, or
to compare the content of one compound (e.g. lipid) to another (e.g. water) within
a given ROI. In total, the image analysis routing returns 35 morphological and com-
positional metrics per imaging field of view, which are then subjected to statistical
139
analysis using linear regression models to identify trends and correlation between the
imaging metrics and the corneometer measurements.
5.3.5 Skin Explant Dehydration
In order to investigate the dynamics of skin dehydration using CRS imaging, two sets
of skin samples were used, where both samples were processed and maintained in an
incubator as previously described in order to reach a steady state of hydration. The
skin samples were then both removed from the incubator, whereupon skin hydration
was measured using the corneometer and CRS imaging was performed on both sets.
Next, one sample was maintained on the nutritive gel bed in order to preserve hydra-
tion; the other was left on a plastic dish under ambient atmospheric conditions (22'C,
24% relative humidity) to facilitate dehydration. Subsequent corneometer and CRS
imaging measurements were then performed 2 more times at 1-hour intervals. This
investigation was performed using specimens from 3 different patients. Of note, the
third timepoint data for Patient #3 could not be collected, as the epidermis of the
skin sample on the gel substrate was compromised after the second timepoint. For
this reason, only the data collected from the first two timepoints for Patient #3 was
included in the statistical analysis.
5.3.6 Skin Explant Rehydration
To study the effects of moisturizing compounds on dry skin, four sets of skin samples
were necessary per patient. All samples were first processed and maintained in an
incubator as described above in order to attain a stable hydrated state. Next, all
samples were removed from the incubator and allowed to dry in plastic dishes under
ambient atmospheric conditions for 2 hours to allow the skin to dry and reach a sta-
ble dehydrated state, as confirmed by corneometry. The samples were then subjected
to corneometry and CRS imaging before undergoing moisturizer treatment in order
to assess the hydration status of the baseline dehydrated state, to be used as the
reference for all rehydration comparisons. To this aim, two moisturizing compounds
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were used, namely 12% deuterated glycerin dissolved in water, and 0.25% hyaluronic
acid dissolved in water, designed to match typical humectant concentrations found
in commercial formulations [231, 232]. The deuterated form of glycerin was selected
in order to avoid CRS signal generation from its CH2 and OH moieties. This was
not a concern in the case of hyaluronic acid for two reasons: (1) its concentration
was nearly 50-fold lower, and (2) it does not contain any CH2 groups. Thus, the
only potential source of spectral cross-talk are the molecule's OH groups, but they
are dwarfed in numbers by the surrounding water molecules. Of each treatment pair,
one subset was returned to the incubator, while the other remained at ambient con-
ditions. Additional CRS and corneometer measurements were obtained 2 more times
at 1-hour intervals. As above, this investigation was also performed using specimens
from 3 different patients. Of note, the samples treated with glycerin absorbed the
formulation over the time course of the experiment, allowing for a straightforward
assessment of the stratum corneum using corneometry and CRS imaging. The skin
samples treated with hyaluronic acid, on the other hand, remained noticeably wet at
their surface throughout the experimental time course, barring any assessment at the
second timepoint without perturbing rehydration dynamics. For the final timepoint,
the residual moisture on the skin surface was carefully wiped with delicate task wipers
prior to data collection.
5.3.7 Statistical Analysis
Processed image data was analyzed using the notebooks written in the R language.
Data was analyzed using R 3.4.1 within the RStudio environment with extra packages
compiled from the R 3.4.3 distribution. Correlation tests were first used to assess
whether certain image analysis outcomes were independent since spectral overlap
between the probed vibrational bands of interest was considered a potential factor
between different chemical weightings (e.g. lipid vs. protein). To examine correlation,
Pearson's R was calculated between image analysis outcomes in a pairwise manner
with a coefficient of correlation greater than 0.8 considered to be highly correlated.
Highly correlated outcomes were considered potentially linked due to spectral overlap.
141
The outcomes calculated from image analysis such as cellular water content mea-
sured via SRS were each subjected to linear regression analysis for longitudinal data.
Cell- and region-specific information was collected from 3 distinct imaging areas across
multiple subjects. As these areas and subjects were statistically exchangeable, they
were considered random factors in the analysis. Linear regression was performed
through the use of linear mixed effect models using the lme4 and imerTest R pack-
ages. In the initial analysis, individual image analysis outcomes were tested serially
via linear mixed effect model regression analysis where the timepoint was treated as
a fixed factor. Subject was considered a random factor and tissue area considered
a random factor nested within each subject. For each image analysis outcome, the
effect size f, t-statistic, and p-value were calculated and tabulated. It should be noted
that while a threshold of 0.05 is conventionally set for p-values in order to determine
significance, linear regression was performed once for each imaging metric across all
paired conditions. Thus, for the dehydration experiment, the Holm-Bonferroni cor-
rection should be used to compensate for family-wise error by adjusting the p-value
threshold given the number of statistical tests run. In the case of both the dehy-
dration and rehydration experiments, this therefore results in a corrective factor of
36.
To compare conditions and assess the effect of treatments, a linear mixed effect
model regression equation was built using the categorical treatment condition values
as independent indicator variables. The baseline comparator condition was set as
ambient environment without topical treatment. The regression equation specifically
included not only the timepoint of the outcome, but also a timepoint-condition in-
teraction term to separately test whether the treatment condition was a modifier for
the time-dependent outcome.
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Chapter 6
Longitudinal Monitoring of Cancer
Cell Subpopulations from In Vitro
to In Vivo Using Fluorescence
Photoconversion
6.1 Introduction
Fluorescent labeling strategies are widely used in microscopy applications in order
to glean a proper understanding of the biomolecular mechanisms underlying normal
and aberrant cellular behaviors [11, 30, 31]. These techniques are highly diverse:
standard immunofluorescence (IF) can be used to tag proteins of interest with high
specificity [32]; genetic engineering can allow for the genomic insertion of fluores-
cent reporter proteins to monitor expression of particular genes [33, 34, 35, 36, 37];
organelle-specific fluorescent dyes can also be used for quantitative and/or qualitative
cytological measurements [38, 39, 40]. Such methods have been used to study key mi-
croscopic processes in models spanning monolayers and 3D spheroids in vitro [30, 38]
all the way up to animal models and humans in vivo [233, 234, 235, 236, 237, 238].
However, despite their widespread adoption in microscopy, traditional fluorescence-
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based techniques are static in their labeling. In other words, they cannot be used to
monitor specific cell populations of interest that have been identified after the initial
labeling step. For example, a population of fluorescently labeled stem cells cultured in
vitro or injected in an animal xenograft model cannot be monitored longitudinally to
study their differentiation, as the dye's fluorescence is an intrinsic molecular property
and is therefore independent of the cell's phenotypic behavior [41, 44).
In fact, there exists a wide variety of applications where the monitoring of spe-
cific cell subpopulations over a particular time course would be of great biological
relevance. Biomolecular reporters such as green fluorescent protein (GFP), for in-
stance, can be useful in determining whether the cells in a cultured population ex-
press a particular gene [35, 36]. However, tracking the fate of specific expressing or
non-expressing cells within the same culture over prolonged periods would pose a
significant challenge [41]. This difficulty is of particular importance in the study of
treatment resistance in the context of cancer. In an ideal scenario, cells of interest
would first be identified based on the expression of some reporter protein. Those
same cells would then be monitored over time as they are challenged with therapeu-
tic strategies in order to ascertain the response to therapy and probe aspects of a
cell population's heterogeneity [239]. One can also envision a similar challenge in
the study of immune infiltration within cancerous lesions. For instance, by using
the techniques discussed above, the rate of immune cell turnover in the context of
immunosurveillance would be extremely challenging to quantify as there is no straight-
forward manner of distinguishing specific immune cells over a longitudinal series of
imaging experiments. These examples highlight some of the current limitations in us-
ing conventional fluorescent labeling strategies, particularly in the context of cancer
research on the cellular scale.
A great deal of effort has been dedicated to the development of photoconvert-
ible fluorescent labels to fill this biotechnological niche [41, 42, 43, 44]. Much like
any other fluorescent molecule, these reporters exhibit a characteristic excitation and
emission profile. However, they are distinct from conventional labels in that their
optical profile can be predictably and reproducibly converted to a new set of excita-
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tion and emission characteristics. The particular set of optical signatures before and
after conversion, as well as the reversibility of the process, are intrinsic properties
of each photoconvertible reporter. Genetic reporter systems such as Kaede[240] and
Dendra2[241] have been been found particularly useful[242], but the natural turnover
of fluorescent proteins makes these labeling strategies transient. Many studies could
benefit from a photoconvertable approach that has permanence over eight or even ten
cell division cycles.
While the excitation and emission properties of fluorescent reporters can range
from the ultraviolet all the way to the near-infrared (NIR) [30], the red end of the
spectrum is typically of greatest value for intravital imaging. These longer wavelength
signals have a lower tendency to be absorbed and scattered by tissues compared to
their bluer counterparts. This allows for increased signal generation and collection,
and thus maximizes penetration depth [11, 30, 45]. One such commercially available
NIR fluorescent label known as DiR (1,1 '-dioctadecyltetramethyl indotricarbocyanine
iodide) is a membrane dye with excitation and emission peaks at 748 nm and 780
nm, respectively [41]. This particular dye has been shown to exhibit irreversible
photoconversion upon irradiation with a mere 8 to 45 mW of 750 nm femtosecond
pulses over a period as short as 5 to 20 seconds depending on the nature of the sample
at hand (i.e. in vitro vs. in vivo) [41].
In the context of this study, we sought to demonstrate the use of DiR as a pho-
toconvertible membrane dye for tracking specific cells in solid tissues. These include
labeling ovarian cancer cells (OVCAR5) in both 2D monolayer and 3D spheroid cul-
tures, performing photoconversion on a given subpopulation, and monitoring their
development over time. The selective isolation of photoconverted cells derived from
such in vitro cultures using fluorescence-activated cell sorting (FACS) is also demon-
strated and highlights the applicability of this method to identify specific cells of
interest within a given in vitro context. Finally, the photoconversion of DiR is also
demonstrated in a melanoma (UACC62) xenograft model in a live zebrafish moni-
tored longitudinally over several days. In building upon prior efforts elucidating the
photoconvertible nature of DiR and similar cyanine dyes [41, 43, 44], these demonstra-
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tions set the stage for novel avenues of research in the context of molecular pathology
where longitudinal monitoring of cell lineages can offer insight pertaining to thera-
peutic response and acquired resistance.
6.2 Materials and Methods
6.2.1 Monolayer Cell Culture
The OVCAR5 cell line (Fox Chase Cancer Center) consists of human epithelial car-
cinoma cells and was derived from the ascitic fluid of a patient with progressive
ovarian adenocarcinoma without prior cytotoxic treatment. Cells were plated onto
6-well glass-bottom plates (Cellvis P06-14-0-N, Mountain View, CA) and cultured
using Roswell Park Memorial Institute (RPMI) culture medium (Corning 10-040-CV,
Corning, NY) supplemented with 10% fetal bovine serum (FBS; Gibco 10437-028,
Waltham, MA) and 1% penicillin-streptomycin (Corning 30-001-CL, Corning, NY).
Each well was seeded with 6.5 x 104 cells and incubated at 37'C with 5% atmospheric
CO 2 for 5 days prior to imaging.
In order to label the cells with DiR, the culture medium was first removed from
each well and substituted with fresh medium containing 5pM of DiR. The cells were
then incubated for 20 minutes at 37'C prior to two washing steps with Dulbecco's
phosphate-buffered saline (DPBS without calcium and magnesium; Corning 21-031-
CV, Corning, NY). Cells were maintained in DPBS for imaging, and switched back
to complete culture medium for longitudinal monitoring.
6.2.2 3D Spheroid Culture
Ovarian cancer spheroids were cultured in a manner consistent with previously de-
scribed methods [243]. Briefly, in order to generate 3D spheroids for in vitro culture,
120 pL of Matrigel basement membrane matrix (Corning 356234, Corning, NY) was
first dispensed uniformly to fill the glass-bottom well of a 35 mm dish (MatTek Cor-
poration P35G-0-14-C, Ashland, MA). The dish was then incubated at 37'C for 45
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minutes. Next, a suspension of cells in complete medium was prepared with a final
concentration of 18,600 cells/mL, such that a total volume of 200 ML of cell suspen-
sion was sufficient to seed the gel with roughly 3,700 cells. The volume was dispensed
drop-wise onto the gel layer and incubated at 37'C for another 45 minutes. Dur-
ing the incubation time, a 2% v/v solution of Matrigel dissolved in complete culture
medium was prepared, of which 1.8 mL was added to the dish following incubation
for a final volume of 2 mL over the gel bed.
Every 2 days following the initial seeding, the culture medium was replaced with
fresh medium containing 2% v/v Matrigel and 10 4M DiR in order to ensure complete
preliminary staining throughout the entirety of the formed spheroids. By maintaining
this routine over the course of 2 weeks, 3D ovarian cancer spheroids with diameters
in the few hundred of microns are readily formed [243, 244].
6.2.3 Spheroid Disaggregation and Fluorescence-Activated
Cell Sorting (FACS)
In order to isolate specific cells of interest from a sample of 3D tumor spheroids using
FACS, the spheroids first required disaggregation. To this aim, the culture medium
was first removed from the glass-bottom dish containing the spheroids. The dish was
then filled with 1 mL of dispase solution (Corning 354235, Corning, NY) and incu-
bated at 37'C for 2 hours to break down the Matrigel matrix. Following incubation,
the dish was supplemented with 1 mL of 10 mM EDTA (ethylenediaminetetraacetic
acid; Fisher Scientific BP120-500, Waltham, MA) in DPBS to stop the dispase re-
action. Next, cells were collected and centrifuged at 250 g for 5 minutes. The su-
pernatant was then removed, and the cell pellet was washed two additional times
with fresh DPBS and centrifugation at 250 g for 5 minutes each time. Next, the cell
pellet was resuspended in 3 mL of 0.05% trypsin protease solution (GE Healthcare
HyClone Trypsin Protease SH30236.01, Chicago, IL) and incubated at 37'C for 10
minutes. The protease solution was then neutralized by adding 5 mL of complete
culture medium following incubation. The cells were then centrifuged one last time
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at 250 g for 5 minutes, and resuspended in 500 pL of FACS buffer consisting of DPBS
supplemented with 5 mL of FBS (1% v/v), 2 mM EDTA, and 25 mM HEPES (4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid; Corning 25-060-Cl, Corning, NY).
The resulting cell suspension was then sorted using a commercial FACS system (BD
FACSAria, Franklin Lakes, NJ), where gating parameters were determined based on
the intensities of two fluorescence channels set to capture fluorescence within the
640-680 nm and 750-810 nm ranges.
6.2.4 Zebrafish Xenograft Model
To generate a short term xenograft model of melanoma, UACC62 melanoma cells
were first cultured in vitro using complete cell medium (RPMI supplemented with
10% FBS and 1% penicillin-streptomycin). For staining the melanoma cells with
DiR, the culture medium was first removed prior to washing with DPBS. Next, the
cells were then exposed to a 5 pM solution of DiR in complete culture medium and
incubated at 37'C for 20 minutes. The cells were then washed twice with DPBS
before reintroducing them to fresh complete culture medium and allowing them to
incubate at 37'C for an additional 20 minutes prior to xenografting.
For the transplantation procedure, zebrafish were handled in full compliance with
a protocol approved by the institutional animal care and use committee (IACUC)
of Massachusetts General Hospital (MGH IACUC protocol #2011-N-000127). The
injection procedure is similar to previously reported methods [245, 246]. First, DiR-
labeled cells were collected and resuspended such that a final volume of 5 PL con-
taining 1.5 to 2 million cells could be used for the xenograft. Fish were anesthetized
by placing them in a dish containing tricaine solution (0.16 mg/mL). Next, each fish
was held dorsal side up for the retro-orbital injection, which was performed using a
Hamilton syringe. With the bevel side up, the syringe was positioned at an angle of
450 relative to the plane of the fish; if the fish's eye were a clock, the syringe was
placed pointing at the 7:00 position of the eye and inserted 1-2 mm into the tissue.
Following the injection, the fish was allowed to recover in fresh water for 7 days prior
to photoconversion experiments.
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6.2.5 Fluorescence Microscopy
Confocal fluorescence microscopy was performed using a commercial inverted micro-
scope (Olympus FV1000 IX81, Tokyo, Japan). All image data was recorded with a
bit depth of 12, i.e. pixel intensities had a dynamic range from 0 to 4095. The 635 nm
continuous wave (CW) laser line was used as the excitation for both standard and
photoconverted DiR for all imaging experiments. Lambda-scan image stacks were
acquired from 650 nm to 790 nm in 5 nm steps, with a spectral bandwidth of 10 nm
at each step.
In the case of the in vivo xenograft model, cellular fluorescence was captured
sequentially: signals emitted between 650 nm and 690 nm were first recorded, followed
by the fluorescence from 760 nm to 800 nm. Z-stacks were acquired over a depth of
300 pm with a step size of 10 pm, using the fish's eye as a fiducial marker to ensure
the same field of view was revisited at each experimental time point.
6.2.6 Photoconversion
A femtosecond pulsed laser source tuned to a center wavelength of 750 nm (Spectra-
Physics InSight DeepSee, Santa Clara, CA) was used to photoconvert the DiR label
[41]. The laser light was routed into the optical input port of the confocal microscope
described in Sec. 6.2.5. The total power at the output of the microscope objective
was kept below 25 mW for all imaging experiments, whether in vitro or in vivo. The
pixel dwell time was limited to 4 ps/pixel, resulting in an approximate scan time of
1 second per frame for a region 512 x 512 pixels in size. Each ROI was thus raster-
scanned over the course of 15 to 30 seconds in order to achieve complete and uniform
photoconversion of the DiR label across the entire field of view.
6.2.7 Image Analysis
All image analysis was performed using Matlab R2017a (MathWorks, Natick, MA).
In order to generate the fluorescence emission profiles of standard and photoconverted
DiR, the pixel intensities of each image slice within a given lambda-scan were summed
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together. Thus, each spectral image stack was reduced in size from 512 x 512 x 29
pixels to a single 29-element vector, with each element corresponding to the total
fluorescence intensity from the entire field of view within a given 10-nm spectral
window. A similar process was used to obtain the emission profiles of specific regions
of interest within a field of view, where the pixels strictly within the ROI were summed
together.
For the xenograft model, given that the z-stacks were acquired sequentially (650-
690 nm first, followed by 760-800 nm), image registration was required to properly
align the two datasets. To facilitate this process, maximum intensity projections
were computed for both z-stacks to generate 2D renditions of the 3D datasets. The
projections were then smoothed using a 2D Gaussian kernel with a standard deviation
of 0.75. The corresponding fluorescent signals from the 650-690 nm and 760-800 nm
channels were then visually matched on a cell-by-cell basis using the control point
selection tool in Matlab (cpselect(). For each image pair, 150 to 250 control point
pairs were manually identified. Next, a geometric transform was computed to fit the
control point pairs via a local weighted mean transformation with 50 nearest points
using the fitgeotrans() Matlab function.
The processed fluorescence intensity images were then overlaid, with the 650-690
nm channel in green (G) and the 760-800 nm channel in red (R), thus generating the
images in the top row of Fig. 6-5. The scatter plots in the middle row were gener-
ated by plotting each pixel's green channel intensity against that of its red channel,
resulting in data representation visually reminiscent of flow cytometry scatter plots.
Finally, the fluorescent signals were gated using two experimentally-derived crite-
ria to generate the discrete images in the bottom row. First, a pixel was identified
as containing DiR if the combined intensity exceeded exceeded a threshold, i.e. if
G + R > Thesh. Next, if G > R/3 + Subthresh then the DiR was classified as
photoconverted; if G < R/3 + Subthresh, then it was considered standard, i.e. its
native non-converted form. In this manner, pixels that remained black were deter-
mined not to contain any detectable levels of DiR. On the other hand, pixels that
were either green or red were classified as containing photoconverted or standard DiR,
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respectively.
6.3 Results and Discussion
6.3.1 Photoconversion in Monolayers In Vitro
Ovarian cancer cells (OVCAR5) were first grown in vitro and allowed to reach conflu-
ence before labeling with DiR. Upon illumination with 635 nm laser light, the bright
fluorescence signals observed from the stained cells revealed the two characteristic
DiR emission peaks located around 660 nm and 760 nm as can be seen in the plotted
emission spectra in Fig. 6-1. By encoding every probed emission wavelength from the
scan to a color scale element from Matlab's "hot" color map, the two standard DiR
peaks result in a vivid yellow false color. On the other hand, photoconverted DiR
exhibits 2 notable spectral features that distinguish it from its standard counterpart:
(1) a marked increase in fluorescence emission at 660 nm, and (2) the elimination
of the second peak at 760 nm. This results in a dark red false color, allowing for a
simple and intuitive visual distinction between converted and unconverted cells.
Building upon these results, fresh OVCAR5 cells were newly plated and stained
with DiR prior to imaging with 635 nm illumination. A single region of interest (ROI)
636 pim x 636 pm in size (i.e. a full field of view at 20x magnification) was photo-
converted on Day 0, where Fig. 6-2(a) and Fig. 6-2(b) show the ROI before and after
photoconversion, respectively. The same ROI was then revisited daily over the next 48
hours and imaged at both 10x and 20x magnification (Fig. 6-2(c-f)). As expected,
the cells were observed to be growing normally and retained sufficient amounts of
the DiR dye to generate readily detectable fluorescence signals despite multiple cell
divisions. Interestingly, after 48 hours following the initial seeding, labeling, and pho-
toconversion, the borders of the ROI became blurred as cells labeled with standard
DiR are seen to infiltrate the area and, conversely, cells with photoconverted DiR are
observed to expand beyond their site of origin.
Given the permanent spectral shift, this methodology can be widely used in in vitro
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Figure 6-1: In vitro monolayer model of ovarian cancer showcasing the fluorescence
of DiR before (a) and after (b) photoconversion, with associated fluorescence spectra
summed across the entire field of view (c).
settings where temporal dynamics are of particular scientific interest. For example,
cell lines genetically modified with the ability report the expression of a gene of
interest using fluorescent proteins can all be uniformly stained with DiR. Then, cells
that do express the reporter protein can be photoconverted in situ while imaging to
permanently mark which individual cells within the heterogeneous population express
the gene of interest on Day 0. In this manner, this subpopulation of interest can be
monitored within the context of its heterogeneous environment over a time course
spanning several days or even weeks as it is challenged with various therapeutic
strategies. This methodology would therefore allow one to monitor the genetic state
of specific individual cells over time, offering insight pertaining to the expression
dynamics of the gene of interest. This methodology can also be applied to cellular
co-cultures in order to monitor key interaction parameters of interest between specific
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members of either cell population.
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Figure 6-2: Longitudinal monitoring of an ovarian cancer cell subpopulation of in-
terest, seen before (a) and after (b) photoconversion on Day 0. The same field of
view was revisited 24 hours (c,d) and 48 hours (e,f) following the photoconversion
process to monitor the cellular proliferation over time. All scale bars correspond to
100 pm. Images in (a,b,d,f) and (c,e) were acquired at 20x and 10x magnification,
respectively.
6.3.2 Photoconversion in 3D Spheroids In Vitro and FACS
While cellular monolayers cultured in vitro are advantageous for study given their
ease of use and simplicity, they are not representative of cancer in vivo. Indeed, in-
teractions with extracellular matrix elements and neighboring cells in all three spatial
dimensions can significantly influence tumor pathophysiology. Three-dimensional in
vitro tumor culture models can replicate many of the molecular and structural fea-
tures of human tumors, and therefore offer a convenient middle ground between in
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vitro monolayer cultures and live animal experiments in vivo [243].
There are many situations where a specific subpopulation of cells within a tumor
spheroid may be of interest. For instance, one may want to differentiate between
the cells located towards the core of a spheroid rather than those on its periphery to
study biochemical pathways related to hypoxia in the context of cancer pathogenesis
[243, 244, 247]. Alternatively, one may expose cultured tumors to particular chemical
gradients in order to model the diffusion of therapeutic compounds, and study the
resulting tumor response at the cellular population level. In such cases, the ability
to visualize, target, and permanently label a portion of the studied tumor would be
of significant value, as it would allow one to correlate longitudinal observations with
spatially-resolved subpopulations of interest within a tumor throughout its develop-
ment.
In order to demonstrate this application, OVCAR5 cells were grown on a bed of
Matrigel, a commercially available gelatinous culture substrate that mimics extracel-
lular matrix and favors the formation of 3D spheroids [243, 244]. Once these cellular
clusters reached a few hundred microns in diameter, a subpopulation of cells along
the topmost peripheral section of a tumor spheroid was targeted for photoconversion
as seen in Fig. 6-3. An ROI defined within the targeted area revealed the signature
twin peaks of standard DiR at 660 nm and 760 nm prior to photoconversion. Fol-
lowing the conversion process, the second peak was found to disappear while the first
peak's signal increased as expected (Fig. 6-3(c)). In examining a second ROI defined
outside the targeted area, the emission signature of standard DiR was preserved all
throughout the procedure. Some minor photobleaching was observed and helps to
explain the modest drop in fluorescence signal.
Given a partially photoconverted tumor spheroid where the optical contrast per-
manently identifies specific cells of interest, it follows that a manner for isolating
said cells for subsequent expansion and study would be of great practical value. For
example, in the context of ovarian cancer metastasis, spheroids are known to spread
intraperitoneally and continue growing at distant sites along the walls of the peri-
toneum [243]. Here, one may seek to optically label the cancer cells in contact with
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Figure 6-3: 3D tumor spheroid of ovarian cancer cells before (a) and after (b) photo-
conversion of the topmost peripheral region indicated by the gray box. Two regions
of interest (ROI) have been selected within the image, where ROI #1 encompassed
photoconverted cells while ROI #2 did not. The corresponding fluorescence spectra
are shown in (c), where solid and dashed lines refer to ROIs #1 and #2, and diamonds
and circles refer to before and after photoconversion, all respectively.
the endothelial cells along the peritoneal walls to later study their protein expression.
To demonstrate the applicability of this platform for such a scenario, 3D in vitro
spheroids of OVCAR5 cells were grown across the entire surface of a glass-bottom
dish filled with Matrigel-rich media and cultured over the course of 2 weeks. This
favored the formation of hundreds of spheroids that are each comprised of many
hundreds more cells [243, 244]. After registering the location of each spheroid via
visual microscopy inspection, the photoconversion routine was automated. At each
location, the external pulsed 750 nm laser light was used to illuminate a coarsely-
defined z-stack through approximately one half of the spheroids. They were then
disaggregated and prepared for cell sorting via FACS.
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The fluorescence captured from a representative sampling of the disaggregated
tumor cells revealed two distinct populations of labeled cells as shown in Fig. 6-
4(a). The fluorescence intensity from the NIR emission band of DiR is shown on the
horizontal axis, while the vertical axis indicates red fluorescence, which is markedly
increased upon photoconversion. Following the sorting process via FACS, the isolated
non-converted and photoconverted cells were plated and cultured as shown in Fig.
6-4(b,c). These results show that not only was the DiR label retained in the cell
membrane despite the multiple processing and handling steps, but both its standard
and photoconverted forms were present at readily detectable levels. Moreover, the
spectral shift following the photoconversion process was indeed found to be permanent
and irreversible, as verified in Fig. 6-4.
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Figure 6-4: FACS plot of a cell sample from disaggregated, partially photoconverted
ovarian cancer spheroids (a), and subsequent seeding of sorted non-converted (b) and
photoconverted (c) cells. The fluorescence spectra from the sorted cells are shown in
(d), demonstrating the irreversible nature of in situ DiR photo conversion.
This methodology is therefore particularly applicable in contexts where an es-
pecially small subpopulation of cells are of interest for subsequent experimentation.
Using in situ photoconversion, these cells can be isolated via FACS and then expanded
in vitro to generate large numbers of cells from the subpopulation of interest.
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6.3.3 Photoconversion in Zebrafish Xenograft Model In Vivo
Finally, in the context of in vivo imaging, there are many scenarios where the labeling
of one cellular subpopulation of interest may be of use. One such example is that of
lineage tracing in the context of metastasis: given an initially heterogeneous popula-
tion of cells within the primary tumor, there is a persistent and challenging need to
identify which ones are the first to spread; which ones divide most rapidly; and which
cell subpopulations grow and expand despite therapeutic administration.
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Figure 6-5: In vivo longitudinal monitoring of a photoconverted subpopulation of
melanoma cells indicated by the gray box in a zebrafish xenograft model following in
situ photoconversion. In all images, the eye is located at the bottom-left of the field of
view and was consistently used as a fiducial marker throughout the experimental time
course to ensure monitoring of the same area over time. The top row shows a colored
overlay of the two collected fluorescence emission bands, namely 650-690 nm in green
and 760-800 nm in red. The middle row shows a scatter plot of each pixel, where
green and red channel intensities are plotted against one another in order to generate
a representation visually reminiscent of flow cytometry plots. The red dashed lines in
the scatter plots correspond to the gating criteria to identify pixels containing either
photoconverted or standard DiR. These gates are then used to recolor the images
from the top row, where the images in the bottom row show photoconverted and
standard DiR fluorescence in green and red, respectively.
In order to better model such a scenario, melanoma cells were first cultured and
labeled with DiR. They were then injected retro-orbitally in zebrafish to produce
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melanoma xenograft models in vivo. After 7 days, the fish were anesthetized and
imaged using confocal fluorescence microscopy with 635 nm illumination to visualize
the implanted DiR-labeled melanoma cells behind the eye as seen in the leftmost
column of Fig. 6-5 (top panel). A small field of view roughly 364 Am x 364 Am in
size containing several tens of cells was then arbitrarily selected for photoconversion.
The overlay in the second column of Fig. 6-5 shows the 760-800 nm intensity in red,
while the 650-690 nm signal is shown in green.
The added convenience of such a platform is that images can be processed in a
manner similar to flow cytometric analysis, where pixel intensities can be shown in
a scatter plot that visually relates one channel's intensity to that of the other. This
familiar data representation then allows for a straightforward gating of the fluores-
cence signals to identify cellular subpopulations of interest over time in a wide variety
of platforms ranging from in vitro to in vivo. Indeed, as can be appreciated in the
bottommost row of Fig. 6-5, the initial cluster of cells within the photoconverted
ROI is clearly visualized on Day 0 and is then seen spreading over the course of the
following week, reaching areas far beyond the original photoconversion site. This
demonstration is of particular value in the context of in vivo animal models of metas-
tasis, where one may photoconvert cells at the primary tumor site that are more or
less likely to metastasize. As tumors then form at distant anatomical sites, their spec-
tral signatures would allow one to infer specifically which cells from the heterogeneous
primary tumor were the ones to metastasize. The major advantage of this approach,
in particular for patient xenograft studies, is that this photoconversion method does
not require cellular genomic manipulation as is the case with fluorescent reporters.
Cells never have to be transformed, grown on hard plastic surfaces, or exposed to cell
culture conditions to prepare for photolabeling. This has the advantage of preserving
tumor cellular heterogeneity and may allow for photoconversion techniques to be used
with minced tumor implantation models [248].
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6.4 Conclusion
The advent of photoconvertible dyes in the context of biomedical imaging has pro-
vided the optics community with a toolkit that allows for the selective labeling of a
specific cellular subpopulation of interest where the parameter of interest is identified
visually in situ. This predictable and convenient conversion process, non-invasively
triggered via an external pulsed near-infrared laser source, is further perpetuated
to the daughter cells of the converted targets thus greatly facilitating longitudinal
studies of heterogeneous cell populations.
The implications for future avenues of research are numerous. Combining this
NIR photoconversion methodology with in vivo flow cytometry in an animal model
[249, 250, 251], for example, would allow one to not only count the number of cells
circulating within a particular vascular network, but to identify which cells have
already been counted by triggering 750 nm pulsed light irradiation for photoconversion
following each detection of a circulating non-converted cell. The DiR labeling the cell
would thus be permanently photoconverted and would allow one to obtain highly
accurate counts of circulating cells by avoiding repetitious counts.
In another scenario, one may seek to characterize the in vivo response to therapy
of a growing tumor exposed to injected therapeutics. For instance, animal models
fitted with window chambers for direct observation of the implanted tumor may be
imaged periodically over a defined time course to study the response of individual
cells to the therapy over time [252, 253]. By photoconverting responsive (or non-
responsive) cells at particular time points in the days and weeks following treatment,
a more complete portrait of therapeutic response in the context of cancer treatment
can be ascertained.
It is worth noting that the photoconversion of DiR can be completed within
seconds rather than minutes of raster-scanning across the targeted area. This can
greatly accelerate experimental protocols compared to the use of other photoconvert-
ible agents such as Dendra2 that require conversion times on the order of several
minutes in addition to genetic engineering [254, 255]. The simplicity of the presented
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approach, where labeling merely requires a brief incubation period in the presence
of the dye without harsh permeabilizing agents, can be easily adopted by scientists
with minimal experience using photobiological assays. The potential applications of
photoconversion technology in the field of cancer research are thus widely diverse,
given the minimally invasive nature and simplicity of the presented methodology.
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Chapter 7
In Vivo Imaging of the
Melanomagenesis-Associated
Pigment Pheomelanin Using
CARS and SFA
7.1 Introduction
The yearly global incidence of melanoma is over 232,000 individuals, with more than
55,000 of those diagnosed succumbing to the disease [100]. Individuals with fair skin
and red hair exhibit the highest risk for developing melanoma [256], with evidence
suggesting the red/blond pigment known as pheomelanin may elevate melanoma risk
through both UV radiation-dependent and -independent mechanisms. Moreover, red-
haired melanoma patients often develop amelanotic lesions, so-called due to the ab-
sence of macroscopically detectable dark eumelanin pigments within the visible tumor
margin. Because they are harder to recognize upon examination, these tumors are
frequently diagnosed at more advanced stages and are associated with higher mor-
tality [257]. Similar amelanotic melanomas arise in mice bred on the Mclre/e genetic
background, which recapitulates the red-haired, fair-skinned phenotype. The non-
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visible pheomelanin in these lesions was found to functionally contribute to melanoma
formation, as the introduction of an albino allele onto the same genetic background
abrogated melanoma risk [258]. Although the ability to identify and monitor pheome-
lanin within skin is vital to improve our understanding of the underlying biology of
these lesions, no tools exist for real-time, in vivo characterization of the pigment.
Studies using Raman spectroscopy to explore the pigment of red bird feathers pre-
viously suggested that a unique vibrational band centered between 2000-2100 cm 1
may be a marker for pheomelanin. However, it was not clear if this weak vibrational
resonance could be used for in situ identification of the red pigment. Coherent anti-
Stokes Raman scattering (CARS) microscopy, a label-free vibrational imaging tech-
nique based on Raman scattering, offers significantly enhanced signal levels compared
to spontaneous Raman scattering, and may be suitable for non-invasively identify-
ing pheomelanin inside the skin in real time. Here, we show that the distribution
of pheomelanin in cells and tissues can be visually characterized non-destructively
and non-invasively in vivo with CARS microscopy. We validated our CARS imaging
strategy in vitro to in vivo using synthetic pheomelanin, isolated melanocytes, and
the Mclre/e red-haired mice model. Nests of pheomelanotic melanocytes were ob-
served in the red-haired animals, but not in the genetically matched Mclre/e; Tyrc/c
("albino-red-haired") mice. Importantly, samples from human amelanotic melanomas
imaged with CARS microscopy exhibited strong pheomelanotic signals. This is the
first time, to our knowledge, that pheomelanin has been visualized and spatially lo-
calized in melanocytes, skin, or human amelanotic melanomas.
7.2 Results and Discussion
7.2.1 Synthetic Pheomelanin
To demonstrate that CARS microscopy can selectively and sensitively visualize pheome-
lanin, the pigment was synthesized following an established procedure that makes
use of the mushroom tyrosinase enzyme [259]. When distributed as small particles
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in a water/hexane emulsion, synthetic pheomelanin was found to yield a very strong
CARS signal whose vibrational spectrum corresponds to that observed with Raman
spectroscopy (Figure 7-1) [260, 261].
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Figure 7-1: Synthetic pheomelanin in a 4:1 water:hexane emulsion. (a) CARS image
acquired at wpws = 2000 cm-1 . Pheomelanin is observed as small, insoluble aggre-
gates with bright CARS intensity. The surrounding water/hexane bubbles show low-
level non-resonant CARS background. (b) Trans-illumination image acquired with
the 861 nm pump beam. (c) CARS spectrum of synthetic pheomelanin referenced
to the wavelength-independent non-resonant signal from a glass coverslip, normalized
by area under the curve. Three synthetic pheomelanin samples were measured, with
each spectrum shown in gray; the curve in red corresponds to the mean of the three
measurements.
7.2.2 Pheomelanin in FACS-Sorted Mouse Melanocytes
With the ability to visualize and spectroscopically confirm the presence of pheome-
lanin using CARS microscopy, the next step was the detection of naturally-occurring
phcomelanin. Red-haired mice (Mclr'/e) were bred to incorporate B6.Cg-Gt(ROSA)
2 6 Sortm6(CAG-ZsGreen1)Hze (Jackson Laboratory catalog #007906) or B6.Cg-Gt(ROSA)
2 6 Sortm9(CAG-tdTomato)Hze (Jackson Laboratory catalog #007909) and melanocyte tar-
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geted CRE (Tyr-CRE) [262], thereby enabling FACS-based isolation of neonatal Zs-
Green or tdTomato fluorescent tagged melanocytes. A detailed protocol regarding
melanocyte extraction can be found in Section 7.3.6. The tdTomato mice were sacri-
ficed, their skin harvested, and dermal cells sorted based on fluorescence of both td-
Tomato and FITC-labeled antibodies tagging c-Kit, a surface marker [263]. ZsGreen-
labelled mice underwent a similar procedure, with melanocytes selected via their
ZsGreen and c-Kit signals. The sorted melanocytes were fixed, and imaged with both
CARS and confocal fluorescence microscopy.
As shown in Figure 7-2, pheomelanin signals exhibited the predicted perinuclear
localization of melanosomes. As a control, genetically matched tdTomato-tagged,
tyrosinase-deficient (Mclre/e, Tyrc/c) "albino-red-haired" mouse-derived melanocytes
were subjected to the same analysis and no visible pheomelanin signals were observed
(Figure 7-3). Importantly, CARS spectra acquired from the red-haired mice, but not
the albino red-haired mice, matched CARS spectra collected from synthetic pheome-
lanin, confirming the ability of coherent Raman scattering imaging to selectively
visualize the red pigment within cells.
7.2.3 Ex Vivo, In Vivo, and Histological Visualization of
Pheomelanin in Mouse Skin
With the evidence that pheomelanin may be selectively visualized in isolated geneti-
cally defined cells, we explored the detection and localization of pheomelanin within
intact mouse skin. Ex vivo ear skin from C57BL/6 (Mclre/e, Tyr+/+) red-haired mice
proved to be an advantageous sample, as brightfield images acquired alongside CARS
could be used to verify the location of melanin within the tissue. Under the eyepiece,
pheomelanotic cells in the thin ear skin appeared brown-red, with visible cell bod-
ies and dendrites (Figure 7-4). Individual pheomelanin-containing organelles were
distinctly visualized via CARS imaging and co-localized with the pigmented areas
observable by brightfield microscopy.
To translate these findings, CARS imaging was carried in vivo on red-haired mouse
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Figure 7-2: Melanocytes isolated from red-haired C57BL/6 (Mclre/e, Tyr+/+) mice
exhibit strong CARS signal at Wp - Ws = 2000 cm-'. (a) Trans-illumination image
acquired with the pump beam, where the overall shape of the cells can be well vi-
sualized. (b) Confocal fluorescence image of tdTomato. (c) False color (Green fire
blue colormap in ImageJ) CARS image mapping intracellular pheomelanin distribu-
tion. (d) 4x-zoomed view of (c) showing a perinuclear distribution of signal intensity,
consistent with the known biology of protective melanin caps.
(Mclre/e, Tyr+/+) ears. Identical patterns of pheomelanin-rich cells were found (Fig-
ure 7-5). Importantly, these ex vivo and in vivo experiments were repeated for both
control albino-red (Mclre/e, Tyrc/c) and albino (Mclr+/+, Tyrc/c) mice: no visible
pheomelanin signals could be observed in the skin of these animals.
To confirm these measurements and positively identify the observed pheomelanin-
rich cells as melanocytes, thin sections (5 pum in thickness) were prepared from
Mclre/e, Tyr+/+ red-haired mouse ears for histology and immunohistochemistry (IHC).
As the red fluorescence from eosin was found to interfere with the CARS signal,
immunostained slides where accompanied by an adjacent unstained slide for coher-
ent Raman imaging. Sry-related HMG-BOX gene 10 (SoxIG) is a nuclear tran-
scription factor that participates in neural crest development and in the specifica-
tion and differentiation of cells of the melanocytic lineage. Soxl0 is expressed in
Schwann cells and melanocytes/melanomas [2641, making it a specific marker for
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Figure 7-3: Melanocytes isolated from albino-red C57BL/6 (Mclre/e Tyrc/c) mice
exhibit negligible CARS signal at wp-ws = 2000 cm- 1. (a) Trans-illumination image
acquired with the 861 nm pump beam. (b) Confocal fluorescence image of tdTomato.
(c) False color CARS image acquired with pump (Ap = 861 nm) and Stokes beams
(As = 1040 nm). (d) False color image acquired only using the pump beam, showing
prominent two-photon fluorescence signals from tdTomato. (e) False color image
acquired only using the Stokes beam, showing weak two-photon fluorescence signals
from tdTomato. (f) False color image illustrating the true CARS signal obtained by
subtracting tdTomato fluorescence in (d) and (e) from the raw CARS image in (c).
dermal melanocytes. Figure 7-6(a) shows IHC staining for Sox1O (EP268, Cell Mar-
que), where the pheomelanin-containing melanocytes were found to be Sox1O positive.
Pheomelanin stores inside the red-haired mouse skin can also be seen under bright-
field illumination in the adjacent unstained slide, as shown in Figure 7-6(b). When
imaging the same unstained slide with CARS targeting the pheomelanin vibrational
band, bright pheomelanin signals were found corresponding to the pigmented areas
seen under brightfield and in the SoxlO positive areas via IHC. A separate experiment
was also conducted to image a different mouse ear sample without IHC staining, such
that CARS imaging can be performed directly on the haematoxylin-stained slice. As
shown in Figure 7-7, pheomelanotic stores are observed as bright granular structures,
consistent with imaging data shown in Figure 7-6.
In order to further cross-validate the pheomelanin signals from the CARS im-
ages, we also simultaneously performed sum frequency absorption (SFA) imaging in
a multimodal configuration, where SFA microscopy is an imaging toolkit that enables
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Figure 7-4: Imaging of pheomelanin stores in red-haired mouse ear skin. (a,c,e)
Brightfield trans-illumination image acquired from the microscope eyepiece. (b,d,f)
Maximal projection view of CARS image stack of the mouse ear, showing bright
granules from the pheomelanin stores (red circles) within melanocytes and at the
base of the hair follicle. A CARS image stack acquired with the pump beam set to
871 nm (Wp - ws = 1866 cm-1 ) was subtracted from the image stack acquired with
the pump beam set to 861 nm (Wp - Ws = 2000 cm- 1 ) to minimize the non-resonant
signal contribution from structures other than pheomelanin. Image stacks are 27 Pm
thick, with a step size of 1 pm. Note that an out-of-focus hair (blue arrow) caused a
shadow in the trans-illumination image (a), whereas CARS is highly depth-resolved;
therefore, the hair was not prominently seen in (b).
the visualization of light-absorbing molecules like pheomelanin [46, 49]. This optical
process is characterized by a molecule's ability to simultaneously absorb two photons
without the necessary involvement of an intermediate real energy level between the
ground state and the final excited state. The signal was confirmed to arise from
SFA and not stimulated Raman scattering (SRS) by tuning the pump wavelength
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(a)
Figure 7-5: Imaging of pheomelanin stores in a red-haired mouse ear in vivo. (a)
Brightfield trans- illumination image acquired from the microscope eyepiece. (b) Max-
imal projection view of CARS image stack of the mouse ear, showing bright signals
from pheomelanin (red circle). A CARS image stack acquired with the pump beam
set to 871 nm (Wp - ws = 1866 cm 1 ) was subtracted from the image stack acquired
with pump beam set to 861 nm (Wp - s = 2000 cm-) to minimize the non-resonant
signal contribution from structures other than pheomelanin. The image stack in (b)
is 15 pum thick, with a step size of 1 pm.
across the expected pheomelanin Raman band. As no variation in signal intensity
was observed, the signal was determined to arise solely from absorption contrast.
As shown in Figure 7-6(e) and (f), a one-to-one correlation can be found between
CARS and SFA images, indicating that pheomelanin within melanocytes can indeed
be well visualized using CARS microscopy. It should be noted that the overlap of
the CARS and SFA images with Figure 7-6(a) is not perfect, as each tissue slice is 5
pm thick. Moreover, the signal-to-noise ratio in the image shown in Figure 7-6(d) is
reduced compared to that obtained in tissue due to the configuration of the imaging
system: as the position of the CARS detector is in the epi-direction, the collected
signal depends in part on back-scattering in order to redirect the forward-generated
anti-Stokes light back into the microscope objective. Considering the 5 pm thickness
of the tissue slice, the CARS image quality in this scenario does not benefit from
the scattering properties of thick biological samples that would otherwise generate a
much stronger signal [28]. It is also possible that the actual amount of pheomelanin
in thin tissue slices is slightly diminished relative to intact tissue as a result of the
frozen section preparation itself. Nevertheless, the consistency in spatial localization
between the signals observed in Figure 7-6(d) and (e) indeed supports the ability of
CARS microscopy to specifically visualize pheomelanin in a label-free manner.
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Figure 7-6: Imaging of pheomelanin stores in a red-haired (C57BL/6 (Mclre/e,
Tyr+/+) mouse ear section (5 gm thickness). (a) Immunohistochemical stain of the
mouse ear slide using anti-Sox-10 antibody (counterstain: haematoxylin), revealing
melanocytes in red, some of which are indicated by black arrows for added clarity.
(b) Image of an adjacent unstained 5 pym thick slide under brightfield illumination,
revealing pheomelanin-rich deposits (shown by black arrows) consistent with the lo-
calization of the melanocytes in the adjacent slide shown in (a). (c) Trans-illumination
image of the unstained slide shown in (b) acquired with the pump beam set to 861
nm. (d) CARS and (e) SFA images of the unstained slide shown in (b), revealing
bright granular signals from pheomelanotic stores consistent with positive staining in
(a) and pigmented areas in (b). (f) False-color overlaid image of (d) in green and (e)
in red. A CARS image acquired with the pump beam set to 871 nm (wp -WS = 1866
cm-1) was subtracted from the image acquired with the pump beam set to 861 rim
(WP - ws = 2000 cm- 1) to minimize the non-resonant signal contribution from struc-
tures other than pheomelanin.
7.2.4 Pheomelanin Detection in Human Amelanotic Melanoma
With evidence showing that pheomelanin can be non-invasively visualized in syn-
thetic, in vitro, ex vivo, and in vivo settings, we investigated whether pheomelanin
could be visualized in human specimens, specifically in the context of amelanotic
melanoma. This melanoma subtype is characterized by its lack of traditional brown-
black pigmentation upon visual inspection, typically presents as a raised lesion on
the skin that is reddish in color, and can easily be misdiagnosed due to its lack
of dark pigmentation [265]. While the terminology seemingly implies the lack of
any pigmentation, it is unclear whether some amelanotic melanoma lesions actually
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(a)
Figure 7-7: Imaging of pheomelanin stores in a red-haired mouse ear section (5
pm thickness). (a) Brightfield trans-illumination image of the haematoxylin-stained
mouse ear slide. (b) Magnified view of the area marked by a red square in (a).
Pheomelanotic stores are seen as slightly pigmented granules. (c) CARS image of
the same field of view as (b), showing bright granular signals from pheomelanotic
stores corresponding to the pigmented areas in (b). A CARS image acquired with
the pump beam set to 871nm (Wp - s = 1866 cm-') was subtracted from the image
acquired with the pump beam set to 861 nm (up - Ws = 2000 cm-') to minimize the
non-resonant signal contribution from structures other than pheomelanin.
do harbor stores of pheomelanin that are simply indistinguishable from surrounding
healthy skin. Moreover, recent studies [258] have indicated the oncogenic potential of
pheomelanin in red-haired and fair-skinned backgrounds, raising the possibility that
at least some seemingly unpigmented melanoma lesions may contain pheomelanin,
but are undetectable to the naked eye. CARS imaging and spectroscopic measure-
ments were performed on fixed and unstained sections (10 pm in thickness) from three
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cutaneous amelanotic melanoma specimens. One such lesion can be seen in Figure
7-8(a) along with its corresponding H&E cross-section. Inspection of normal, healthy
perilesional skin with CARS (Figure 7-8(c-e)) did not reveal detectable pheomelanin.
Within the amelanotic melanoma lesion, however, strong pheomelanin CARS signals
were observed indicating a high density of pheomelanin (representative images shown
in Figure 7-8(f-h)). Pheomelanin was ultimately detected in all three patient samples
imaged, with representative images from a second patient shown in Figure 7-8(i-k).
This suggests that amelanotic melanoma lesions can indeed contain dense stores of
pheomelanin, which may be detected non-invasively using CARS imaging.
It should be emphasized that the number of human samples surveyed in this work
was limited to three, corresponding to the total number of amelanotic melanoma
tissues available for study. In order to truly determine the incidence of pheomelanotic
melanoma lesions among those diagnosed as "amelanotic", this proof-of-concept work
will have to be expanded into a broader study: one where multiple CARS image stacks
taken from a large patient cohort will be processed and statistically analyzed to gain
insight that can impact clinical practice.
Indeed, it has been proposed that an intrinsic pheomelanin pathway may rep-
resent a biologically significant contributor to melanomagenesis [258]. Building a
complete understanding of this contribution, however, has been hampered by an in-
ability to spatially map and quantify pheomelanin within skin. While the detection
and differentiation of melanins has been accomplished using pump-probe microscopy
[48, 49, 266, 50], measurements of pigments' excited state can be complicated by
compounds in the local environment (e.g. metals such as iron). Moreover, distin-
guishing melanin subtypes using pump-probe microscopy requires the acquisition of
so-called "delay stacks", where images are sequentially acquired with varying time
delay between the pump and probe beams in order to obtain transient absorption
traces on a pixel-by-pixel basis. From there, melanin subtypes can be differentiated
using post-processing techniques such as principal component [49] or phasor analyses
[50]. However, each frame typically requires an acquisition time of several tens of
seconds, leading to a total acquisition period ranging from 5 to 15 minutes for a sin-
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(9)
Figure 7-8: Imaging of human amelanotic melanoma. (a) Clinical photograph of one
amelanotic melanoma lesion. (b) H&E stain of the patient slide (10x magnification).
(c) Perilesional skin showing normal architecture of both epidermis and dermis. (d)
Brightfield trans-illumination image acquired from the microscope eyepiece from the
perilesional area. (e) CARS image of the same perilesional area compared to (d)
(image acquired with pump beam wavelength at 841 nm (Wp - ws = 2275cm- 1 )
was subtracted from the image acquired with pump beam wavelength at 855 nm
(Wp - WS = 2081 cm- 1) to minimize the non-resonant background from structures
other than pheomelanin). (f) View of the amelanotic melanoma area showing high
density of cells with no obvious sign of melanin. (g) Brightfield trans-illumination
image acquired from the microscope eyepiece from an unstained slide of the melanoma
area, showing slightly pigmented granular structures (red circle). (h) CARS image of
the same tumor area compared to (g), with the same settings as for (e). Saturated
bright pheomelanin signals were found (red circle) corresponding to the minimally
pigmented region shown in (g). (i,j,k) Respectively H&E, trans-illumination, and
CARS images of the tumor area of slides from a second amelanotic melanoma patient.
Strong pheomelanin signals were again observed (red circles).
gle delay stack [50]. On the other hand, CARS imaging offers a specific, direct, and
facile route for the detection of pheomelanin in vivo in real-time, since the detected
signal arises from the generation of a new color of light mediated by the pheomelanin
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pigment itself. In this regard, CARS microscopy offers many of the same benefits as
multiphoton microscopy: the signal can be readily detected using an appropriate set
of laser sources and optical filters, and has additionally been shown to operate up to
video-rate imaging speeds [267].
Prior investigation of melanin pigments using spontaneous Raman spectroscopy
found pheomelanin to harbor three broad vibrational peaks at 500, 1490, and 2000
cm-1, while eumelanin was shown to have peaks at 500, 1380, and 1580 cm- [260,
261]. The first two peaks of pheomelanin as well as all those of eumelanin are located
within the fingerprint region of the Raman spectrum; they are therefore unlikely to
offer a straightforward route to highly specific detection of melanin pigment subtypes
in the native context of human skin, as vibrational peaks from other chemical species
would result in spectral interference. However, in the particular case of pheomelanin,
the broad vibrational peak of interest in this study is located in the 2000-2100 cm-1
range [260, 261], well within the so-called "silent region" of the Raman spectrum of
biological samples [28]. This spectral region, which ranges approximately from 1800
to 2700 cm- 1, is devoid of vibrational peaks that may arise from other endogenous
biochemical moieties, making this particular band of pheomelanin an ideal target
for future clinical CARS imaging with minimal interference from other compounds.
It is worth nothing that the use of deuterated chemical groups as Raman reporters
may interfere with pheomelanin imaging, as the carbon-deuterium vibrational band
is located around 2200 cm 1 . In this highly special case, the use of hyperspectral
coherent Raman imaging may be used to distinguish the peaks in the event of signal
overlap between pheomelanin and deuterated probes. It should also be noted that the
unlikely possibility of interference from eumelanin at the 2000-2100 cm- 1 band was
also investigated in the context of this study. Importantly, no coherent Raman signals
could be detected from eumelanin within the pheomelanin Raman band range (data
not shown), further strengthening the specificity of CARS for the direct visualization
of pheomelanin without interference from its eumelanin counterpart.
In this work, the use of multiple genetically controlled systems, including the Mclr
mutant mice and their corresponding albino/red-haired controls (Mclre/e, Tyrc/c),
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enabled confirmation of the CARS signal as specifically arising from pheomelanin
since these animal models are incapable of producing eumelanin [258]. Interestingly,
the strength of the observed anti-Stokes signal was far greater than anticipated based
on the previously published spontaneous Raman scattering data [260, 261], indicating
the possibility that the observed signal is resonantly enhanced [28].
Furthermore, for future work in translating this imaging modality for clinical stud-
ies, CARS microscopy has even been performed using a single laser source, where one
portion of the laser light was used as the pump beam, while the remainder was
routed through either a tapered fiber [268] or a photonic crystal fiber [269] in order
to generate the Stokes beam. This flexibility in terms of optical design in conjunction
with the chemical specificity offered by CARS imaging makes it a prime candidate
as an imaging tool for future clinical investigations in human patients. In fact, as
portable CARS systems are already commercially available [56], the translation of
the presented technology for further investigation in research or clinical settings can
be immediate and rapid. We believe this imaging approach will aid in improving
our biological understanding of skin changes in the context of pheomelanin, including
both UV-induced and UV-independent effects. This imaging approach may also help
to refine our understanding of which cutaneous lesions are truly "amelanotic" as op-
posed to those that may be "pheomelanotic" and currently invisible to the naked eye.
Additionally, the method may help to define inhomogeneously colored melanocytic
or non-melanocytic lesions, whose "unpigmented" regions might contain detectable
pheomelanin, and represent challenges in defining surgical margins. The ability to
identify such lesions non-invasively and non-destructively will enable future studies
investigating the impact of pheomelanin on melanoma formation, pathogenesis and
metastasis in different human skin types. The prospect of utilizing this method to
detect suspicious, pre-malignant lesions in high-risk (red-haired, fair-skinned) indi-
viduals, may offer new diagnostic tools able to translate knowledge from basic science
to clinical application.
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7.3 Materials and Methods
7.3.1 Mice
Mice with the Mclr frameshift mutant allele (Mclre/e) have a phenotype analogous
to red-hair/fair-skin in humans (also caused by non-functional alleles of MC1R) [258].
As a control, we crossed these mice to the albino allele (Mclre/e, Tyrc/c), which ablates
all melanin pigment production. All mouse strains were maintained on the C57BL/6
background.
7.3.2 CARS Microscopy
The CARS microscope was built over a customized confocal microscope (Olympus
FV1000, Center Valley, PA, USA), which has an additional laser entry port to ac-
cept external light sources. CARS microscopy was performed using a dual output
femtosecond pulsed laser system (Spectra-Physics Insight DeepSee, Santa Clara, CA,
USA), where the first output is tunable from 680 to 1300 nm, while the second is fixed
at 1040 nm. To achieve CARS imaging at the reported 2000 cm-- band of pheome-
lanin, the 1040 nm output was chosen as the Stokes beam (Ws), while the pump beam
(Wp) was set to 861 nm and 855 nm (Wp - ws = 2000cm- 1 and wp - Ws = 2081cm- 1 ,
respectively), in order to generate anti-Stokes signals at 735 nm and 726 nm, respec-
tively. A half-wave plate and a polarizer were placed at each of the two laser output
ports of the DeepSee system to adjust beam power. To focus the beams onto the
sample, a 1.20 NA 60x water immersion microscope objective (Olympus UPLSAPO
60XW, Center Valley, PA, USA) was used. The CARS signal was detected in the
epi-direction using both a shortpass and a bandpass filter (Chroma ET750sp-2p8 and
ET730/40m, Bellows Falls, VT, USA) placed in front of a thermoelectrically cooled
photomultiplier tube (Hamamatsu H7422PA-50, Hamamatsu City, Japan). The sum
power of the two beams at the objective was less than 10 mW for all experiments
performed in this study. In order to correct for the non-resonant background signal
generated in tissues, both resonant and non-resonant CARS images were obtained in
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order to subtract the non-resonant contribution from the resonant CARS images. To
this aim, the pump beam was tuned to either 841 nm or 871 nm (resulting in a Raman
shift of 2275 cm 1 or 1866 cm 1 , respectively). In both of these non-resonant imaging
settings, the background levels were found to be identical; the choice of tuning the
pump beam to 841 nm or 871 nm was therefore simply based on the convenience of
the experiment at hand. This correction was not necessary for cellular samples, as the
signal detected in the epi-direction contains minimal contribution from back-scattered
light and has inherently low non-resonant background [28].
7.3.3 SFA Microscopy
All SFA imaging experiments were performed simultaneously with CARS imaging on
the same system as described above, using the same wavelengths and power levels.
However, instead of detecting signal in the epi-direction, the SFA detector was placed
downstream of the sample in the trans-direction. The 1040 nm beam was modulated
at 20 MHz using an electro-optic modulator (ThorLabs EO-AM-R-20-C2, Newton,
NJ, USA), and the modulation transfer from the 1040 nm beam to the pump beam
was detected using a photodiode coupled to a lock-in amplifier (APE Lock-In Am-
plifier, Berlin, Germany). In order to restrict the light incident on the SFA detector
to only that of the pump beam, a shortpass filter (ThorLabs FES0950, Newton, NJ,
USA) was used to eliminate the 1040 nm light. Ordinarily, this detection setup would
be sensitive to stimulated Raman scattering (SRS) signals as well. However, it was
found that when imaging pheomelanin, the detected signal remained constant across
a range spanning 1866 to 2275 cm 1 . This observation was additionally confirmed
in synthetic pheomelanin samples, which showed the same temporal and wavelength
tuning properties as the pheomelanin detected in tissue samples. This suggests that
the signals obtained from pheomelanin are primarily a result of its absorptive prop-
erties, rather than its intrinsic vibrational modes.
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7.3.4 Preparation of Synthetic Pheomelanin
Pheomelanin was synthesized following the protocol published by d'Ischia et al. [259].
The synthesized pheomelanin was then lyophilized to yield a dense, reddish-brown
powder. To emulsify the pheomelanin, a small quantity (~0.1 mg) was placed in a 2
mL microcentrifuge tube, to which 1 mL H 20 and 0.25 mL hexane were added. The
resulting mixture was sonicated for two cycles of three minutes each to generate an
emulsion of pheomelanin microparticles. The sample was then sandwiched between a
glass slide and a coverslip with an imaging spacer (Grace Bio-Labs Secure-Seal, Bend,
OR). To prevent sample evaporation, the edges of the coverslip were sealed to the
glass slide with nail polish.
7.3.5 CARS Spectral Data Acquisition and Processing
In order to generate CARS spectra of pheomelanin samples, the pump wavelength
was tuned from 841 nm to 871 nm in single nanometer increments. For each wave-
length value, 3 images were acquired: the first with only the pump beam, the second
with only the Stokes beam, and the third with both. While the first two image sets
showed only minimal intensity, they nevertheless corresponded to the weak multipho-
ton fluorescence of pheomelanin and were thus subtracted from the CARS images to
isolate the coherent Raman signal. In order to normalize the CARS signal against a
neutral reference, the sample's glass coverslip was also imaged under the same con-
ditions. Glass produces a non-resonant background signal that is invariant across
the spectral range of interest, justifying its use as a reference to compensate for
wavelength-dependent intensity variations that may arise from the optical compo-
nents throughout the imaging system.
In order to generate the spectra, the 31 corrected CARS images were first summed
together, and the resulting image was binarized to generate a mask. The mask was
then applied to all CARS and glass images in order to isolate the regions corresponding
to pheomelanin. The masked CARS images were then divided by the masked glass
images on a pixel-by-pixel basis, and the resulting ratiometric values were averaged to
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obtain a single data point for a given wavelength. This process was iterated across all
31 sampled wavelengths, and the resulting spectra were normalized by the area under
the curve and multiplied by a factor of 30 (corresponding to n - 1 data points) such
that a flat spectral response was centered at a normalized value of 1 across the entire
spectral range. The experiment was performed in triplicate, where each individual
spectrum is plotted in gray and the mean of the three measurements is plotted in
red. As an added control, the analysis was repeated for the image background by
inverting the binary mask generated earlier. Given that the image background signal
arises from the non-resonant background generated by the water and hexane emulsion,
the analysis performed on the background revealed a flat spectrum centered at 1, as
expected.
7.3.6 Melanocyte Extraction
Two mouse strains were utilized to isolate neonatal cutaneous melanocytes: 1) Mclre/e-
K14-SCFTg+ [258]; Tyr-CreTg+ [262]: B6.Cg-Gt(ROSA) 2 6 Sortm9(CAG-tdTomato)Hze/J
(Jackson Laboratory catalog #007909) and 2) Mclre/e: K14-SCFTg+; Tyr-Cre:
B6.Cg-Gt(ROSA) 2 6 Sortm6(CAG-ZsGreen1)Hze/J (Jackson Laboratory catalog #007906)
were used as sources of neonatal pheomelanotic cutaneous melanocytes. The K14-
SCF transgene mimics human epidermal expression of SCF and enhances the yield
of cutaneous melanocytes [258]. Melanocyte targeted fluorescent tags were generated
using the constitutive Tyr:Cre transgene [262]. Neonates (day 2) were euthanized.
The truncal skin was peeled away and washed twice with PBS containing Pen:Strep
and Fungizone. The skin was then placed in a 60 mm tissue culture dish with 3 mL
of dispase (25 mg/mL) and placed in a 37'C, 5% CO2 incubator for 2 hours. The
epidermal layer was peeled away and incubated in another 60 mm tissue culture dish
containing 3 mL of 0.25% trypsin for 15 minutes at 37'C. The skin tissue was washed
in 10 mL of Hams F10 medium containing 10% FBS, ten times. The cells removed
using this procedure were then washed and suspended in PBS that contained DNAse
I (50 pg/mL) and 5 mM EDTA. The cells were sorted for the highest expression of
either tdTomato or ZsGreen in a BD FACSAria II SORP cell sorter. ZsGreen cells
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were excited with a 488 nm laser and detected with a 525/50 nm bandpass filter;
tdTomato cells were excited with a 561 nm laser and detected with a 582/15 nm
bandpass filter. To confirm the identity of the melanocyte population, the tdTomato
cells in another experiment were counterstained with FITC c-Kit, a surface marker
for both melanocytes and mast cells. When imaging FACS-isolated cells using CARS
microscopy, the presence of fluorescent proteins in the sample (i.e. tdTomato and
ZsGreen) sometimes resulted in a background signal generated via two-photon ex-
citation fluorescence from either or both the pump and Stokes lasers. To correct
for this, a raw CARS image was first acquired using both lasers; then, two-photon
fluorescence images were acquired by using each laser beam individually. The result-
ing fluorescence images were then subtracted from the raw CARS image in order to
isolate the true CARS signal from the sample.
7.3.7 Mouse Ear Imaging
For ex vivo mouse ear imaging, the ear tissue was acquired via ear punch (# = 3
mm). A commercial hair removal lotion (Nair, Church & Dwight Co., Inc., Prince-
ton, NJ) was used to remove fine hairs from the ear tissue. The sample was then
sandwiched between a coverslip and a glass slide, and imaged as described above. For
in vivo mouse ear imaging, the mice were anesthetized with isoflurane mixed with
0.2 L/min oxygen and 0.8 L/min air via face mask. Fine hairs were removed using
the same hair removal lotion as in the ex vivo sample. The ear was then fixed onto
a coverslip using double-sided tape, and imaged as described above. All studies and
procedures involving animal subjects were approved by the Institutional Animal Care
and Use Committee of Massachusetts General Hospital, and were conducted strictly
in accordance with the approved animal handling protocols.
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Chapter 8
Outlook and Future Perspectives
Nonlinear optical imaging technologies comprise a subset of microscopy tools that
have been gaining considerable momentum in terms of their applicability in cancer
research over the past couple of decades. Since the first uses of multiphoton fluo-
rescence imaging [9] and coherent Raman scattering microscopy [53], these nonlinear
modalities have undergone several generations of technological advancement. The
past decade alone has seen considerable efforts on topics ranging from signal process-
ing and algorithm development on the software side, to improved detector design and
fiber optic implementation for endoscopic applications on the hardware side.
A variety of biotechnological advances are sure to maintain the forward momen-
tum of these nonlinear optical techniques. One example in the field of coherent
Raman scattering is the use of alkyne tags of varying length and isotopic mass, which
can be used as CARS and SRS labels due to their sharp characteristic vibrational
peaks. With the added benefit of their small relative size, they can be used in a
manner that is minimally perturbative to study various biomolecular processes of
interest, foregoing the need for bulkier fluorescent reporters [270]. These tagging
techniques are of particular interest in the case of pharmacokinetic and pharmaco-
dynamics (PK/PD) studies, where the visualization of small-molecule drugs or the
solvents carrier molecules themselves may be of interest. In such contexts, the use
of Raman-active tags for CRS imaging may offer a solution that allows for accu-
rate and specific imaging of the compound of interest without significantly altering
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its biochemical properties. Another still is in the development of next-generation
photoconvertible fluorescent dyes, where efforts are converging on the development
of two-photon photoconvertible reporters, which would allow for a high degree of
conversion selectivity in situ [43].
It is also worth emphasizing the various engineering efforts at institutions that have
focused on the acceleration of imaging speed through creative hardware innovations.
One exemplary group at MIT has pioneered the application of multiphoton imaging in
a wide-field setting using temporal focusing in order to allow for acquisition of three-
dimensional datasets in very short periods of time [271]. Such technologies can prove
to be a useful tool for in vivo monitoring of rapid-timescale biological events such as
cancer cell migration in the context of metastasis. Parallel advancements in the field
of CRS imaging include the advent of hyperspectral modalities, typically achieved
either through spectral focusing or wavelength tuning. With further development
in the field of hyperspectral SRS imaging in particular, interpretation of pathology
slides may be greatly simplified and rendered possible in the operating room itself,
foregoing the need to prepare, stain, and examine samples over the course of days
[57]. Indeed, the combination of hyperspectral SRS imaging and machine learning
in the image analysis space can offer pathologists an intuitive false-color rendering
of the pathological sample, reminiscent of conventional H&E staining. In turn, this
familiar visualization would save a considerable amount of time and hospital resources,
ultimately benefiting patient health.
The application of these powerful advanced microscopy toolkits to cancer research
has taken the nonlinear optical community several decades of combined and comple-
mentary effort, and the current results are indeed remarkable. With some of the
clinical specificities and sensitivities of Raman technologies exceeding 95% (see 2),
their application in the context of cancer research is growing still, with improvements
being published every year. Naturally, the next step and perhaps the biggest chal-
lenge yet is the widespread adoption and successful translation of these technologies
to the clinic.
In order to propel the adoption of these advanced technologies into the therapeutic
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work flow, a considerable amount of conscientious effort must be dedicated to the
interpretation of the various images that are generated. For example, it cannot be
expected of a dermatologist to learn the specifics of fluorescence lifetime imaging in
order to develop an intuition for the range of NADH lifetimes within the cells of a
suspicious lesion that may be indicative of skin cancer. Similarly, a pathologist cannot
be expected to examine the individual Raman spectra of a hyperspectral SRS image
set to identify whether the margins of a resected sample are positive. It is in these
contexts that clinical research will be of great use in order to develop a large body of
reference data that has been validated by pathologists. These datasets can then be
used to train machine learning algorithms such that image features and/or diagnostic
results can be provided directly to the healthcare professional in order to best guide
medical decision-making.
Of course, this is not to say that the outputs of these complex tools must be
reduced to a straightforward binary response. However, the current state of imaging
complexity in the research space is unlikely to offer informative value to a healthcare
professional in a realistic hospital setting. An ideal middle ground, for example,
would be to highlight regions of interest within the imaged sample that may be of
particular clinical interest. One can also envision complementing these highlighted
regions with some probability or other numerical or categorical indicator of disease
likelihood. These metrics may then serve the medical team to inform them whether
a certain clinical risk is worth taking, when considering the patients overall health
status.
All things considered, nonlinear optical technologies are unlikely to bear an impact
on clinical work flow unless a variety of biomedical engineering factors are taken into
account. These imaging tools must offer clinicians sensitivity and specificity in order
for them to obtain as much clinically relevant information as possible, all while main-
taining affordability. Furthermore, they must operate at rapid acquisition speeds;
tools like FLIM, for example, require several minutes of imaging time, which may be
prohibitively long in some clinical contexts. Finally, once the data is acquired, the
analysis and interpretation must be performed at a similarly rapid pace in a manner
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that informs the medical staff and guides their decision-making, rather than provid-
ing a direct diagnosis or medical recommendation. Investing in both technological
advancements of imaging hardware as well as next-generation image analysis using
machine learning and artificial intelligence are likely to accelerate the adoption of
advanced microscopy technologies in the clinical space, contributing the improved
patient care, survivability, and well-being.
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Appendix A
MATLAB Scripts and Functions
A.1 Simulation of Binary Mixture
1 %4-Iiitializations
2 close all
3 clear all;
4 clC
6 saveFiles = 0;
saved
7 saveFig = 0;
XFlag determining
%XFlag deteJrrminIing
whether
WIet her
or niot fi I e S a
oI: not fig ures
saved
(Stait tinier
10 efine S 1111 tiil at .0i I'a) R I* C e t (e- S
11 numPixelsY = 512;
12 numPixelsX numPixelsY;
13
14 %--Phot onIs I)er pixel: 1000
15 tau-error = 0.05;
185
8 tic ;
9
a1(
16 tauTheoreticalA = 2.5E-9; %Coullarill 6
17 tauSigmaA = tau-error*t auTheoretical-A;
18 tauTheoreticalB = 1E-9*[0.77 1.21 3.71 4.78]; WNADH
19 tauSigma-B = tau-error*tauTheoretical_B;
20 alpha-error 0.15;
21 alphalB = 0.15;
22 alphalsigmaB = alpha-error*alphalB;
23 alphalImageB = alphal-B + alpha1_sigmaB *randn (numPixelsY,
numPixelsX) ;
24 alpha2_B = 0.25;
25 alpha2_sigma-B = alpha-error*alpha2_B;
26 alpha2_ImageB = alpha2_B + alpha2_sigmaB*randn(numPixelsY,
numPixelsX);
27 alpha3_B = 0.35;
28 alpha3-sigmaB = alpha-error*alpha3B;
29 alpha3-ImageB = alpha3_B + alpha3-sigmaB*raiilnd(numPixelsY,
numPixelsX);
3o alpha4_B = 0.25;
31 alpha4_sigmaB = alpha-error*alpha4-B;
32 alpha4_ImageB = alpha4_B + alpha4_sigma-B*randn(numPixelsY,
numPixelsX) ;
33 totalNumPhotonsSignal = 1000;
34
35 %-Define mh111ber of sp tri OIIs n oise( 1 )hotOnS
36 totalnumPhotonsNoiseA = 0; %Set 1oise to 0 for comlpound
A
37 photonCountImageNoiseA = totalnumPhotonsNoiseA *ones (
numPixelsY , numPixelsX) ;
38 tot alnumPhotonsNoiseB = 0; %Set nOise to ) 0 for compollu1n(d
186
39 photonCountlmageNoise-B = totalnumPhotonsNoiseB *ones (
numPixelsY , numPixelsX);
40 totalnumPhotonsNoiseMix = 0; %Set n.ois to 0 for mn ixt Iure
41 photonCountlmageNoise -Mix = tot alnumPhotonsNoise _Mix* ones (
numPixelsY , numPixelsX);
42
43 %A-Nixtiire t1 e 1. a 111 follo Wing sin '2 aid cos '2 distribl0ti()ns
44 x = linspace (0, pi , numPixelsX);
v c c 1 0) I
45 concA = repmat(sin(x). ^2, [numPixelsY ,1]);
of A
46 conc-B = repmat (Cos (x) .
d(Is I It ) ]t 11.
^ 2 , [ numPixelsY , 1] ) ;
of B
4 cmapA = hot (512);
red hot )
48 cmapB =
% Clf irm
,/c ()( I ol-iiia
fliI)Ir (cmapA);
can .h( t)
49
50 %--Displav th1eorc0tical
51 f21 = figure ;
52 imagesc (concA , [0
53 c0lor map (cmapA)
54 COlorbar ;
s axis image;
56 titlel( Theoretical
c o 11 c c 1 t ra t 1 o 11 maps_) of A 11d B
1]);
oicentrat io n Map o f Compound A )
57 f31 = figure ;
58 images (concB , [0
59 colorinap (cmapB)
60 C ( o)(r ar
61 axis image;
for A
for. B(
1]);
187
,XCIDefil.le SIIj_)pc)l .t
di1s tr ibu)ti n I(1
C oin ce it rat i on Map of Compound B ) ;
63
64 '/(--Sa V(e fi 'ures if specified
65 if saveFig
saveas ( f2 1 .CoiiCentratioiMapATlheoretic al_
numPixelsY) ...
num2str (
lpx num2str (tot alNumPhotonsSignal) ph. t if ] )
saveas (f31 , [ ' ConcentrationMapB Theoretical_ num2str (
numPixelsY) ...
ipX nurn2str (tot alNumPhotonsSignal)
72 W-St ph - - Sr t ran s for m
73 harmonicNumber = 1;
7 steps = 0.0025;
75 freqO = 80E6;
76 histogramThreshold = 0.
77 cmap = 'jet';
78 drawEllipse-A = 0;
79 drawInterceptsA =
80 drawEllipseB = 0;
81 drawlnterceptsB =
anid histogram paam(t(rs
001;
0;
0;
82 drawEllipse-Mix = 0;
83 drawInterceptsMix =
84 numSpeciesA = 1;
85 numSpecies-B = 1;
86 numSpeciesMix =
0;
2;
87
88 W-SO-t i inage pa rameterS
89 imageParametersA = default imageParameters (tauTheoreticalA)
188
66
67
68
69
70 (1(
71
62 tfit Ile ( ' Theoretic a I
ph1. t i f );
90 imageParameters-A. tau-sigma = tauSigmaA;
Ii fet1im ni U l1 e(rtaiintyv
91 imageParameters-A. display = 1;
displaI.Ng111 comI.Ipltation pro)gress
92 plotsA .G = zeros (numPixelsY, numPixelsX)
array for A
93 plots-A.S = plotsA .G;
array for A
94 imageParametersB = default-imageParameters
%(onpound A
%AFlag for
%I1 a:iIaliz G-
% I Initialize S-
(tauTheoreticalB)
95 imageParametersB. tau-sigma = tauSigmaB; %Coipon1d H3
lifetime11 uncer aInt y
96 imageParametersB. display = 1; %Flag for
display (in.g .OMpi 'tat ki progress
97 plotsB .G zeros (numPixelsY , numPixelsX) ; %In i t i l. z e G-
rr ay fo 13
98 plotsB.S = plotsB.G; %Initi'alize S-
array for B
99 imageParametersMix = default-imageParameters ([
tauTheoretical-A ...
100 tauTheoreticalB ]) ;
101 imageParametersMix. tau-sigma = [imageParametersA. tau-sigma
102 imageParameters-B. tau-sigma I.; %Compomd A and B
lifi ime iuii.ertaijnties
103 imageParametersMix. display = 1; %cFlag for
(isplying cmutl)lltion progrjcss
104 plotsMix.G = zeros(numPixelsY,numPixelsX); KInit iaize G-
arrav flor mlixtulre
189
105 plotsMix.S = plotsMix.G;
rra 1 1 for IiiX1,11re
106
107 photonCountImageSignalA =
108
totalNumPhotonsSignal *...
ones (numPixelsY , numPixelsX) ;
r fr [e n I e I iIt e11sit v
109 decaylmageA = simulateDecaylmage (photonCountImageSignalA
photonCountImageNoiseA , imageParameters-A) ; %Creat Ce deci a v
image A
i1 photonCountImageSignalB = round (totalNumPhotonsSignal* cat
(3 ,...
112 alphalImageB , alpha2_ImageB ...
alpha3_ImageB , alpha4_Image-B));
in t e siy Y
IC tCreate reference
iage B
114 decayImageB = simulateDecaylmage (photonCountlmageSignalB
photonCountImageNoiseB , imageParametersB);
image B
% C a tc dC ( c av
116 photonCountImageSignalMix = round (tot alNumPhotonsSignal* cat
(3 ,...
117 conc-A , conc_B * alphalImage B , conc_B * alpha2_ImageB ,....
conc-B .* alpha3_Image B ,concB .* alpha4_Image-B));
() ve rI C1a i d
%'Cr eate
milixture 1i.n tensit' image
119 photonCountlmageSignal-sumMix = sum (
photonCountImageSignalMix ,3) ; %Create m ire int ensit y
imilage
120 decaylmageMix = simulateDecaylmage(
photonCountImageSignal Mix
photonCountImageNoise-Mix, imageParametersMix) ;
190
irmage A
110
%eC I e at e
113
115
118
121 % Ce ( te
%"I i t ialIz S_
mixture dccav ilage
f r
122
123
124
125
126
end
eild
140
141 %-Generate phasor plots for all sets of transformieid ccav
142 tauA = phasorPlot (plotsA .G, plotsA .S ,...
143 harmonicNumber , steps , freqO , histogram Threshold , cmap, ....
144 drawEllipseA , drawInterceptsA ,numSpeciesA)
145 f11 = gCf;
146 t it1e( Phasor Plot of Compound A')
191
!o1-1.pIte ) as() r t r a n1 S fo . nis S f o 1. 1 3 e(1 y ic a I g es
m = 1: numPixelsY
fo r n = 1: numPixelsX
decayPixel = phasorTransform (decayImage-A (m, n)
harmonicNumber) ;
plotsA .G(m,n) = decayPixel .G;
plotsA.S(m,n) = decayPixel.S;
clear decayPixel ;
decayPixel = phasorTransform (decaylmage-B(m, n)
harmonicNumber) ;
plots-B .G(m,n) = decayPixel .G;
plotsB.S(m,n) = decayPixel.S;
clear decayPixel;
decayPixel = phasorTransform (decaylmageMix (m, n)
harmonicNumber) ;
plotsMix .G(m,n) = decayPixel .G;
plotsMix.S(m,n) = decayPixel.S;
clear decayPixel;
127
128
129
130
131
132
133
134
135
136
137
138
139
tau-B = phasorPlot (plotsB.G, plotsB .S ,....
harmonicNumber , steps , freqO , histogramThreshold , cmap, ....
drawEllipseB , drawIntercepts-B , numSpecies-B);
f12 = gef;
title ('Phasor Plot of Compound B');
[tauMixB ,tauMixA] = phasorPlot (plots-Mix.G, plots-Mix.S,.
harmonicNumber , steps , freqO , histogramThreshold , cmap ,...
drawEllipseMix , drawInterceptsMix , numSpeciesMix);
f13 = gef;
title ( Phasor Plot of Mixture');
if
Sv.VV FiguI lres if s p cci fi e (d
saveFig
saveas (f11 , [ 'PhasorPlot_A_ num2str (numPixelsY) ...
px . num2str (totalNumPhotonsSignal) 'ph. t if ] ) ;
saveas (f12 , [ 'PhiasorPlot _B_ num2str (numPixelsY) ...
px 'num2str (tot alNumPhotonsSignal) 'ph. t if ] )
saveas (f13 , [ PliasorPlot Mixture num2str (numPixelsY)
px' num2str ( tot alNumPhotonsSignal) ph. t if ] )
enld(
%c- R c foriIat
plotsA .G =
plotsA.S =
plotsA .Z =
plotsB .G =
plots-B.S =
plotsB .Z =
plots-Mix .G
plots-Mix. 
phasor coordin i ate arra8 ys into column vectors
reshape(plotsA.G,[numel(plots A .G) 1]) ;
reshape (plotsA.S,[numel(plotsA.S) 1]) ;
[plotsA .G, plotsA .S];
reshape (plotsB .G, [numel(plotsB .G) 1]) ;
reslia)e(plotsB.S,[numel(plotsB.S) 1]);
[plots-B .G, plotsB .S];
= reshape (plots _Mix .G, [ numel(plots _Mix .G) 1]);
= reshape(plotsMix.S,[numel(plotsMix.S) 1]) ;
192
[ plotsMix .G, plots-Mix .S];
178
179 --- Co]lpu t Euclidean1 (i St caIceS )ct wec1I Z
180 edMixB =
181 edMixA =
Sq1t (sum((plotsMix.Z - mnean(plots-B.Z)).^2,2));
s(lrt (sum((plotsMix .Z - mean(plotsA .Z) ) .2 ,2) );
182
183 -- 1ljl to k-ar ra vs S's)cia t e(1 With Eill(;idean diSt a11ceS
c a c u 1a te (I a) ) bOve
184 (NIi XtUr
185 k-edMixA = reshape (edMixA. / (ed-MixA+edMixB) , [ numPixelsY
numPixelsX ]) ;
186 k-ed-MixB = reshape (edMixB./(ed-MixA+edMixB) ,[numPixelsY
numPixelsX ]) ;
187
188 - oljplI Malha alltobiS diStances hetWO( Z arraiyS
189 mdMixB = sqrt (mahal(plotsMix .Z, plotsB .Z));
190 mdAB-Ref = sqr t (mahal(mean( plotsA .Z) , plotsB .Z));
191 mdMixA = sqrt (mahal(plotsMix.Z, plotsA.Z)) ;
192 mdBA-Ref = sqrt (mahal(mean( plotsB .Z) , plotsA .Z) );
193
194 (--CO1)lpU.t e k-a rraY s associated With [ahalan0his ( i St a 1C1 c S
cailculated above
195 cmixture
196 k-mdMixAO = mdMixA/mdBARef;
197 k-mdMixBO = mdMixB/md-AB-Ref;
198 k-mdMixA = (k-mdMixAO + (1-k-mdMixBO)) /2;
199 k-mdMixB = (k-md-MixBO + (1-k-md-MixAO)) /2;
200
201 k-mdMixA (k-mdMixA > 1) = 1;
202 k-md-MixA(k.mdMixA < 0) = 0;
193
a rray s
17 plotsMix . Z =
203 k-mdMixA = reshape (k-mdMixA, [numPixelsY
204
205 k-mdMixB (k-mdMixB > 1) = 1;
206 k-md-MixB(k-mdMixB < 0)
207 k-mdMixB = res ha pe (k-md-MixB, [numPixelsY numPixelsX ]) ;
208
est i nIateS
210 %i\ Ia halao.bi.0) s map
211 f22 = figur e ; imagese (k-mdMixB, [0
cmapA) ; colorbar;
1]) ; axis
Imr ages
image ; colormiap (
212 t it le ( IMahalanobis
213 has1 maa ) I) 1 p o f (colmrpoun(Id 13 in Ni
of Coipound A');
xture imlage
214 f32 = figure ; imagese (k-mdMixA, [0
cmap-B) ; colorbar;
1]) ; axis image ; colormnap (
215 t it le ( 'Mahalanobis
216 /%" Li d I (10 111 )Iap of
217 f23 = figure ;images (k-edMixB,[0
cmapA) ; colorbar ;
Concentration Map of Co mpound B );
iII NIMixtur: i inage
1]) ; axis
218 title ( 'Euclidean Concentration Map of
uage; colormap (
Compound A');
219 %(Euclideani mt1ap of compounid 13 in Mixtu-Are im8age
220 f33 = figure;imagesc(k-edMixA [0
cmapB,) ; colorbar;
1]) ; axis image ; colormap (
221 title ('Euclidean Concentration Map of Compound B );
222
figures . if Sp e cifi edc
224 if saveFig
225 saveas ( f22 , [ 'ConcentrationiMapAMiahalanobis_' num2str
numPixelsY) ...
pX num2str ( tot alNumPhotonsSignal)
saveas ( f32 , [ 'Concentr at ionMapliBMahalanobis_'
i ph . t if 9 ]);
num2str (
194
= 0;
209 (---i)sp a V
A in iMixture image
223 /-S
226
227
numPixelsX ]) ;
COmplite( d is trib i ol t1 .
of compoun'd
comipound A.
numPixelsY) ...
piX 1unr2str (totalNumPhotonsSignal) ph. t if ] )
saveas (f23 ,[C~oneeiil rationMapAEuclidean_' num2str(
numPixelsY) ...
px num2str (totalNumPhotonsSignal) 'ph. t if ])
saveas (f33 , [ ' ConcentrationMapB-Euclidein_ ' num2str (
numPixelsY) ...
px' num2str (totalNumPhotonsSignal) 'ph. t if )
228
229
230
231
232
233
234
235 %Columnn-WiSC e incans of compound A iii Mixturc inlage
236 f4 = figure
237 plot (1:numPixelsX , sin (x) .2 , 'k LineWidth
238 plot ( 1: numPixelsX , nean(k-mdMixB) , 'r , LineWidth
239 plot (1: numPixelsX , mean (k-ed-MixB) , b: , LineWidth
240 Xlabel ('Column Index')
241 vlabel (R elative Concentration')
242 xlim ([1 numPixelsX])
243 ylim ([-0.1 1.1]) ;
244 t i t 1 e ( Column-wise Means of Compound A Cont ributi
245 legend ( 'Simulation , Mahalanobis ', uclidean , 'L
NorthEast ') ;
hold on;
,3)
,3)
oi ) ;
)cation'
KColumn-wise ineanS of cOmpound B in Mixture image
f42 - figure
plot (1: numPixelsX , cos (x). ^2, 'k , . LineWidth ',1.5) ; hold on;
plot (1: numPixelsX , mean(k-mdMixA) , r , 'LineWidth ',3)
p lot (1: numPixelsX , mean (k-ed-MixA) , b: , ' LineWidth ' 3);
xlabel ( 'Columni Index
yla bel ( Relative Concentration )
195
(I1A1d
246
247
248
249
250
251
252
253
254 xlim ([1 numPixelsX])
255 ylim([-O.1 1.1]) ;
256 title ( 'Coimnin-w ise Means of Compound B C o n t r ibut ion' );
257 1egen ( Siinulatioi , n ' ahalancbis ElcIi dea ' , ' Location
SouthEast ") ;
-- Save fi U 1r e s if e ci e d
if saveFig
saveas ( f41 , [ 'ColumnWiseMeas-A_' nun12str
)X num2str (tot alNumPhotonsSignal)
saveas (f42 , [ ' ColumnWisM eansB_ ' nun12str
pX num2str (totalNumPhotonsSignal)
e 11(1
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
num2str (d . Minute, '%02.2u)
(numPixelsY)
* ph . t i f ' I ) ;
(numPixelsY)
A ph. t i f ' ]) ;
num2str (d. Month, '%02.2ii')
num2str (d . Hour , "X%02.2u')
. nat ' ] , '-v7.3 ' ) ;
e id
%---isplav tot- al elapsed siniulation tine
elapsedTime = toe;
fp r i TI t f ([ '\n Total sinuIlat ion time: ..
nun2str ( fl o or (elapsedTime /3600) , '%402.2u ')
num2str (rem( floor (elapsedTime /60) ,60) , 1%02.2u ')
196
Save worksp aCe, if speCeified
if saveFiles
d = datetime;
save ( [ ' Simnilat ion -
num2str (d. Year , %04.4u ')
num2str (d. Day, (%02.2u')
273
274
275
276
277
278
279
280
nun2str (rein (round ( elapsedTime ) ,60) , "%02.2u )
\n saveFiles
\n saveFig
\inn ) ;
num2str(saveFiles)
- num2str(saveFig) ...
A.2 Simulation of Ternary Mixture
1 -- I itil 1za1 ions
2 close all
3 clear all
4 Cle;
6 saveFiles = 0;
sav(d
saveFig = 0;
% Flag (ete rmin1ng
%Flag o det erini nng
wh ether
Whether
or I t fit s a 1'e
or not figures
save
%> S tart tI I I II (e I
10 X-Define siluilatioil paraleters
11 numPixelsY = 512;
12 numPixelsX = numPixelsY;
13
14 %4>-Ph1oto S per pixel:
15 tau.-error = 0.05;
16 tauTheoretical-A = 4.1E-9;
17 tauSigmaA
18 tauTheoreticalB =
19 tauSigmaB =
= tau-error*tauTheoretical-A ;
1.6E-9;
tau-error*tauTheoreticalB;
20 tauTheoretical-C = 0.6E-9;
21 tauSigmaC = tau-error*tauTheoretical_C
197
281
282
283
284
8 tiC ;e
1)0 0
22 totalNumPhotonsSignal =
23
24 %-Defin m11111her of spurious
25 totalnumPhotonsNoiseA = 0; (Set noise to) 0 forv comllpouniidl
A
26 photonCountlmageNoiseA = totalnumPhotonsNoiseA*ones(
numPixelsY , numPixelsX);
27 totalnumPhotonsNoiseB = 0; % (Se t .n .oise to 0 for com(upou id
B
28 photonCountImageNoiseB = tot alnumPhotonsNoise _B *ones (
numPixelsY , numPixelsX);
29 totalnumPhotonsNoise-C = 0;
B
30 photonCountImageNoiseC = tot alnumPhotonsNoiseC *ones (
numPixelsY , numPixelsX);
31 totalnumPhotonsNoiseMix = 0; %/(SetI~ise to ( for miixture
32 photonCountlmageNoiseMix = tot alnumPhotonsNoiseMix*ones (
numPixelsY , numPixelsX);
33
34 -- M.iXti ( following 3 pha1 -rlse-shIifte C
fl n 11 c ti o ii S
35 x = linspace(0,2*pi ,numPixelsX);
36 y = (1+cos(x))/2;
37 y2 = (1+cos (x+2*pi /3))/2;
38 y3 = (1+cos (x-2*pi/3))/2;
39 yyl y1 . /(yly2 y3);
40 yy2 = y2 ./(yl+y2+y3);
41 yy3 = y3./(yl+y2+y3);
42 concA = repmat (yl , [numPixelsY ,1]);
43 concB = repmat (y2 , [ numPixelsY , 1]);
%/ Dcfi noc support v c c to . r
%X D efinc d is t ribit ion
%cDecf 11 e d Is, t r. 1) but i. 11
198
1000;
o ise 1hct,)s
c 0 S i II e
of A
) f B
%ASet nomise to0 for)I comIIpoutlld
p
g enIIeralti.n ()
u conc-C = repmat (y3, [numPixelsY , 1]);
45 cmapA = hot (512);
WDeftine distrihution of B
for A r (Ied hot)
46 cmapB =
)
4cmapC =
circshift (cmap-A,1 ,2);
circshift (cmap-A,2 ,2) ;
for 11 (cyan%C olorlap
%eColcrmnap
hot
for 13 (miagenta
hot)
48 CCi
49 -iSlplay t he ( o 1 e ti C a.1. C OCeIn. 1 tr t i 01I of A., 1. and
50 f21 = figure ;
51 imagese (repmat (yyl , numPixelsY , 1]) , [0 11);
52 coloriap (cmapA)
53 Colorbar;
54 axis image;
55 title ( 'Theoretical
56 f31 = figure
57 imagese (repmat (yy2
58 C() lormiap (cmap-B)
59 COlorbar ;
60 axis image;
61 title ( Theoretical
62 f41 = figure ;
63 imagesC (repmat (yy3
64 C Oirmap (cmapC)
65 Co lorbar;
66 aXiS image;
67 title ( Theoretical
68 (X
C 0i C en tI t i (I Map of Compound A );
, [numPixelsY ,1]) ,[0 1]) ;
Concentration Map of Compound 3
, [ numPixelsY , 1]) , [0 1]) ;
Coin c ent rat i o 11 Map of Compound C )
69 Wc--S8Ve figures , if SIpeCcifie d
70 if saveFig
71 saveas (f21 , ConcentrationMapA _TheoreticaLTern512px . t if )
199
n.4a.S
72 saveas (f31 , ConcentrationlapBTheoreticaLTerS12px. t if )
73 saveas ( f41 , Concentration MapC_ TheoreticalTern512px . t if )
74 C,11(1
75
76 -Set p asor t ra sfor in and Ii's togr amIi.i .para.etecrS
77 harmonicNumber = 1;
78 steps = 0.0025;
79 freqO = 80E6;
80 histogramThreshold = 0.001;
81 cmap * Ct
82 drawEllipseA = 0;
83 drawInterceptsA = 0;
84 drawEllipseB = 0;
85 drawInterceptsB = 0;
86 drawEllipseC = 0;
87 drawlnterceptsC = 0;
88 drawEllipseMix = 0;
89 drawInterceptsMix = 0;
90 numSpecies-A 1;
91 numSpeciesB = 1;
92 numSpeciesC 1;
93 numSpecies-Mix = 2;
94
95 %- t im11age pJ)a r aicter' S
96 imageParametersA = default-imageParameters(tauTheoreticalA)
97 imageParametersA. tau-sigma = tauSigma-A; %Compound A
200
life t i Ic uleerta ilt Y
98 imageParametersA. display = 1;
dis Ip Ia y in g colm plitation prot)gress
99 plotsA .G = zeros (numPixelsY , numPixelsX) ;
arav for A
1oo plotsA . S = plots-A G;
%Flag for
( I i t i al i .z e
(%I 1 i t i ali z Ce
array fOr A
101 imageParametersB = default-imageParameters(tauTheoreticalB)
102 imageParametersB. tau-sigma = tauSigma-B;
lifetimle 111ncertaliltyv
103 imageParametersB. display = 1;
d l y () )1, 11gt co puat ion p rogr(ss
104 plots..B .G zeros (numPixelsY , numPixelsX)
array for
105 plotsB.S =
B
plotsB G;
%/C(Mipound B
%FTlag f0r
%I it i a liz e
%.I nit i a 1 i zCe
ar.1r L. V f(.) V 13
106 imageParameters-C = default _imageParameters (tauTheoreticalC )
107 imageParametersC .tau-sigma = tauSigmaC;
lifetime111( un1certlainty
108 imageParametersC. display =
(Ii S p layi g
1;
'Xnpound C
%lag
copliu)Htation progress
109 plots _ C .G = ze ros (numPixelsY , numPixelsX) ;
arIay for
% I nt i t i al Ii z e
C
no plotsC.S = plotsC.G;
array for C
i1 imageParameters-Mix = default-imageParameters ([
tauTheoreticalA ...
112 tauTheoreticalB tauTheoretical-C])
201
S-
fr.) r
C-
S-
113 imageParametersMix. tau-sigma =A
imageParametersB. tau-sigma , imageParametersC. tau-sigma ] ;
%Coipounr1(d A., B., ( 1 I -i I i c S
115 imageParameters-Mix. display = 1; %Y F i ag fo r
()mput ati Oil progreSs
116 plot s _Mix .G = zer o s (numPixelsY , numPixelsX) ; %i n i t i (1i z (,
a.ray for
-'I
"3-
mixt ure
117 plotsMix .S = plots-Mix.G; %AJ iii ti ali z(,
array for mixture
118
119 photonCountImageSignalA = totalNumPhotonsSignal*...
ones (numPixelsY , numPixelsX) ; c r e at e
r c f C r c ii c c ilitC Sity
121 decayImageA = simulateDecaylmage (photonCountImageSignal-A
photonCountImageNoiseA , imageParametersA);
iiage A
123 photonCountImageSignalB = totalNumPhotonsSignal * ...
ones (numPixelsY , numPixelsX) ;
r (- f C r c II c C int c ns it Y
125 decayImage-B = simulateDecaylmage(photonCountImageSignalB
126 photonCountImageNoiseB , imageParametersB) ; %C cat dec c av
i..age B
127 photonCountImageSignalC = tot alNumPhotonsSignal*...
ones (numPixelsY , numPixelsX) ;
I- r f r c (, int C I it v
129 decaylmageC = simulateDecaylmage (photonCountImageSignalC
202
114
120
i-li (agc A
122
124
imicage 13
128
11 ge I I gCI
[ imageParametersA . tau-sigma
d i splayig V1.
%Cre atle de a~y
% Cr ec at e
%/(C rcIat e
photonCountImageNoise-C , imageParametersC) ;
image C
131 photonCountImageSignalMix = round (totalNumPhotonsSignal* cat
(3 ,...
conc-A , concB , concC) ) ;
ov \ U r1a i (id m1lixtulre iltenlsity
VCre te
iIa ge(
133 photonCountImageSignal-sum-Mix = sum(
photonCountImageSignalMix 3) ; %Crea( t e ixture ilt U I Sit y
Iag1 (1.
134 decayImageMix = simulateDecaylmage (
photonCountlmageSignalMix ....
photonCountlmageNoise-Mix ,imageParametersMix) ; %Crca t e
IlXtilre deCay IlILOage
r) s o traIIsforin s for all 3 dcaY images
138 for m = 1: numPixelsY
n = 1: numPixelsX
decayPixel = phasorTransform(decayImage-A(m,n)
harmonicNumber) ;
plotsA .G(m,n)
plotsA . S(m,n)
= decayPixel.G;
= decayPixel .S;
clear decayPixel;
decayPixel = phasorTransform (decaylmageB (m,n)
harmonic Number) ;
plotsB.G(m,n)
plotsB .S(m,n)
= decayPixel.G;
= decayPixel.S;
clear decayPixel;
decayPixel = phasorTransform (decaylmageC (m, n)
harmonicNumber) ;
plotsC.G(m,n) = decayPixel.G;
203
132
135
136
139
140
0 1'
141
142
143
144
145
146
147
148
149
% ,C re a- t (, dIc .a~y130
137 -COmp t 1.1U.C
plots-C.S(m,n) = decayPixel.S;
clear decayPixel;
decayPixel = phasorTransform (decaylmageMix (m,n)
harmonicNumber) ;
plotsMix.G(m,n) = decayPixel.G;
plotsMix .S(m,n) = decayPixel.S;
clear decayPixel;
150
151
152
153
154
155
156
157
158
c 1 d
159 -- 1 1 Cii r at ) p , a S o r
i. a. g e
160 tauA = phasorPlot
161 harmonicNumber
162 drawEllipseA
163 fi 1 = (Yf
164 title ( Phasor Plot
165 tau-B = phasorPlot
166 harmonicNumber
167 drawEllipseB
168 f12 = gef;
169 title ( Phasor Plot
170 tau-C = phasorPlot
171 harmonicNumber
172 drawEllipseC
173 f13 = gef;
174 title (' Phasor Plot
175 [tauMix ,tauMix2
harmonicNumber176
177
pl o t S fto r a 11 S c t S of t ran al s fo r tn e d. (1 C ay
(plots-A .G, plotsA .S , ...
,steps , freqO , histogramThreshold , cmap , ...
drawIntercepts-A numSpeciesA)
of Compound A )
(plotsB.G, plotsB .S,...
,steps , freqO , histogramThreshold , cmap , ...
drawlnterceptsB numSpeciesB)
of Compound B' )
(plotsC.G, plotsC .S,...
,steps , freqO , histogramThreshold , cmap , ...
drawInterceptsC numSpecies-C)
of Compound C')
= phasorPlot (plotsMix.G, plotsMix.S ,..
,steps , freqO , histogramThreshold , cmap, ....
drawEllipseMix , drawlnterceptsMix , numSpeciesMix) ;
204
c I d
f14 = gCf;
title ( 'Phasor Plot of Mixture )
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
1) e c.i f ied(
PhasorPlotATern512px t if )
PhasorPlot-BTern512px t if )
PhasorPl ot C-Tern5 1.2px t if )
PhasorPlot-Nixture _Tern5 12px t if )
-11a
i' iii fo-nat phliasor COOl(t1.1ate &r ay '1I:Vi *5 into0 0 111 co lll Xrc orus
plotsA .G
plotsA .S
plotsA .Z
plotsB .G
plotsB .S
plotsB .Z
plotsC .G
plotsC .S
plotsC . Z
plotsMix
plotsMix
plots Mix
reshape (plotsA .G, [ numel(plots-A .G)
S
z
reshape (plots-A .S, [
[ plotsA .G, plots-A.
reshape (plotsB G,
reshape (plotsB .S,
[ plotsB G, plots-B .
reshape (plots C G,
reshape (plotsC .S,
[plots-C G, plotsC.
= reshape (plots-Mix
= reshape (plotsMix
[plotsMix .G, plot
---Co)ipute Euclidean t
A-ref.G = mean(plotsA
B-ref.G = inean(plotsB
Cref.G = mean(plots-C
Aref.S = iean(plotsA
r i aiil a g
.G ) );
.G ) );
.G (:) )
.S(:) )
1]);
numel(plots-A .S) 1]);
S];
numel(plots-B .G) 1])
numel(plotsB .S) 1])
SI;
numel(plots-C .G) 1])
numel(plotsC.S) 1]);
S];
.G, [numel(plotsMix .G)
.S, [numel(plotsMix .S)
s._Mix. S ] ;
a r e a S
205
-- Save fgres
if saveFig
saveas(fll,
saveas(f12,
saveas(f13,
saveas(f4,
1]);
1]);
208 B-ref.S = mean(plots-B .S(:) )
209 C-ref.S = nle(an(plots-C .S (:) )
21o refArea = polyarea([A-ref.G B-ref.G
C-ref.S]);
C-ref.G,[A-ref.S
211
212 k-ed-A = zeros (size (plotsA .G));
213 k-edB = k-edA;
214 k-ed-C = ked_A;
215
216 for p = 1:numel(k-edA)
k-edA (p) = polyarea([plotsMix.G(p)
[plots-Mix S (p)
B-ref.G C-ref.G]
B-ref.S C-ref.S])/refArea;
219 k-edB(p)
[A-ref.S
k-ed-C (p)
[A-ref.S
= polyarea([A-ref.G
plots-Mix.S(p)
= polyarea ([A-ref.G
plots-Mix .G(p) C-ref.G]
C-ref.S]) /refArea;
B-ref .G plotsMix .G(p) ]
B-ref.S plotsMix.S(p)])/refArea;
225 k-edA =
226 kedB =
227 k-edC =
reshape (k-edA ,[numPixelsY numPixelsX])
reshape (k edB , [numPixelsY numPixelsX])
reshape (k-edC , [ numPixelsY numPixelsX ]) ;
228
229 %-Display
230 %Euc, dean
computed distribution
iap of comipound A. in
231 f23 = figure ; imagesc (k-edA ,[0
) ; colorbar;
estiniates images
Mixture image
1]) ; axis image ; colormaj) (cmap-A
232 title ( Euclidean Concentration Map of Compound A')
233 (%EuEclidean map of compound 13 in ixture image
234 f33 = figur e ;images (k-edB ,[0
) ; colorbar ;
1]) ; axis image ; col ormap (cmapB
206
B-ref.S
217
218
220
221
222
223 end
224
11
title ( Euclidean Concentration
%/Enclidean ma)p of comnpound 13 I
f43 = figure ; imagese (kedC , [0
) ; colorbar
title ( Euclidean Concentration
235
236
237
238
239
240
241
242
243
244
Map of Compound B')
I] N i xt ure iinage
1]) ; axis image; colormap (cmap-C
Map of Compound C' );
, if SpI)e'c if ied(
'Concentration\M.lapA-Euclidean-Tern512px. t if )
ConcentrationiMapBEuclideanTern512px. t if )
CoiientrationMapC-EuclideaniITern512px. t if )
247 4
248 ---- Cp1)t(' Malaanobis distances
249 plots-A .Zmean = mean(plotsA .Z);
250 plotsB.Zmean = mean(plots-B .Z);
251 plotsC .Zmean = mean(plotsC .Z)
252
between Z aC-r aYs
253 md-MixA
254 mdMixB
255 mdMixC
sqr t (mahal(
s qrt (mahal(
sqrt (mahal(
plots-Mix .Z
plotsMix .Z
plotsMix .Z
, plotsA .Z));
, plotsB .Z));
, plots-C .Z));
256
257 k-mdA = zeros (size (plotsA .G))
258 k-mdB = kmd_A;
259 k-mdC = kmd_A;
260
261 for p = 1:numel(k-mdA)
262 mMixA = (plots-Mix .S(p)-plotsA. Zmean(2) ) /(plotsMix.G(p
)-plotsA .Zmean(1));
207
(--Save fii gu. res
if saveFig
saveas(f23,
saveas(f33,
saveas(f43,
245 C(I d
246
263
264
265
266
267
268
269
270
271
272
273
284 m-MixC = (plotsMix.S(p)-plotsC .Zmean(2))/(plotsMix.G(p
)-plot sC .Zmean (1) );
285 bMixC = plots-C.Zmean(2) - mMixC* plots _C . Zmean (1);
286 mAB = (plotsA.Zmean(2)-plotsB.Zmean(2))/(plotsA.Zmean
(1)-plots _B .Zmean(1));
287 bAB = plots _A. Zmean (2) - mAB* plot sA. Zmean (1);
208
bMixA = plots-A.Zmean(2) - mMixA*plotsA.Zmean(1);
m_BC = (plotsB.Zmean(2)-plotsC .Zmean(2))/(plotsB.Zmean
(1)-plots_C.Zmean(1));
b_BC = plotsB.Zmean(2) - mBC*plots-B .Zmean(1);
Y_MixABC = (g) mMixA*g + bMixA - (mBC*g + bBC);
RBC.G = f z e r o (YMixABC, 0. 5);
R3C. S = YMixABC (RBC.G);
RBC.Z = [RBC.G RBC.S];
mdRBC = sqrt (mahal(RBC.Z, plotsA .Z));
k-md-A(p) = 1 - mdMixA(p)/mdRBC;
mMixB = (plots-Mix.S(p)-plotsB.Zmean(2))/(plotsMix.G(p
)-plotsB .Zmean(1));
bMixB = plotsB.Zmean(2) - mMixB* plots _B . Zmean (1);
m_AC = (plotsA.Zmean(2)-plotsC . Zmean(2) ) /(plotsA.Zmean
(1)-plotsC .Zmean(1));
bAC = plots -A. Zmean(2) - mAC* plots _A. Zmean(1);
Y_MixBAC = @(g) mMixB*g + bMixB - (mAC*g + bAC);
RAC.G = f z e r o (Y-MixB-AC, 0. 5);
RAC. S = YMixBAC (RAC.G);
RAC.Z = [RAC.G RAC.S];
mdRAC = sqrt(mahal(RAC.Z,plotsB.Z));
k-mdB (p) = 1 - mdMixB (p) /mdR-AC;
274
275
276
277
278
279
280
281
282
283
288 YMixCAB = L(g) m-MixC*g + b-MixC - (mAB*g + bAB);
289 RAB.G =f z e r o (YMixCAB, 0. 5)
290 RAB. S Y-MixCAB(R-AB.G);
291 RAB.Z= [RAB.G RAB.S];
292 mdRAB = sqrt (mahal(RAB.Z, plotsC .Z));
293 k-mdC(p) = 1 - mdMixC(p)/md-RAB;
294 (d.
295 (/
296 k-mdA = reshape (k-mdA, [numPixelsY numPixelsX ])
297 k-md-B = reshape (kmdB , [numPixelsY numPixelsX])
298 k-mdC = reshape (k-mdC , [numPixelsY numPixelsX])
299
300 Dispi.1V coIIlpited( (list ribut 1 011 CS t iiia tes IIiagi S
301 %Mah alan ois 8ip of compound A in M ixture image
302 f2 2 = fig ure ; imagese (kmd-A, [0 1) ;axis image ; colormap (cmap-A
) ; colorlbar;
303 title ( Mahalanobis Concentration Map of Compound A.)
304( %Mh1anob is map of colpound B 1in Nixture image
305 f32 = fig ur e ; imagesc (k-mdB , [0 1]) ; axis image ; colormap (cmapB
) ; C olorb ar ;
306 title ( 'Mahalanobis Concentration Mal) of Compound B');
307 %Nkahalanobis map of compound B in Mixtlure inage
308 fN2 = figure ; imagesc (k-mdC , [0 1]) ; axis image; colornap (cmapC
) ; colorbar ;
309 title Malialanobis Concentration Map of Compound C')
310
311 % avc figurs CS if Specified
312 if saveFig
313 saveas (f22 , ConcentrationMapAMahalobisTerl512px . t if )
209
314 saveas ( f32 , ConeentrationMapBlMahalauobis_ Tern 512px t if )
315 saveas ( f42 , CoIcen tr a ion.M apC Ma haanobi s Aern5 1.2 x. t if )
316 C11(1
317
318 j/
319 CEOluii-WI se means of compound A in i\IiXtiu re irnage
320 f51 = figure
321 plot (1: numPixelsX , yyl, k LineWidth ,1.5); hold on;
322 p 10 t (1: numPixelsX , mean (k-mdA ) , ' LineWidth , 3)
323 plot (1: numPixelsX , mean (ked-A ) , : ' LineWidth , 3)
324 xlabel ('Colimn Index ');
32.5 vlabel (Relative Concentration')
326 Xlim ([1 numPixelsX ]);
327 ylim([-0.1 1.1])
328 t i t le ( Column-wise Means of Compound A Con tribtioin );
329 legend ( 'Siimula tion ,'Mahalanobis ' Euclidean Location
NorthEast )
330
331 KColinin-WiS means of compound . in N ixture image
332 f52 = figure;
333 plot (1: numPixelsX , yy2, k ' , LineWidth ',1.5); hold on;
334 Plot (1: numPixelsX ,mean (k-mdB ) , r : ' LineWidth' ,3) ;
33 Plot (1: numPixelsX , mean (k-edB) , 'b: , ' LineWidth ' ,3) ;
336 Xlabel ( 'Column Index )
337 Vlabel( Relative Concentration )
338 xlim ([1 numPixelsX ]);
339 ylimU-0.1 1. 1
340 tit le ('Coluin-wise Means of Compound B Cointribution )
210
341 legend ( 'Siniul atio1
NorthEast *) ;
'Malialanobis E uclideai L o a 1
342
343 NColumh-wise
344 f53 = figure;
iN NIixt ine I11l8g(
345p lot (1: numPixelsX , yy3 , k , 'LineWidth ', 1.5) hold on;
346 plot (1: numPixelsX , mean (k-mdC) , r :' , Line\Width ' ,3) ;
347 plot (1: numPixelsX , mean(ked-C ) , : ' , 'LineWidth, ,3) ;
348 Xl a b e 1 ( ' Column IndeX );
349 y abel ( elat i ve ConCenit rat ion )
350 xlim ([1 numPixelsX])
351 ylim ([-0.1 1.1]) ;
352 t it 1 e ('ColumnI-wise
353 legend (' Simulation
MNeains of Cmpound C
Miahlalanobis
C)o1ntribution );
'Euclidean Locati () n
NorthEast )
354
355 %---S ave fi I 1 1 es . if specified
356 if saveFig
saveas (f51 , ColumnWiseMeansA-Tern5i2px .
saveas (f52 , 'ColumnuWiseMeans-BIern5i2px .
saveas (f53 , 'ColiuniWiseMeans 
_C-Tern5i2px V.t i f
360 (1(
361
362 -S aLVC workspace
363 if saveFiles
364 d = datetime;
save ( [ Simulcat ion _ . ..
nunm2str (d.Year , *%04.4u )
nuimn2str (d .Day, '%02.2u ')
num2styr (d . Month,
numn2str (d . Hour , '%02.2u
211
357
358
359
tif *);
tif *)
365
366
367
'%02.2u ')
- cation
LIan s .)I. Cpo un 1- 3
it' specified
368 num2str (d. Minute , '%02.2u )
369 e 11d
370
371 %-D oispla t(dtal S ai)sd si11ulati 101
i. at ] , -v73 )
tiIe
372 elapsedTime = toe ;
Total simlhliationi
numn2str( floor (elapsedTime/3600) , '%02.2u)
nuin2str (rem( floor ( elapsedTime /60) ,60) , '%02.2u )
1um2str (rem(round (elapsedTime ) ,60) 02.2u)
\n saveFiles
\ Sisa veFig
= 'num2str(savcFiles)
iun2str(saveFig) ...
r9 n )
A.3 MATLAB Functions for Phasor Analysis
A.3.1 Loading Default Simulated Image Parameters
i function imageParameters = default-imageParameters (tau)
2 % defCAlult t, r <a c ( l a rm e I I t e rs d efault (ec a'y tra ce
SimUlatio paralie(ers
3 % DEFAULT[TACEPAPAMEPERS()
4 %C
fi uoreS cenice decav
tr (a c. pa 'r ame1 Ct ('rs
gen erates
given the specified
a set of deflalt
liumber of
filO(reSc enc e specieS
5 % (1mExp)oIl tials )
no life t i s c s a.r( specified .. use defaiult value of 2
if isempty (tau)
imageParameters. tau
374
375
376
377
378
If
US
8
9 = 2E-9;
212
373 fp1)rin1.t f ( [ '\n 1 t iim e:
3
10 %--ther-wise .use lif etiies specified by user
11 elseif isnumeric(tau)
12 imageParameters .tau = tau;
13 'k -ClleCk. for error iii in plit
14 else
error ( ERROR,: Input must be empty or numeric
scalar or array.)
15
16
17
ei. (I
18 c--- R c Sape i et i Ill air lv Io row V cc to 1
19 imageParameters. tau = reshape (imageParameters. tau ,...
20 [1 numel(imageParameters. tau) ]) ;
21 %X--DefaUlt tinceirtaInty on life ct im i alc: t 0 ns
22 imageParameters. tau-sigma = zeros (size (imageParameter
tau))
23 :-Defalt nunher of teniporal biins 256
24 imageParameters .numTimeBins = 256;
25 %--Dfauht laser repetition frequency :80 MHz
26 imageParameters. freqO = 80E6;
27 'k--BOolelil valtie Specifying Wllet il( a plWt o detectio
evenit exceeding
28 0/c 111. 1 ase r repe t iii or period s1ot.il1(1 l)e wrappe( to th1e
next cycle or
29 rodra wil froni tH P oisso1iai 1 di 1 i nit i oil
30 imageParameters .wrapLongEvents 1;
31 %/--Bo(lea~n value specify ing. whether progress text sho
l)b( (is)laed
32 imageParameters. display = 0;
33
34 r/s---Loa ( 'e If e 1Ce iil r1in t icSp ise hiit io n (1 F) file
213
s.
1I
U11d
S load ( 'IRFtOAUC1.mat , IRF , IRFN')
36 ---iRt 1id IRFN are tlie ra1,w plhoton1 counts
inst1llmieiint response
(XfIl 11.( t i. o II as well 41 tIie .lIll)er ()i [) i() t O.S ii thle IRF trace
imageParameters.IRF = IRF;
imageP arameters . IRFN = IRFN;
40 -- Create 1) 1
imageParameters .t = (1/(imageParameters. freqO*
imageParameters. numTimeBins) ) * ...
(0: imageParameters. numTimeBins-1);
43 i- i I i .Iliz e d(i s t r i) ut i 0 11's W\it 111d without
IBF
imageParameters.prob = zeros (length (imageParameters. tau)
imageParameters . numTimeBins);
imageParameters. probIRF = imageParameters .prob;
47 ('11d
A.3.2 Simulating a Decay Image
1 function decayImage = simulateDecaylmage (...
2 photonCountImageSignal , photonCountImageNoise ,
imageParameters)
3 (,s1 iii uate DeCaIlm age Generate f 1luo i. c nc c c
FLIN) iiage
% SIM [LATEDIE)C AYIMAGE()
give t.i he nuiiiber
ge ne rCa t es a fli ores cice
5 % of timte bins (1num imeBiins)
f r ( l CI I (; Y
the laser repctition
i Ii z ( fIeq0
6 %) 1 ,iIaly 76 MHz or 80 Niiz for mnost nitrafaSt
so 11rCs ) ,
37
38
39
of t htie
41
42
44
45
46
decay (
dec ay t race
t II e
a ser
214
35
temN11)o r al row Nrector
p)r ob1 ab iIi ty
a, simula11"ted
lifetine ( tauTheore cal i 
numil ber o f photos011
8 C ( in1 t ie f r C e ( e il 1 () l J . h t st 11 e l1 aIrl I i C
Il]un1) rof tfl (A
9 ( plIsor tr8nsfOiril ( harin()niNumbi er) . and a flag to
(eterInine Wxhether or
10 C I t e v e ItS thlat OC Ci W it ha *1*l i'i V.al 1i.lic exceeding
1 i s C r
1 C re p e t it 0 p erio d a8.1 Wrapped into the subsequenit
p.) cr i 0d
12 (X4 ( wrIa)pLOgEven ts )
13
14 % The fu ict h it Outpults phasor cO 0 r din at c s
inu)Ut d (.1c
as Well
ass i 1111
as a Cst ilnlate Of the fluoresCence
8 single
IIod ei ( i . e. t a u E x 1) er i ine iit A 1
17 % S( harmoniN CNumuber*2* pi * freq0*C))
18 (
19 Assuiptions
20 C > cial) should
S etc . )
21 % > numi~iSpec'(ies
1e ,. mlJatlab So (..11-1 a.rm (e.g. parula , jet
must be (ither 1 or 2
22 C
23 C D e f ault v alues :
24 %4 > nuimTiimeBis = 256
25 % > freqO
26 X > numnPhotons = 5000*o11(s(1, length ( talTheoret ical ) )
27 % > harmonCNumler
28 C > wrxapLongEve1lts
1
215
t lhe
15 (A:(
trace .
(G.,S)
16 % eX)Oileliti i
()f tle
Ii f e.i IIe
hot
7 % thI-Ior et ic al n secon()ids . the
d et cc tio ,)1
= 80E6
29
30
31
numPixelsY
numPixelsX
= s i z e (photonCountlmageSignal ,1) ;
= s iz e (photonCountlmageSignal ,2) ;
en d(
- If iimage paramCtcrs arn1 speCified .use (lCtaU its
if isempty (imageParameters)
imageParameters = default imageParameters ([])
else if isnumeric (imageParameters)
tau = imageParameters;
clear imageParameters;
imageParameters = default imageP arameters (tau);
clear tau
eIseif ~isstruct (imageParameters)
error ERROR: 'inageParameters should be struct
or numeric Ii fet i me value. ');
49 end
50
%-Check Vthat lifetime is defined
i f ~ s f i eld (imageParameters , 'tau )
error ( [ ' ERROR: Attempted to simulate decay (FLIM)
image' . . .
216
% -Ch ck for c n i i st c v in imjage dielnsions
if size (photonCountImageSignal ,1) ~= size (
photonCountlmageNoise , 1) 11 ...
size (photonCountlmageSignal ,2) ~= size (
photonCountlmageNoise ,2)
error ( ERROR: Signal and noise images size
mismnatch .)
e ls e
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
51
52
53
1,
with undefined f Lu orn e e C e
I1l1I1her ) f 11o 1e S cl]I ti
lifetim e . 1 ) ;
Spe C Ci e S
numExponentials = length (imageParameters. tau) ;
59
60 St de fault values ia fIlnSpeCified
if ~ is field (imageParameters , *tau-sigiia )
imageParameters. tau-sigma =
enld
i f ~ i s f i e l d (imageParameters ,
imageParameters. numTimeBins =
zeros (1, numExponentials) ;
66 end
67 i f ~ is field (imageParameters , freq O)
68 imageParameters. freqO = 80E6;
69 e 1.1 (1
i f ~ is fie l d (imageParameters , wrapLongEvents *)
imageParameters. wrapLongEvents =
72 clI(1
73
IaSer rSe e)ttio 
75 T = 1/imageParameters. freqO
76
consiste lIC in numi ber of flulores c e nt
i f s i z e (photonCountlmageSignal ,3) ~= numExponentials
length (imageParameters. tau-sigma)
numExponentials
ERROR1: Inputs for lifetiie
counts Per fluorophore
217
54
55
56
(elid
57 - )I11t
58
61
62
63
64
65 256;
70
71
74
1;
77
78
79
s .) c c i c S
80 error ([
numiriimefins )
%-D)e f in e p.)(erIod
%-Check for
anld phlotonl
are misiatCled .] )
d(Cca I J.R s i UC t it r c
decaylmage (numPixelsY , numPixelsX) .N
for m = 1: numPixelsY
f c r n = 1: numPixelsX
W--Cei1eraite a roW
1];
vector coni tai 1ifl1 all arrival
t im e s for e a ch photo .
decaylmage (m, n) .N = sum( photonCountImageSignal (m,
n,:)) +
photonCountlmageNoise (m, n);
for p = 1: length (imageParameters. tau)
tau = imageParameters. tau (p) +
imageParameters. tau-sigma (p) *randn;
imageParameters. prob (p,:) = (1/tau)*exp (...
-imageParameters. t /tau)
prob-IRF = conv(imageParameters.prob(p,:)
imageParameters . IRF) ;
imageParameters .probIRF (p,:) =
probIRF (1: imageParameters .numTimeBins);
end
R = zeros (1 , decayImage (m, n) .N)
R_IRF = R;
R(1: photonCountImageSignal (m, n, 1)) = datasample
imageParameters . t , photonCountlImageSignal (m, n
,1 ) ,...
218
81
82
83
el( d
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
84 %- I i1.a1iZ e
106
107
error ( EMORI-: Non-wra)ped
functioality Yet )
w hile sI ze (R(A,) 2) >
k fi(1 (1>T) ;
f o 1
tau(t) +
r11(di) ;
eve1ts5 S (a U t a
p 1: s ize (R(>T) .2)
IA(k ( ))) - eXprud ( illage23dmfetei5
imaIgCPa.Inleters . taiisigiia (1) *
en1l
onid
if numExponentials > 1
for p = 2:numExponentials
R(sum( photonCountlImageSignal (mn, 1,1: p-1) )
(1: photonCountImageSignal (m, n, p) ) )
datasample (. ..
128 imageParameters. t
219
Weights , imageParameters . prob (1,:));
RIRF (1: photonCountImageSignal (m, n,1)) =
datasample ( ...
imageParameters . t , photonCountImageSignal (m, n
,1 ) ,...
' Weights' , imageParameters . prob-IRF (1,:));
if imageParameters .wrapLongEvents 1
R(R>T) = rem (R(R>T) ,T) ;
RIRF (R-IRF>T) = rem (RIRF (RIRF>T) ,T);
else
108
109
110
i1
112
113
114
115
116
117
118 /C
119 C
120 %/
121 ,(
122
123
124
125
126
127
photonCountlmageSignal(m,n,p) ,...
Weights , imageParameters. prob (p ,: ) ) ;
RIRF (sum (photonCountlmageSignal (m, n, 1: p
-1)) + . . .
(1: photonCountImageSignal (m, n, p))) =
datasample (...
imageParameters. t ,
photonCountImageSignal (m,n n, p) ,...
Weights' , imageParameters. probIRF (p
if imageParameters .wrapLongEvents - 1
R(R>T) = rei (R(R>T) ,T) ;
RARF (RIRF>T) = rem (RIRF (RIRF>T) ,T
else
error ( ERROR: Non-wrapped events
aren t a functionality
whlile SIZc (R(IR>T) .2)
yet . )
>)
k = find (R>T):
f o r 1 =: 1: size (R(R>T) .2)
142 %A R(k(i1)) = expriud(
im age P a m et ers . tan (m)
ta -Sigma (mu) * raidn );
end
e(I d.
+
inageP a ramet ers .
e 11d
c1ld
II ( d
if sum (photonCountImageNoise (:) )
220
129
130
131
132
133
134
135
136
137
138
139
140
141
%A
%Ac
143 (.
(A
Wj
144
145
146
147
148
149
0
150
151
152
153
154
155
156
157
158
159 if S p C c ifi ( by user wrap 10lolg
flext, period Ot herwise
as long as ther(- are photois wi
times exceeding the laser
rel)etitio)i Perio(. replace themn
si 111111ated 1 a rival timte
(o force a sub-period arri vral t
SiIuiated (vents.
eVH .S OtO
th arrival
With a .e wlv
i.111 for all
A--G en1e(Ce t, Vlie (leCaUy trace a.(ile s ) )iPort
Vector via histograming .
[decayImage (m, n) . trace , decaylmage (m, n) . t]
histcounts (R, ...
[imageParameters. t T])
decayImage (m, n) . traceIRF = hist counts (RIRF,[
imageParameters. t T]) ;
decayImage (m, n) t = decayImage (m, n) .t (1: end-1);
isequal (decaylmage (m, n) . t , imageParameters. t
error (' ERROR: Time domain defin ition
221
traceNoise = T*rand (1, photonCountImageNoise (m
,n)) ;
R(sum( photonCountImageSignal (m, n,:) ) + ...
(1:photonCountImageNoise(m,n)))
traceNoise ;
RIRF (sum( photonCountImageSignal (m, n,:)) +
(1:photonCountImageNoise(m,n)))
traceNoise
011(d
160
161
162
163
164
165
166
167
168
169
170
mismatch .
('11d
decayImage (m, n) . freqO = imageParameters. freqO;
decayImage (m, n) .numTimeBins = imageParameters.
numTimeBins;
decaylmage (m, n) .IRF = imageParameters. IRF;
decaylmage(m,n).IRFN = imageParameters.IRF-N;
e (td
if imageParameters. display
171
172
173
174
175
176
177
178
179 fprintf ([ '\n
n u n 2 st r (M)
fprintf ( [ '\n
num2str (M)
1) ;
fprintf ( '\ii
simu1lated
Finished sini u1 a tin g row #
of ' nun2str (numPixelsY)
Finished simulating row #
of num2str (numPixelsY)
Success fl ge n (- r at e (1
FLIM data!\n');
185 end
186 C,'1d
A.3.3 Performing the Phasor Transform
I function decayPixelOut = phasorTransform(decayPixelIn ,
harmonicNumber)
2 %phasor ransform 1 r aiis for II temnpora 1 dle ay into phasoI
C, PHAS )VRTANSF ORM()
decaV trace inHto a
transforms ta I t1plolr)a f I )I e s c e n c
222
if m < numPixelsY
180
181
e I S o
182
183
184
e('ld
end
') ;
4 A pir .f pha8sor cOOrdinAtes
e' x p r u n e 11.t 8 1
5 1uo I. cS c e IIce l.i f et IIllie (tZAu
1. 0 1li a ) t Q 0 1 e1 Qe 11 I 11 ' I 1
v'elat ion taill
6 S/ (n*omnega*G) Where n is
llarmlOniiCNurlr() and
7 01li1iega iS the 8 ngular laSer
as 2*pi * freqO.
C
(/
C
A
G and S. a1(d computes 11
Experinmental) usin g the
the harmonic nu mbner (
repetitio11 [reqellv defilted
ssuml1ptiOnls:
D(cav spa11s entire int erpil1Se period ald begiris at t
0.
Default values
> freq = 80EG
> liar'll1.iNit11 er 1
16 le(icck isf freqp is specci id nOt fOice default
value
17 if isemipty (decayPixelIn)
18 decayPixelIn = simulateDecayTrace ([])
19 elseif isnumeric(decayPixelln)
20 decayPixelOut. trace = decayPixelIn;
21 decayPixelOut . traceARF = zeros ( size (decayPixelOut.
t race ) );
22 clear decaySampleIn;
23 decayPixelIn. trace = decayPixelOut. trace;
24 decayPixelIn .traceIRF = decayPixelOut . trace _RF
25 elseif ~isstruct(decayPixelln)
26 error ( 'EROR: decaySampeIn ' sould be st rict
223
8
9
10
11
12
13
14
15
or numeric
27 (11d.
28 if isempt y (harmonicNumber)
harmonicNumber = 1;
eI)(I
if ~isfield (decayPixelIn , *traee )
error ([ ERROR.: Attempted
tralnsfor I .
oil undefilled decav trace
elseif isfield (decayPixelln , 'N')
i f ~isequal (sumn(decayPixelln . trace) , decayPixelIn
.N)
isequal (sum( decayPixelln . traceIRF)
decayPixelln .N)
error ([
corn t a in
ERROR: Decay trace was not found to
sp eci fi c'(I nurlber of plo1tons
~1) ;
end
if ~isfield (decayPixelln , 'freq( ')
decayPixelln. freqO = 80E6;
end
if ~isfield (decayPixelln , 't ')
decayPixelln .t = 0:1/( decayPixelln. freqO *256) :255/(
decayPixelln . freqO *256)
end
if decayPixelln. freqO
decayPixelln . t (2) )
~= 1/( decayPixelIn 
. t (end)+
224
29
30
31
32
33
34
35
36
37
38
39
40 end
41
42
43
44
45
46
47
48
49
1r r ay .v
t o 1)e r form" phtias or
50 error (' ERROR: Laser repetition frequency does not.
iatch time bill edges . ') ;
51 elseif length (decayPixelln .trace) length (decayPixelln.
t)
52 error ( ERROR: Decay trace and time vector size
niisinatcl );
53 elld
54
55 %--Define (1 Zig i l s r r ep it iti 11 frequency
56 omega=2*pi*decayPixelln. freqO;
57 decayPixelOut = decayPixelln;
58
59 G--Coiite  and S viia t rapczoidal numcrical integration
60 decayPixelOut.G-ref = trapz(decayPixelln.IRF * ...
61 Cos(omega * harmonicNumber * decayPixelln.t)) / ...
62 trapz (decayPixelln. IRF) ;
63 decayPixelOut. S-ref = trapz(decayPixelln.IRF 
.* ...
64 sin (omega * harmonicNumber * decayPixelln .t)) / ...
65 trapz (decayPixelln . IRF) ;
66 decayPixelOut. G2_ref = trapz (decayPixelIn .IRF * ...
67 cos(omega * 2*harmonicNumber * decayPixelln.t)) / ...
68 trapz ( decayPixelIn . IRF) ;
69 decayPixelOut. S2-ref = trapz (decayPixelln.IRF 
.*
70 sin (omega * 2*harmonicNumber * decayPixelln. t)) / ...
71 trapz (decayPixelIn. IRF);
72 m0-ref = decayPixelOut. G-ref - 4*decayPixelOut. G2_ref;
73 mlref decayPixelOut. Sref - 2*decayPixelOut. S2_ref;
74 m2_ref = -decayPixelOut . G-ref + decayPixelOut. G2_ref;
75 m3_ref = -decayPixelOut . Sref + 0.5* decayPixelOut . S2_ref;
76 delta-ref m2ref*m0_ref - ml-reV2;
225
77
78
79
80
81
226
thetalref = (m3-ref*mOref - m2_ref*mlref)/delta-ref;
theta2_ref = (m3-ref*mlref - m2_ref^2)/delta-ref ;
al-ref = (thetal-ref - sqrt(thetalref^2 - 4*theta2_ref))
/2;
a2_ref = (thetal-ref + sqrt (thetal-ref^2 - 4*theta2_ref))
/2;
f2_ref = (decayPixelOut. G-ref - (1+(harmonicNumber*alref
^2)^-(-l)) / ...
((1+(harmonicNumber*a2._ ref) ^2) ^(-1) - (1+(
harmonicNumber * a 1 _ r e f 2) ^(-1));
if f2_ref < 0
f2_ref = 0;
elseif f2-ref > 1
f2-ref = 1;
en1ld
flref = 1-f2 _ ref
decayPixelOut.biexp.tau-ref = [al-ref a2_ref]/omega;
decayPixelOut.biexp.f .ref = [fl-ref f2_ref];
decayPixelOut .G= trapz (decayPixelIn. trace .* ...
cos (omega * harmonicNumber * decayPixelln . t)) / ...
trapz ( decayPixelln. trace ) ;
decayPixelOut . S = trapz (decayPixelln. trace .* ...
sin (omega * harmonicNumber * decayPixelIn.t)) / ...
trapz (decayPixelln. trace);
decayPixelOut. G2 = trapz (decayPixelIn. trace .* ...
cos (omega * 2*harmonicNumber * decayPixelIn . t)) / ...
trapz ( decayPixelIn. trace ) ;
decayPixelOut . S2 = trapz ( decayPixelIn . tr ace .* ...
sin (omega * 2*harmonicNumber * decayPixelln . t)) /
trapz ( decayPixelIn. trace ) ;
82
83
84
85
El
103 mO = harmonicNumber^2*decayPixelOut .G - (2*harmonicNumber
) ^2*decayPixelOut .G2;
104 ml = harmonicNumber*decayPixelOut .S - (2*harmonicNumber)*
decayPixelOut. S2;
105 m2 = -decayPixelOut .G + decayPixelOut .G2;
106 m3 = -decayPixelOut . S/harmonicNumber + decayPixelOut . S2
/(2* harmonicNumber);
107 delta = m2*mO - m1^2;
108 thetal = (m3*mO - m2*ml)/delta;
109 theta2 = (m3*ml - m2^2)/delta;
110 al = (thetal - sqrt(theta1^2 4*theta2))/2;
ill a2 = (thetal + sqit(theta1^2 - 4*theta2))/2;
112 f2 = (decayPixelOut .G - (1+(harmonicNumber*al)^2)^(-1))
113 ((l+(harmonicNumber*a2) ^2) ^(-1) - (1+(harmonicNumber*
al)^2)^(-1)) ;
114 if f2 < 0
11 f2 = 0;
116 elseif f2 > 1
117 f2 = 1;
118 e d
119 fi = 1-f2;
120 decayPixelOut. biexp. tau = [al a2]/omega;
121 decayPixelOut.biexp. f = [fi f2];
122 decayPixelOut.GIRF = tr apz(decayPixelIn.trace-IRF .*
123 cos (omega * harmonicNumber * decayPixelln . t)) / ...
124 tralpz ( decayPixelln . traceIRF ) ;
125 decayPixelOut .S-IRF = trapz(decayPixelln.trace-IRF .F*
126 sin (omega * harmonicNumber * decayPixelln.t)) / ...
127 trapz (decayPixelln. traceIRF);
227
128 decayPixelOut.G2-IRF = trapz(decayPixelln. traceIRF
cOs (omega * 2*harmonicNumber * decayPixelIn . t) )
trapz (decayPixelln. traceIRF ) ;
decayPixelOut. S2_IRF = trapz (decayPixelln. traceIRF
sin (omega * 2*harmonicNumber * decayPixelln . t))
/
/
133 trapz ( decayPixelln. traceIRF ) ;
134 mOIRF = decayPixelOut.GIRF - 4*decayPixelOut.G2_IRF;
135 ml-IRF = decayPixelOut. SIRF - 2* decayPixelOut 
. S2IRF;
136 m2_IRF = -decayPixelOut 
.G-IRF + decayPixelOut.G2-IRF;
m3_IRF = -decayPixelOut . SARF + 0.5* decayPixelOut . S2_IRF;
deltaIRF m2_IRF*mO-IRF - m1_IRF^2;
thetalIRF = (m3-IRF*mOIRF - m2_IRF*m1IRF)/deltaIRF;
theta2_IRF = (m3_IRF*m1_IRF
alIRF = (thetal-IRF -
- m2_IRF^2)/deltaIRF;
sqrt (thetalIRF^2 - 4*theta2-IRF))
/2;
a2-IRF = (thetalIRF + sqrt(thetalIRF^2 - 4*theta2_IRF))
/2;
f2_IRF = (decayPixelOut . GIRF - (1+(harmonicNumber*a1_IRF
)^2) ^(-1)) /...
((1+(harmonicNumber*a2IRF) "2) ^(-1)
harmonicNumber*alIRF) ^2) ^(-1));
f2_IRF < 0
f2-IRF = 0;
eif f2-IRF > 1
- (1+(
f2_RF = 1;
('11d
flIRF = 1-f2_IRF;
decayPixelOut . biexp . tau-IRF = [alIRF a2-IRF]/omega;
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129
130
131
132
137
138
139
140
141
142
143
144
if
els
145
146
147
148
149
150
151
152 decayPixelOut. biexp. fIRF =
iiip~ate ex erill riI a. fl I s cr( c eYce life t i1e
decayPixelOut .N = sum(decayPixelOut 
. trace)
if isfield (decayPixeln , 'N')
if decayPixelOut.N ~= decayPixelln .N
153
154
155
156
157
158
159
160
161
162
163
164
lislIatch.
e(n d
ei (I
decayPixelOut . freqO = decayPixelIn . freqO;
decayPixelOut . t = decayPixelln. t ;
decayPixelOut. harmonicNumber = harmonicNumber;
decayPixelOut. phiref = atan (decayPixelOut. Sref /
decayPixelOut. G-ref) ;
decayPixelOut. m-ref = sqrt (decayPixelOut . G-ref^2 +
decayPixelOut . Sref ^2) ;
decayPixelOut. phi2-ref = atan (decayPixelOut . S2_ref /
decayPixelOut. G2_ref) ;
decayPixelOut. m2_ref = sqrt (decayPixelOut. G2-ref^2 +
decayPixelOut. S2_ref ^2) ;
decayPixelOut. phi = atan (decayPixelOut . S / decayPixelOut .
decayPixelOut .m = sqrt (decayPixelOut .G^2 + decayPixelOut .
S^2) ;
decayPixelOut. phi2 = atan (decayPixelOut . S2
decayPixelOut .G2) ;
decayPixelOut .m2 = sqrt (decayPixelOut .G2^2
decayPixelOut. S2 ^2) ;
/
+
decayPixelOut . phiIRF = atan ( decayPixelOut . SIRF
decayPixelOut. GRF) ;
/
229
error (' ERROR: PhotoH COunlting
165
166
167
168
169
170
171
172
[ fl-IRF f2-IRF ] ;
decayPixelOut .mIRF = sqrt (decayPixelOut .GIRF^2 +
decayPixelOut. S-IRF ^2) ;
decayPixelOut .phi2_IRF = atan (decayPixelOut .S2IRF /
decayPixelOut. G2_IRF) ;
decayPixelOut .m2_IRF = sqrt (decayPixelOut .G2_IRF2 +
decayPixelOut. S2_IRF ^2) ;
decayPixelOut. phi _corr = decayPixelOut .phiIRF -
decayPixelOut. phi-ref;
decayPixelOut. mcorr = decayPixelOut .m-IRF/decayPixelOut.
m-ref;
decayPixelOut . tauP-ref = (1 /(omega*harmonicNumber) )
tai (decayPixelOut. phiref ) ;
decayPixelOut . tauM-ref = (1 /(omega*harmonicNumber) )
abs(sqrt (1/decayPixelOut . mref^2 -
decayPixelOut . tauP =
*
*
1));
(1 / (omega* harmonicNumber)) *
tan (decayPixelOut . phi) ;
decayPixelOut .tauM = (1 / (omega*harmonicNumber) )
abs ( sqrt (1/ decayPixelOut .m^2 -
*
1));
decayPixel Out . tauPIRF = (1 / (omega*harmonicNumber))
tan (decayPixelOut . phiIRF) ;
decayPixelOut . tauM-IRF = (1 /(omega*harmonicNumber))
abs(sqrt(1/decayPixelOut.mIRF^2 -
*
*
1));
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
a)s ( sqrt (1/decayPixelOut . mcorr^2 -
*
*
1));
230
173
-I
174
175
176
177
decayPixelOut . tauP-corr = (1/(omega*harmonicNumber) )
tan (decayPixelOut . phi-corr)
decayPixelOut.tauM-corr = (1/(omega*harmonicNumber))
196 decayPixelOut. phi-sigma-ref = ...
197 sqrt (1-decayPixelOut . m2-ref*cos (2* decayPixelOut.
phi ref-decayPixelOut. phi2-ref)) /...
198 (decayPixelOut . mref * sqrt (2*decayPixelIn .IRFN));
199 decayPixelOut. m-sigma-ref
200 S(lrt (1 - 2*decayPixelOut. m-ref^2 + ...
201 decayPixelOut. m2_ref*cos (2* decayPixelOut. phi-ref -
decayPixelOut . phi2-ref))/...
202 sqrt (2* decayPixelln .IRFN)
203 decayPixelOut . phi-sigma = ...
204 sqi-t (1-decayPixelOut .m2*cos (2* decayPixelOut . phi-
decayPixelOut . phi2)) /...
205 (decayPixelOut .m * sqrt (2* decayPixelOut .N))
206 decayPixelOut . m-sigma
207 s(lrt (1 - 2*decayPixelOut .m^2 + ...
208 decayPixelOut .m2*cos (2* decayPixelOut .phi-
decayPixelOut . phi2) ) / ...
209 S(r1t (2*decayPixelOut .N)
210 decayPixelOut . phi-sigmaIRF =
211 sqrt (1-decayPixelOut .m2_IRF* cos (2* decayPixelOut.
phiIRF-decayPixelOut . phi2_IRF)) / ...
212 (decayPixelOut.mIRF * sqrt(2*decayPixelOut.N));
213 decayPixelOut . m-sigmaIRF =
214 sqrt (1 - 2*decayPixelOut.mIRF^2 +.
215 decayPixelOut . m2-IRF* cos (2* decayPixelOut . phi-IRF-
decayPixelOut . phi2_IRF)) /...
216 sqrt (2*decayPixelOut .N) ;
217 decayPixelOut. phi-sigma-corr = sqrt (decayPixelOut .
phi-sigma-ref^2 + ...
218 decayPixelOut . phi-sigmaIRF ^2);
231
219 decayPixelOut. m-sigma-corr = sqrt (decayPixelOut.
m-sigma-ref^2 + ...
220 decayPixelOut . m-sigmaIRF 2);
221
222 decayPixelOut . tauP-sigma-ref decayPixelOut.
phisigmaref /(omega*harmonicNumber *...
223 ( cos (decayPixelOut. phi-ref ))^2) ;
224 decayPixelOut . tauM-sigma-ref = decayPixelOut. m-sigma-ref
/ (omega*harmonicNumber * ...
225 decayPixelOut . m-ref^2 * sqrt (1 - decayPixelOut . m-ref
^2));
226 decayPixelOut . tauP-sigma = decayPixelOut . phi-sigma /(omega
*harmonicNumber * ...
227 (cos (decayPixelOut. phi) ) ^2);
228 decayPixelOut . tauM-sigma = decayPixelOut . m-sigma/(omega*
harmonicNumber * ...
229 decayPixelOut .m^2 * sqrt (1 - decayPixelOut .m^2));
230 decayPixelOut . tauP-sigmaIRF = decayPixelOut.
phi-sigmaAIRF /(omega*harmonicNumber *...
231 (cos(decayPixelOut.phi-IRF)) ^2);
232 decayPixelOut . tauM-sigmaIRF = decayPixelOut . m-sigmaIRF
/ (omega*harmonicNumber * ...
233 decayPixelOut .mIRF^2 * sqrt (1 - decayPixelOut .mIRF
^2)) ;
234 decayPixelOut. tauP-sigma-corr = decayPixelOut.
phi-sigma-corr /(omega*harmonicNumber *...
235 ( cos (decayPixelOut. phi-corr )) ^2) ;
236 decayPixelOut . tauM-sigma-corr = decayPixelOut.
m-sigmacorr /(omega*harmonicNumber * ...
237 decayPixelOut . m-corr^2 * sqrt (1 - decayPixelOut.
232
m-corr 2) ) ;
decayPixelOut . tauP-interval-ref = decayPixelOut . tauP-ref
1.96*[-decayPixelOut . tauP-sigma-ref decayPixelOut .
tauP-sigma-ref ];
decayPixelOut. tauM-interval-ref = decayPixelOut . tauM-ref
1.96*[ - decayPixelOut . tauM-sigma-ref
tauM-sigma-ref ];
decayPixelOut. tauPinterval
1.96*[ - decayPixelOut . tauP-sigma
decayPixelOut.
= decayPixelOut . tauP +
decayPixelOut.
tauP-sigma 1;
decayPixelOut . tauM-interval = decayPixelOut .tauM + ...
1.96*[-decayPixelOut .tauM-sigma decayPixelOut.
tauM-sigma 1;
decayPixelOut . tauPintervalIRF = decayPixelOut . tauPIRF
1.96*[ - decayPixelOut . tauP-sigmaIRF decayPixelOut.
tauP-sigma-IRF ];
decayPixelOut . tauM-intervalIRF = decayPixelOut ..tauMIRF
1.96* [ - decayPixelOut . tauM-sigma-IRF decayPixelOut.
tauM-sigmaIRF ];
decayPixelOut. tauP-interval-corr = decayPixelOut .
tauP-corr + ...
1.96*[-decayPixelOut . tauP-sigma-corr decayPixelOut.
tauP-sigma-corr ];
decayPixelOut. t auM _interval corr = decayPixelOut.
tauM-corr + ...
233
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254 1.96*[-decayPixelOut .tauM-sigma-corr decayPixelOut.
tauM-sigma-corr ] ;
255 decayPixelOut. FPref = (decayPixelOut . tauPsigma-ref/
decayPixelOut . tauPref) * ...
256 sqrt (decayPixelIn .IRFN) ;
257 decayPixelOut . FMref = (decayPixelOut . tauM-sigma-ref/
decayPixelOut . tauM-ref) *...
258 SqTrt (decayPixelln .IRFN) ;
259 decayPixelOut . F-P = (decayPixelOut . tauP-sigma/
decayPixelOut . tauP) *...
260 sqrt (decayPixelOut .N)
261 decayPixelOut .FM = (decayPixelOut . tauM-sigma/
decayPixelOut .tauM) * ...
262 sqrt (decayPixelOut .N)
263 decayPixelOut . F-PIRF = (decayPixelOut . tauPsigmaIRF/
decayPixelOut . tauPIRF) *...
264 sqrt (decayPixelOut .N) ;
265 decayPixelOut . FMIRF = (decayPixelOut . tauM-sigmaIRF/
decayPixelOut .tauMIRF) *...
266 sqrt (decayPixelOut .N) ;
267 decayPixelOut . FPcorr = (decayPixelOut . tauP-sigma-corr/
decayPixelOut . tauPcorr) *...
268 sqrt (decayPixelOut .N) ;
269 decayPixelOut. F-M-corr = (decayPixelOut . tauM-sigma-corr/
decayPixelOut. tauM-corr)*...
270 s(lrt (decayPixelOut .N)
271 ('11d
A.3.4 Generating the Phasor Plot
1 funct ion varargout = phasorPlot (G, S, harmonicNumber , steps
234
freqO ,...
histogramThreshold ,cmap, drawEllipse , drawIntercepts
numSpecies)
3 %phlasor lOw P ot a pilasor 1 a. pit asor arayI Onto (GS)
Coordiinat e map.
4 PLAS RPL )T() plOts either a single phasor mr1
phaso:rs onto a
5 pliaSor plOt giveil inpJilte pasor coordinates G and S.
harmonic
6 1J4 1number ( 1arinoiiNumber ) used to compute the phasor
C001(dinates must be
7 .( specified ( ot1erwise the default vali e 1. will be assumed
The 2D
8 c histo(gra n Step Size ( Steps ) tll. laSer repetitioni
f r ! q1 cli 11eV
tle inilinii r aC t i on Of plhasmrs a given 21. bin 11must
C01tain t () e
10 C displayed 0i tite phasor p1 0t re I a t i v C to the InaXIIiuinU
cOun It
C % ( hi stogra in'I hresbol d), the o IlO'rmla ) to be used for
(isp] ayi ng
S% p lot ( emap ) a fi ag
shoul) 11d b) c
to specify whether r not ain ellipse
13 % fitted and drawn 8ar0ud th e phasor cluster
and the
14 (, iiuinber of
Specified .
15 ( Otherwise
f 1 (orosceint
they
Sl)tCieS ( 11 ln.1S1)e(itS)
( drawEllipse)
unist also be
will all be set to their default v lIsi .
either outnilts)
235
an array of
The
( frcq() ) I
bi)11
16 (
17 1 The 0i11Cti.011
tephascor
a sinlgle lifet ime i f
I 1l11 Sp CIec s I or
18 C )01 the short aTI(l long li fe t i res i f nuSpeCies 2.
19 X
20 Assunipt Ions
21 C > C-riap s1ould be a ]\latLb colormuap (e g . parll i,et ilot
.etC 
.)
22 > uIni]Species miust be either I or 2
23 C
24 % Def Ul t valuies:
25 % > harmlonieNumb~ler = I
26 % > steps 0.0025
27 freq 80E6
28 > h ist ogr ranThreshold 0.001
29 C > CH 1 jet
30 f > drawEllipse 
- 0
31 > rlllnSpeeiS I
32
33 % - I i t iatIz falgS
34 flagLongInfinite 0;
35 flagShortZero = 0;
36
37 A-Set default values if unspeCified
38 if isempt y(harmonicNumber)
39 harmonicNumber = 1;
40 (11d
41 if isempty(steps)
42 steps 
- 0.0025;
43 eOT1 
44 if isempty(freqO)
45 freqO = 80E6;
236
(i(d
i f
end
i f
e 1.1(1
if
eid((
if
en11d
i f
ed 11(1
'X---Rearrano-ge (t an (
if size(G,2) > 1 1
G = reshape (G,
S = reshape (S,
end
%- (Rimove NaN valu
G(isnan(G)) = [1;
S(isnan(S)) =
Z = [G,S];
S into cOlUlOn
size (S,2) >
numel(G) 1])
numel(S) 1)
(' s a1(1d defiine Z airay
%-Define histogora.n bill e ers and lrinlber of bills
G-bins = 0:steps:1;
S-bins = 0:steps:1;
237
isellpty (histogramThreshold)
histogramThreshold = 0.001;
isemy1)tv (cmap)
cmap = jet;
isempty (drawEllipse)
drawEllipse = 0;
isempty ( drawIntercepts)
drawIntercepts = 1;
isempty (numSpecies)
numSpecies = 1;
v c ( t or S
72
73
74
75
76
77
78
79
80
iA 1 s IIl (in o
LNumBins ,G, linear
G-NumBins = length (Gbins);
SNumBins = length (S-bins);
W S oI.' 1 . 1 ((.'. S) c (o i. (lj 111 C c \
Gi = round ( interp1(G-bins ,1: C
Si = round ( interpi ( S-bins 1: S
%-Remove binu Values O8ts1id( t
G _i = max ( mi ( G A , G-NumBins) , 1
S-i = max(min( Si , SNumBins) ,1
%-Cmt billn coinis
H = accumarray ([ Si (:) Gi (:)
he range
extrap
extra p
[1 ,Numnlins]
1 , [SNumBins GNumBins]) ;
87 Plot 2D histogram using bin counts and (GS) bin
c Ce rit c 1S
88 figure
89 imagese (G-bins , Sbins ,H)
90 %-Apply spc e i fi d'(1 Matlab1i (o ma ( lCf8 iilt :j j(t )
91 cmap-fh = str2func (cmap) ;
92 j = cmapfh(round(1/histogramThreshold))
93 W%-Force sub-threshold bin courits to appear as White
94 i f stremp (cmap, 'hot )
95 j(1,:) =0.85* ones (1 ,3);
96 else
97 j (1,:) ones(1 ,3);
98 end
99
100 -- App lV colo r18p
101 colormap ()
102 /;<.--Akdd ind lablel colorbar
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_NumBins,S, linear 1,
81
82
83
84
85
86
cb = colorbar ;
vlabel (cb, Phasor Counts )
set (gca , 'Ydir 'Normal')
hold on
%--Calenlate the eigelivectors an1d c (igelnva1Ucs
covMatrix = cov (Z, ' omitrows )
[V,D] = eig(covMatrix);
%u--Gt the index of the largest eigenvector
eigenvalueMajor = max(sum(D));
eigenvalueMinor = ini (sum(D) );
if D(1) - eigenvalueMajor
eigenvectorMajor = V(: 1) ;
else
eigenvectorMajor = V(: ,2) ;
en1d
%--Calculatc the angle b(twQco the x--axis and the la rgest
ig e 11 v e c t o r
angleMajor = atan2(eigenvectorMajor (2) , eigenvectorMajor
(1));
%-Thi s angle can be anywhere between -pi and pi this
shift, ellsures
%4 that it is between ( and 2*pi
if (angleMajor < 0)
angleMajor = angleMajor + 2*pi;
e n d
239
122
123
124
125
126
127
128
129
130 %--Omput, phasolust(1 1HCan
Z-mean = mean (Z, oinitnan' )
132
i. 111 C v 8 1133 (/o-Get th1.e 95% confidenice
134 theta = linspace (0 ,2* pi)
135 G-mean = Zmean(1);
136 S-mean Zmean (2) ;
a = sqrt (eigenvalueMajor
b sqrt ( eigenvalueMinor
* chi2inv (0.95 ,2));
* chi2inv (0.95 ,2));
iI X u(d V c(0(rdiIadtCS
*cos(theta);b*sin (theta)]';
t i o) in a tIiix
R = [ cos (angleMajor)
cos (angleMajor) ];
sin (angleMajor) ; -sin (angleMajor)
e- G otc t 
ellipseGSR
149 (--Draw t 1I e
e li ps 1 1 all Ig I ii A Iige I ap r
- ellipseGS * R;
erI.)r ellipSe
if drawEllipse
plot (ellipseGSR (: ,1)+G-mean, ellipseGSR (: ,2)+S-mean,
' LineWidth , 1);
end
154 %--UNWEIASAL CIRCLE,
155 r--Plot
156 g =0:0
157
Ni s I ' 1
FITTING.
c ir c I !
.001:1;
semicircle = sqrt (0.25 - (g -0.5) .^2) ;
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131
137
138
139
140 -11 (e 'I lii 1. S C
141 ellipseGS = [a
142
143 e--- ---- C fine roti
144
145
146
147
148
150
151
152
153
C 0 1'd in f)t-,cs
err'Vo)r e l Iip)S e
ETC.--%
plot (g, semicircle 1
axis equal tight ;
axis ([0 1 0 0. 6]);
Xlabe1( G );
I If let ji.l C, S,
majorAxis = U(g) (eigenvectorMajor (2) /eigenvectorMajor (1)
) *(g-G-mean)+S-mean;
S(iIi I r 0l ff(g) sq (0.25
intersectionMajorAxisSemicircle = A(g) sqrt (0.25 (g
-0.5).^2) -
(eigenvectorMajor (2) /eigenvectorMajor (1) ) *(g-G.mean)-
S-mean;
, maxIntersectionIndex ] = max (
intersectionMajorAxisSemicircle (g)) ;
try
G-interl = fzero (intersectionMajorAxisSemicircle ,[0 g
(maxIntersectionIndex) ]) ;
catch
warning ( 'Warning:
infinite . ');
G-interl = 0;
flagLongInfinite
Long life ti IIC computed to be
= 1;
n d
t ry
G_inter2 = fzero (intersectionMajorAxisSemicircle
maxIntersectionIndex)
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158
159
160
161
162
163
165
166 C(
167
168
169
170
171
172
173
174
175
176
177
178
179
180 catch
1I);
, iLiincWidth ,1) ;I'
164 1/(-- &1 C 111. a e
(og--0.5) . '2)
warning( IWarning:
than 0 ps . ');
Short lifetime compited to be less
G_inter2 = 1;
flagShortZero = 1;
majorAxis(G-interl);
= majorAxis (G-inter2);
189 omega = 2*1pi*freq0;
190
191 if numSpecies - I
varargout{1} = S-mean/ (harmonicNumber*omega*G-mean);
if drawIntercepts
if (Ginterl-G-mean)^2+(S-inter1-S-mean)^2 <
G _inter2-G-mean) ^2+(Sinter2-S-mean) ^2
plot ( G interi , S-interl ,...
else
'Marker I, ' , Color ,[0 0.666 0],
LineWidth ' 1, MarkerFaceColor
0.666 0]);
plot (Ginter2 , S_inter2 ,
Marker , (1 'Color , [0
(
,[0
0.666 0] ,
LineWidth , 1, iMarkerFaceColor , [0
0.666 0]);
end
end
if ~flagShortZero
242
181
end
182
183
184
185
186
187
188
S-interl
S_inter2
192
193
194
195
196
197
198
199
200
201
202
203
204
else
S int er 2 / (harmonicNumber*omega*
G-inter2); ~2< Slioit life ti In C ill Seconds
e 1S e
varargout{1} = 0;
end
if ~flagLongInfinite
varargout{2} =
G-interl);
S int er l / (harmonicNumber *omega*
.i. t(, I i 1
else
varargout{2} =
end
if drawIntercepts
p.lot ([ Ginteri
iarker , d
JIf ;
Ginter2 ] , [ S-interl
' Color 1, [0
S-inter2 ] , ..
0.666 0], LineWidth
,1, 'iMarkerFaceColor ,[0 0.666 0]) ;
219 end
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206
207
208
209
210
211
212
213
214
215
216
217
218
enU d
e 11 (1
varargout{1} =205
%/ I.onI].g ill Seconds
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